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ABSTRACT 
Damage to joints predisposes to osteoarthritis. The mechanism by which injury to 
cartilage might lead to net matrix loss and cartilage degeneration remains unknown. 
Following experimental sharp injury to porcine articular cartilage (dissection from, or 
scoring of the articular surface), our group has previously shown rapid activation of 
the 3 mitogen activated protein kinase (MAPK) pathways in cartilage. Activation of 
ERK, and probably also p38 MAPK, is due to release of fibroblast growth factor 
(FGF) from the matrix after injury. However, despite a long search, the cause of JNK 
activation following sharp injury remains unknown. I investigated the extent and 
regulation of inflammatory signalling after cartilage injury and whether it was 
sufficient to cause expression of inflammatory response genes.  
In this work, I show that a number of intracellular signalling pathways including PI3 
kinase and IκB kinase (IKK) (which leads to activation of NFκB) are activated by 
sharp injury to cartilage. The signalling following injury was sufficient to induce a 
wide range of inflammatory response mRNAs, including pro-inflammatory cytokines 
such as IL-6, COX-2 and proteinases such as MMP-1 and ADAMTS-4 in a pattern 
which was not entirely IL-1-like. Pharmacological inhibition experiments suggested 
that the production by injured cartilage of an inflammatory response gene which could 
be assayed at the protein level, activin A, was regulated by FGF-mediated pathways 
(ERK) as well as by NFκB and tyrosine kinases (src family kinases).  
Given these findings, the role of tyrosine kinases in the early response of cartilage to 
injury was explored. By phosphotyrosine immunoprecipitation and purification from 
injured cartilage lysates, FAK and its substrate paxillin were identified from silver-
stained gels by mass spectrometry. The phosphorylation of these src substrates 
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accounted for rapidly inducible bands seen on phosphotyrosine western blotting of 
injured cartilage lysates. However, no evidence of a role for src kinases in the 
regulation of MAPK/IKK signalling upon injury was found. In contrast, blockade of 
another tyrosine kinase, the FGF receptor, led to partial inhibition not only of the 
ERK pathway following sharp injury, but also the other MAPKs and IKK. Whilst 
activation of the same pathways was also seen following injury to synovium, FGF 
receptor inhibition had no effect on this signalling. This suggested that FGF may have 
a pro-inflammatory action following injury in vivo which is a particular feature of 
cartilage. 
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1.1 Background 
Osteoarthritis (OA) is a common, disabling arthropathy whose pathogenesis is not 
understood. Injuries to articular cartilage, or to a joint, such as destabilising 
ligamentous tears, predispose to OA. Understanding the molecular processes involved 
in the response of cartilage to experimental injury should give insights into cartilage 
physiology and its degeneration.  
Our laboratory has been investigating the cellular responses of porcine articular 
cartilage to injuries such as scoring its surface, or dissecting the tissue into culture 
(explantation). Such damage is simple and reproducible, and causes rapid activation 
of the mitogen-activated protein kinases (MAPK) (Gruber et al., 2004). Explantation 
of cartilage also causes some degree of degradation of the inhibitor of kappa B 
(IκBα), implying that there may be activation of nuclear factor kappa B (NFκB), and 
there is also evidence of induction of expression of interleukin (IL)-1. The pattern of 
intracellular signalling pathway activation which follows cartilage injury is very 
similar to that caused by IL-1. IL-1, as is well known, causes catabolism (breakdown) 
of the cartilage matrix, so the signalling caused by injury could have a similar effect 
and therefore lead to degeneration. This might be a direct effect, or secondary to 
production of IL-1. 
Tonia Vincent in our laboratory has shown that the activation of one of the MAPK 
pathways, the extracellularly regulated kinase (ERK), was due to the release following 
injury of fibroblast growth factor-2 (FGF-2) from the pericellular matrix (Vincent et 
al., 2002; Vincent et al., 2007). FGF-2 may be involved in gene expression in 
cartilage after injury but it would be unlikely to account for the induction of IL-1 gene 
expression observed by (Gruber et al., 2004). The mechanism of activation of the 
other MAPK pathways is unknown, as are the extent and significance of activation of 
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NFκB. Members of our laboratory have searched extensively for a soluble factor 
released from the cartilage upon injury that was capable of activating the c-jun N-
terminal kinase (JNK) MAPK pathway in cultured chondrocytes or cartilage explants, 
but none has been found (A. Didangelos, Ph.D. thesis, 2008). 
The aims of my research project were firstly to investigate whether signalling 
pathways were activated in response to cartilage injury that would lead to activation 
of NFκB. Secondly, to investigate the extent and degree of expression of 
inflammatory response genes following injury and to define pharmacologically which 
signalling pathways this depended upon. Lastly, I wished to investigate the 
mechanism by which intracellular signalling was initiated by injury. 
To introduce the work, I will describe the anatomy and physiology of articular 
cartilage and summarise knowledge of the extracellular matrix and its turnover. 
Current views of the pathogenesis of OA including the role of mechanical factors will 
be reviewed. Lastly, I will describe the intracellular signalling pathways being 
studied, and review our knowledge of the effects of injury on cartilage. 
1.2 Cartilage structure and function 
A synovial joint is comprised of two articulating surfaces, coated with hyaline 
(articular) cartilage, encased in a capsule which is lined by synovium. The synovium 
produces synovial fluid which serves as both a surface lubricant and a source of 
nutrients for the articular cartilage. It is an ultrafiltrate of plasma with additional 
components secreted by synoviocytes and chondrocytes. Articular cartilage has 
exceptional mechanical properties (Buckwalter and Mankin, 1998b). It is composed 
of a strong, resilient extracellular matrix whose major components are type II collagen 
fibres and the aggregating proteoglycan aggrecan. 75% of the matrix is comprised of 
water. Of its dry weight, 70% is collagen, 20% is proteoglycan and 10% other matrix 
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proteins (Eyre, 2002). Articular cartilage is avascular and aneural. There is only one 
cell type: the chondrocyte. 
1.2.1  The chondrocyte 
Chondrocytes are derived from the mesenchyme (Goldring et al., 2006). They are 
about 10 microns in diameter, with a large nucleus to cytoplasm ratio. The 
chondrocyte is a metabolically active cell which exists in relative hypoxia, depending 
mainly on anaerobic metabolism (Archer and Francis-West, 2003). It is uncertain 
whether or not cell division occurs in articular cartilage after an individual reaches 
skeletal maturity and in the absence of disease. In human articular cartilage, 
chondrocytes are sparsely distributed, comprising just 1% of its volume. They mostly 
exist in isolation, but sometimes in twos and threes and are surrounded by specialised 
extracellular matrix.  
1.2.2 The extracellular matrix of cartilage 
The extracellular matrix is a system of fibres and soluble polyelectrolytes in which the 
chondrocytes are embedded.  
Collagen: Collagens type II, VI, IX, X and XI are all present in articular cartilage, but 
the major structural collagen of cartilage is type II. The procollagen molecule is 
processed during secretion by the chondrocyte. The release of the C-propeptide of 
type II procollagen (CPII) is measured as a surrogate marker of new synthesis of the 
molecule (Nelson et al., 1998). The α-helical region of the type II collagen 
polypeptide has repetitive tri-peptide sequences of gly-pro-X, or gly-X-hyp, X being 
any amino acid. Because of this unique sequence, the α-helices of the collagen IIα1 
chains form a triple helix of three polypeptide chains, which then associate to form 
collagen fibrils. Bunches of collagen fibrils form fibres, which are responsible for the 
form and tensile strength of cartilage (Eyre, 2002). The fibres form arcades, which are 
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predominantly perpendicular throughout the middle zone of cartilage, but curve to lie 
horizontally across the superficial zone, forming the basic architecture of the cartilage. 
Little type II collagen is synthesised in adulthood and the matrix is potentially 
vulnerable to catabolism of this molecule by metalloproteinases (Hermansson et al., 
2004). 
Proteoglycans: 90% of the proteoglycan mass of cartilage is made up by aggrecan. 
Each aggrecan molecule consists of a protein core, with three globular domains. This 
has covalently attached to it numerous sulphated glycosaminoglycan chains (long 
unbranched chains of repeating disaccharides that contain an amino sugar) of keratan 
and chondrotin sulphates. Aggrecan molecules aggregate to a backbone of hyaluronan 
and this interaction is stabilised by link protein. Aggrecan thus forms huge aggregates 
which fill the interfibrillar space of the matrix (Roughley, 2006). The 
glycosaminoglycan chains of aggrecan repel each other and are hydrophilic. In 
cartilage they are underhydrated and exert a swelling pressure which enables the 
cartilage to resist compression. The repulsive forces of cations mean that the effective 
pore size of cartilage is low: large proteins such as albumin and smaller negatively 
charged proteins tend to be excluded from the matrix (Buckwalter and Mankin, 
1998b). Proteinases secreted by the chondrocyte are able to cleave aggrecan, leading 
to its loss from the matrix. Aggrecan is constantly synthesised in adult cartilage to 
counteract this loss. 
Decorin, biglycan, fibromodulin and lumican are small proteoglycans found in the 
matrix which have functions in its organisation and stabilisation (Roughley, 2006). 
The glycoprotein cartilage oligomeric matrix protein (COMP) is found mainly, but 
not exclusively in cartilage, and is important for binding and stabilising collagens 
(Posey and Hecht, 2008). Fibronectin is a ubiquitous extracellular matrix glycoprotein 
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also found in cartilage. It can bind integrins, collagen and heparan sulphate 
proteoglycans.  
Pericellular matrix: The region of matrix immediately surrounding the chondrocyte 
is known as the pericellular matrix. This is structurally and biochemically distinct 
from the ‘territorial’ extracellular matrix. It is abundant in perlecan (a heparan 
sulphate proteoglycan) and type VI collagen. Perlecan binds other matrix molecules 
and growth factors such as FGF-2 (Vincent and Saklatvala, 2006). Cell-matrix 
interactions are likely to allow the chondrocyte to respond to mechanical forces. 
Examples of interactions between cell surface molecules and the extracellular matrix 
include integrins binding to collagen and fibronectin, the tyrosine kinase receptor 
DDR-2 binding to collagens, and the cellular receptor CD44 binding to hyaluronan 
(Knudson and Knudson, 2004; Vogel et al., 1997; Xu et al., 2007).  
1.3 Cartilage extracellular matrix metabolism 
The chondrocytes remodel the matrix by synthesising matrix components and their 
proteinases: matrix metalloproteinases and aggrecanases.  
1.3.1 Proteinases 
Metalloproteinases (MMPs): MMPs are zinc-dependent multi-domain 
endopeptidases which are capable of degrading a wide variety of substrates including 
all extracellular matrix proteins. There are five main groups: the collagenases, 
gelatinases, stromelysins, matrilysins and the membrane-associated MT-MMPs 
(Murphy et al., 2002). MMPs are secreted as latent propeptides and activated by 
proteolytic cleavage. The type II collagen triple helix can be cleaved by MMPs-1,-8 
and -13 at a specific site three quarters along the length of the molecule, generating 
characteristic one-quarter and three-quarter fragments. The neoepitopes formed by 
this cleavage can by detected by antibodies (COL2-1/4N1 and COL2-3/4Cshort) 
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(Billinghurst et al., 1997; Hollander et al., 1994). At physiological temperature this 
cleavage causes the triple helix to unwind, rendering it susceptible to cleavage by 
gelatinases such as MMP-9, and stromelysins such as MMP-3. MT1-MMP (MMP-14) 
also displays collagenolytic activity (Mengshol et al., 2002). 
Aggrecanases: Aggrecan contains two major cleavage sites between its first two 
globular domains (the interglobular domain, or IGD). The first site between residues 
Asn341 and Phe342 is susceptible to all known MMPs. The second site between Glu373 
and Ala374 is susceptible to aggrecanases of the A Disintegrin And Metalloproteinase 
with ThomboSpondin type 1 Motif (ADAMTS) family, resulting in the C-terminal 
neoepitope NITEGE and the N-terminal neoepitope ARGSV (Nagase and Kashiwagi, 
2003). 
Western blotting of synovial fluid and cultured cartilage with antibodies to the various 
neoepitopes formed by aggrecanolysis has made it clear that the IGD ‘aggrecanase’ 
cleavage site is functionally the more important (Lohmander et al., 1993; van Meurs 
et al., 1999). There was a long search to identify the key aggrecanase in cartilage 
(Sandy et al., 1991). The multidomain ADAMTSs-1,-4,-5,-8,-9,-15,-16 and -18 can all 
cleave aggrecan at the Glu373-Ala374 bond, but of these ADAMTS-4 and ADAMTS-5 
are the most active aggrecanases under physiological conditions (Fushimi et al., 
2008). ADAMTS-5 appears to be the most efficient aggrecanase (Gendron et al., 
2007). It has also been implicated as the major aggrecanase in both in vivo and in vitro 
murine models of degeneration (Glasson et al., 2005; Stanton et al., 2005). However, 
in human cartilage, ADAMTS-4 may also be important in aggrecan degradation, 
because there has been one report that suppression of ADAMTS-4 and ADAMTS-5, 
either individually or in combination, inhibited the degradation of aggrecan in 
cytokine-stimulated human cartilage explants (Song et al., 2007). Recently, there has 
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been a report of novel aggrecanase activity which is up-regulated by retinoic acid in 
mouse cartilage deficient in ADAMTS-4 and -5. The identity and physiological 
relevance of this putative aggrecanase is unknown (Rogerson et al., 2008). 
1.3.2 Tissue inhibitors of the matrix metalloproteinases (TIMPs) 
The net amount of proteolysis in cartilage is dependent on the balance of proteinase 
and TIMP levels (Murphy et al., 2002). 4 TIMPs regulate the extent of proteolysis: 
they are synthesised by chondrocytes and are also present in other connective tissues. 
TIMP-3 inhibits ADAMTS-4 and -5. Its Ki is in the subnanomolar range (Nagase and 
Kashiwagi, 2003). IL-1-induced cleavage of the porcine aggrecanase site is blocked 
by TIMP-3 (Gendron et al., 2003). Transforming growth factor (TGF)β and oncostatin 
M both induce TIMP-3 in vitro (Li and Zafarullah, 1998).  
1.3.3 Factors regulating turnover of cartilage extracellular matrix  
Chondrocytes in vitro respond to various growth factors, cytokines and other agents, 
but the importance of these molecules in in vivo matrix metabolism is poorly 
understood (Hui et al., 2001; Nieminen et al., 2005). 
IL-1 and other catabolic factors: IL-1 is a prototypical pro-inflammatory cytokine, 
locally causing cell activation, leucocyte egress to sites of damage and tissue 
resorption (see also sections 1.4.6 and 1.5). If it enters the systemic circulation it 
causes fever and is partly responsible for the acute phase response. It causes 
chondrocytes to degrade rapidly the proteoglycan of their extracellular matrix by 
induction of aggrecanases, while collagen degradation occurs more slowly and 
depends upon MMPs (Kobayashi et al., 2005). IL-1 also inhibits the synthesis of 
proteoglycan (Bau et al., 2002; Hui et al., 2001; Vincenti and Brinckerhoff, 2002).  
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Tumour necrosis factor (TNF)α also has IL-1-like effects on cartilage, although is 
probably less potent than IL-1 (Kobayashi et al., 2005). IL-17 appears to potentiate 
the effects of IL-1 and TNFα on proteoglycan degradation, although has no effect on 
its own (Durigova et al., 2008; Van Bezooijen et al., 2002). Oncostatin M enhances 
the resorptive effects of IL-1 (Barksby et al., 2006). Vitamin A (retinoic acid) also 
causes degradation of matrix in cultured cartilage explants, either alone, or in 
combination with IL-1 (Flannery et al., 1999). However, there is little evidence to 
suggest that any of these agents are normally produced by the chondrocyte and are 
therefore relevant to physiological matrix turnover (Barksby et al., 2006; Flannery et 
al., 1999). Other factors present in human cartilage have been reported to up-regulate 
specific proteinases. Connective tissue growth factor up-regulates ADAMTS-5 
expression in synovium (Blaney Davidson et al., 2006) and galectin-3, a soluble 
lectin, weakly stimulates ADAMTS-5 in OA chondrocytes (Janelle-Montcalm et al., 
2007). 
Insulin-like growth factor-1 (IGF-1): IGF-1 is present in plasma and is a normal 
constituent of extracellular fluid. Treatment of cultured articular chondrocytes with 
IGF-1 causes increased proteoglycan synthesis, as measured by sulphate incorporation 
(Loeser et al., 2005). IGF-1 is thought to regulate proteoglycan turnover (Luyten et 
al., 1988). Although active secretion of IGF-1 by cartilage is difficult to demonstrate, 
insulin-like growth factor binding proteins are expressed by cartilage, and probably 
act to regulate the autocrine effects of IGFs on cartilage (Sun T. et al., 2008) 
Transforming growth factor β: The TGFβ superfamily includes the TGFβs, the 
bone morphogenetic proteins (BMPs) and the activins, and is involved in growth, 
differentiation and development. There are conflicting reports of the effects of TGFβ 
on cultured chondrocytes: both stimulation (Morales and Roberts, 1988) and 
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inhibition of proteoglycan synthesis have been documented (Posever et al., 1995; van 
der Kraan et al., 1992). A recent study showed that cultured bovine chondrocytes 
treated with TGFβ synthesised more glycosaminoglycan and collagen type II than 
untreated cells (Davies et al., 2008). TGFβ might also partially inhibit IL-1 induced 
aggrecan degradation (Andrews et al., 1989).  
Bone morphogenetic proteins: BMPs were first identified by their ability to induce 
new bone formation. They are important for chondrogenesis and probably in 
maintenance of cartilage. BMP-2,-4,-6 and -7 are expressed by chondrocytes. BMP-7 
(also known as osteogenic protein 1) stimulates cartilage proteoglycan synthesis in 
vitro and potentiates the anabolic effects of IGF-1 (Chubinskaya et al., 2007a; 
Chubinskaya et al., 2007b). BMP-7 may also counteract the catabolic effect of IL-1 
on human chondrocytes (Huch et al., 1997). 
Activin A: Activin A is another member of the TGFβ superfamily. It is a homodimer 
of inhibin βA chains. There are 4 different mammalian inhibin β chains. On 
heterodimerisation with inhibin α chains they form inhibins. Activins are antagonised 
by inhibins (which compete for cell surface receptors) and by a binding protein 
follistatin. Activins bind and activate activin receptors (transmembrane serine-
threonine kinases on the cell surface related to TGFβ receptors) and signal via ALK-4 
and smad 2 and 3 signalling (also activated by TGFβ).  
Activin A is an important regulator of chondrogenesis, osteogenesis and cell 
proliferation (Hubner et al., 1996). Inhibin βA knockout mice are born with severe 
craniofacial abnormalities including cleft palate and eyelid defects and die within 24 
hours of birth. There is evidence that activin A plays a role in the healing of tissues. 
For example, its over-expression increases granulation and scar tissue following 
wounding (Munz et al., 1999). Activin A is expressed by cultured chondrocytes in 
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response to a number of growth factors and pro-inflammatory cytokines including 
FGF-2, TGFβ and IL-1α (Hermansson et al., 2004). It is also produced in vivo at sites 
of inflammation (Hubner et al., 1997; Yu et al., 1998).  
Work from our laboratory identified inhibin βA by mass spectrometry in medium 
from cultured human cartilage. No other inhibin or TGFβ family members were found 
by proteomic analysis suggesting that, of this family, activin A was the major member 
expressed by mature articular cartilage (Hermansson et al., 2004). Consistent with this 
was the observation that all secreted TGFβ-like activity in cartilage cultures appeared 
to be due to activin A (Alexander et al., 2007). Activin A induced TIMP-1 in 
chondrocytes, suggesting that it might have an anti-catabolic role in cartilage 
(Hermansson et al., 2004). 
Fibroblast growth factor: FGF-2 is sequestered in the pericellular matrix of articular 
cartilage, bound to the proteoglycan perlecan (Vincent et al., 2007). FGF signalling is 
necessary for the function of the chondrocytes of the growth plate: FGF-1 and FGF-2 
are both expressed here (Jingushi et al., 1995). Achondroplasia is caused by activating 
mutations in fibroblast growth factor receptor-3. However, the role of FGFs in normal 
adult cartilage is not understood. 
FGFs are a family of at least 15 structurally related heparin-binding growth factors 
which primarily exert their effect on cells of mesenchymal and neuroectodermal 
lineage. FGF receptors (FGFRs), of which there are four, are tyrosine kinases. FGF 
binding to an FGFR causes receptor dimerisation and auto-phosphorylation on 
tyrosine residues (Ensoli, 2003). This leads to activation of a number of signalling 
pathways (see section 1.6 & Fig 1.1).  
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Figure 1.1. FGF-induced signalling in mammalian cells.
Fibroblast growth factor (FGF) binds to a transmembrane receptor causing it to 
dimerise. Adaptor proteins are recruited causing activation of the MAP kinase
(MAPK) pathways extracellularly regulated kinase (ERK) and p38 MAPK and 
src family kinases (src). The phosphoinositol (PI)3 kinase pathway and protein 
kinase C (PKC) are also activated. 
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FGFs have important roles in embryonic growth, specifically in limb and skeletal 
development. They cause cell survival, proliferation (including angiogenesis) and 
differentiation, and are implicated in haematopoiesis and tumorigenesis (Ensoli, 2003; 
Ribatti et al., 2007). 
The effects of FGF on cartilage seem complex. It appears to be important in 
maintaining chondrocyte phenotype in vitro (Murakami et al., 2000), and may 
enhance extracellular matrix formation in vivo (Cuevas et al., 1988). FGF-2 induces 
TIMP-1 in cultured chondrocytes, but also induces metalloproteinases (MMP-1 and -
3) (Vincent et al., 2002). In an in vitro model of aggrecan breakdown in cartilage 
explants, pre-incubation with exogenous FGF-2 suppresses IL-1-induced aggrecan 
neoepitope formation, suggesting that FGF is anti-catabolic in this system (Sawaji et 
al., 2008). However, another group has shown that FGF-2 inhibits in a dose-
dependent manner the anabolic effects of IGF-1 and osteogenic protein 1 on human 
articular chondrocytes (Loeser et al., 2005).  
1.3.4 Mechanotransduction 
Low levels of load-bearing appear to be necessary for maintenance of normal 
cartilage. The thickness of knee cartilage significantly reduces after one year in 
patients who are not weight-bearing because of spinal cord injury (Vanwanseele et al., 
2003). How cartilage senses and responds to mechanical stimuli is not well 
understood (Millward-Sadler et al., 1999; Vincent et al., 2004). 
Integrins: Integrins are a family of extracellular matrix receptors. At least 20 
different integrin heterodimers exist, made up of combinations of various α with β 
subunits. Chondrocytes express a number of these, and much speculation has 
surrounded whether or not they represent cartilage ‘mechanotransducers’ (Loeser, 
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2002). α1β1, α2β1 and α10β1 can all bind collagen type II and α5β1 is the chondrocyte 
fibronectin receptor. Each α and β subunit consists of a large extracellular domain, a 
transmembrane region and a cytoplasmic tail. Integrins do not have intrinsic 
signalling activity. Their cytoplasmic tails interact with the actin cytoskeleton and 
various adaptor proteins, including molecules in the focal adhesion complex 
(Millward-Sadler et al., 1999).  
Integrins cause mechanically induced stiffening responses in endothelial cells (Wang 
et al., 1993). Integrin-dependent cellular responses to mechanical stimuli (which are 
reduced in the presence of inhibitory integrin peptides) are reported in a number of 
cultured cells including cardiac myocytes and chondrocytes (Millward-Sadler et al., 
1999). The number of α5 subunits rises in response to mechanical stress applied to 
bovine cartilage explants (Lucchinetti et al., 2004). However, there is no direct 
evidence for a role for integrins in the response of intact cartilage to injury. 
Other potential mechanisms of mechanotransduction: It is possible that soluble 
factors such as growth factors transduce biomechanical signals. Even very gentle 
cyclical loading of cartilage explants causes release of FGF-2 from the cartilage and 
related intracellular signalling which is prevented by pre-incubation with an FGF 
receptor inhibitor (Vincent et al., 2004). One group has reported that applying cyclic 
tensile strain to chondrocytes causes intracellular signalling which suppresses IL-1-
induced NFkB signalling, and is presumably therefore anti-catabolic (Dossumbekova 
et al., 2007). Intracellular calcium movement can be detected in response to stretch of 
cultured chondrocytes. Blocking this may inhibit stretch-induced cellular responses 
(Guilak et al., 1999). Another suggested mediator of mechanical signals is the NMDA 
receptor (Salter et al., 2004). 
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Loading of cartilage explants: Rested cartilage explants (dissected discs of articular 
cartilage) can be exposed to various single or repeated loads using loading rigs. In 
culture, there is increased sulphate incorporation into cultured cartilage explants after 
high frequency cyclical loading. However, static or high loads seem to suppress 
proteoglycan synthesis (Larsson et al., 1991). Loading of cartilage explants appears to 
induce proteinases in cartilage. One group has shown the up-regulation of MMP-3,-13 
and ADAMTS-4 mRNA following cyclical loading, but down-regulation of MMP-1 
and ADAMTS-5 (Fitzgerald et al., 2004). However, the net loss of 
glycosaminoglycan by the cartilage explants seen in this system following injury 
appears to be due to a passive process, as it is not inhibited by cycloheximide, a 
protein synthesis inhibitor (DiMicco et al., 2004). Other groups have shown increased 
immunohistochemical staining of MMP-3 and denatured collagen type II following 
loading, suggesting increased proteinase activity (Lin et al., 2004; Tew et al., 2000).  
1.4 Osteoarthritis 
Osteoarthritis (OA) is the clinical and pathological outcome of a range of disorders 
that results in structural and functional failure of synovial joints (Nuki, 1999). 
Although osteoarthritis affects various parts of the joint, it has long been thought to 
initially and primarily affect the articular cartilage (Collins and McElligott, 1960). 
There is also a view that the primary change may be in the subchondral bone and that 
cartilage degeneration is secondary to this (Quasnichka et al., 2006). 
1.4.1 Clinical aspects of osteoarthritis 
OA is the commonest arthropathy and typically affects the knee, hip, hand, spine or 
feet. OA may be restricted to one joint or area, or be ‘generalised’. These different 
subtypes may have different risk factors and aetiologies (Buckwalter and Mankin, 
1998a; Felson et al., 2000). Nearly 5 million people in the UK are estimated to have 
Chapter 1                                                                                                                                 Introduction 
 
 34
radiological evidence of moderate to severe OA of their hands, knees or hips. It is the 
commonest cause of disability in the UK. 36 million working days are estimated to be 
lost each year due to OA, which costs £3.197 billion in lost production (Department 
for Work and Pensions: Analytical Services Division, 2000). 
OA causes pain and loss of function of affected joints. Signs include bony swelling, 
crepitus and restricted range of movement of joints, often with associated deformity. 
Raised serum C-reactive protein (CRP) and COMP may represent biomarkers for 
more rapid progression and ‘erosive’ disease (Posey and Hecht, 2008; Punzi et al., 
2005). Plain radiographs remain the gold standard for diagnosis and assessment of 
progression. Pharmacological therapy for OA is symptomatic and supportive 
(Conaghan et al., 2008). No widely accepted disease modifying OA drugs 
(DMOADs) exist. Strategies for development of new therapies broadly involve either 
boosting anabolic cartilage responses (growth factors such as FGF, modulation of 
TIMPs) or blocking catabolic molecules (MMP and aggrecanase inhibitors) (Chuma 
et al., 2004; Fosang et al., 2008; Little et al., 2007; Troeberg et al., 2008). Ultimately, 
in advanced OA, joint replacement remains the final resort. 
1.4.2 The aetiology of osteoarthritis 
Many risk factors for development of OA have been identified (Buckwalter and 
Mankin, 1998a; Felson et al., 2000). Considering all types of osteoarthritis, more 
women are affected than men, and incidence increases with age. A family history of 
OA is often present. Genome wide scanning and other approaches have identified 
candidate gene loci such as the IL-1 gene cluster, the IL-4 receptor, frizzled-related 
protein-3 and asporin (hip OA) and matrilin-3 (hand OA) (Loughlin, 2005). Such 
approaches have highlighted the problem of heterogeneity in OA populations and 
have been largely disappointing in identifying polymorphisms which confer risk to 
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large groups of patients. Other factors which are probably important include bone 
density, oestrogen deficiency and vitamin D status (Felson et al., 2000). However, 
probably the most important risk factors are mechanical – through excessive use 
(occupations in the past at high risk have included miners, cotton mill workers and 
shipyard workers) (Hunter et al., 2004), obesity and malalignment (or congenitial 
deformity of the joint) (Buckwalter and Mankin, 1998a). These are arguably all 
insidious forms of joint injury.  
Joint injury: One of the strongest predictors of OA is joint trauma. At least 10% of 
cases are post-traumatic in origin (Furman et al., 2006). Direct damage to the articular 
cartilage or indirect damage, via damage to other joint structures, predisposes to OA. 
Various joint injuries (Gelber et al., 2000), including intra-articular fracture (Furman 
et al., 2006), anterior cruciate ligament (ACL) rupture (Lohmander et al., 2004), 
meniscal damage (Sharma et al., 2008) or menisectomy (Englund and Lohmander, 
2004) are all associated with an increase in an individual’s risk of developing OA. 
Interestingly, although ACL rupture appears to be a potent risk factor in animal 
models, in humans with established OA, its effect appears to be mediated by 
concurrent meniscal pathology (Amin et al., 2008). There is also a significant 
correlation between the presence of asymptomatic partial thickness cartilage defects 
and development of knee OA (Cicuttini et al., 2005). In several studies in young 
patients without OA, around 30% of defects improve over a two year period on MRI, 
suggesting that in those individuals, a repair response is at least partially successful 
(Ding et al., 2007). Factors associated with progression to OA after trauma include 
obesity, female gender, increasing age, positive family history of OA, malalignment, 
muscle weakness, smoking, presence of osteophytes and tibial subchondral bone size 
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(Ding et al., 2007; Ding et al., 2008). The mechanisms by which injury to a joint leads 
to degeneration are unknown. 
Animal models: Certain animals, such as the male STR/ort mouse and the male 
Dunkin-Hartley guinea pig develop spontaneous osteoarthritis and so have been used 
to study the disease (Clements et al., 2003). However, as in human OA, the point of 
disease initiation is difficult to identify in these animals. The relationship between 
trauma and OA has been exploited in animal models. The Pond-Nuki model (dog 
ACL section), or medial meniscectomy in dogs, rabbits, rats or mice lead to rapidly 
progressive cartilage degeneration. A less traumatic murine model involves 
transection of the anterior attachment of the medial meniscus causing its 
displacement, with more insidious development of degenerative changes akin to 
human osteoarthritis (Glasson et al., 2005). Such models provide a useful platform for 
testing the effects of gene deletions or overexpression on the development and course 
of the disease. However, potential species differences in matrix catabolism have to be 
borne in mind. 
1.4.3 Histological changes in osteoarthritis 
The histological changes of OA are well recognised and progress through a number of 
stages (Buckwalter and Mankin, 1998a; Collins and McElligott, 1960; Meachim et al., 
1965). The earliest change is the loss of integrity of the articular cartilage surface, 
with superficial fibrillation and loss of sulphated proteoglycan (Collins and 
McElligott, 1960). Clustering of chondrocytes is associated with increased 
proteoglycan staining around chondrocytes, suggesting increased anabolic activity. 
Later, there is more generalised proteoglycan loss, with empty lacunae suggesting cell 
death. This is associated with the formation of progressively deeper clefts leading to 
full thickness cartilage defects. In addition, there is subchondral sclerosis of bone, 
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bone cysts and new bone formation. Synovitis may be present. To what extent 
changes in bone and synovium are primary or secondary events remains controversial.  
1.4.4 Molecular changes in osteoarthritis 
The molecular changes in OA are difficult to investigate and poorly understood. Most 
cartilage available from human patients with OA comes from specimens taken at joint 
replacement surgery and has advanced degenerative changes. Investigation of early or 
disease-initiating events in cartilage is therefore difficult except in animal models (see 
section 1.4.2). There is evidence that chondrocytes in osteoarthritic cartilage produce 
more type X collagen, and may revert to a ‘juvenile’ phenotype, re-expressing type 
IIA procollagen possibly in an attempt at repair (Aigner et al., 1999). There may be 
increased chondrocyte apoptosis in OA, although the reasons for this are not 
understood (Hashimoto et al., 1998). 
1.4.5 Proteinases and osteoarthritis 
Although aggrecan degradation occurs before collagen degadation in in vitro models 
of degeneration, loss of collagen may be more important, because it is not replaced. 
Changes in mRNA levels of metalloproteinases have been reported in chondrocytes 
from human osteoarthritic cartilage, although these seem to vary depending on the 
stage of disease (Aigner et al., 2003; Bau et al., 2002). MMPs-1,-3 and -13, and 
ADAMTS-4 and -5 have all been implicated in the matrix loss seen in in vitro models 
of cartilage degeneration (Bau et al., 2002; Song et al., 2007; Stanton et al., 2005; 
Vincenti and Brinckerhoff, 2002). Overexpression of constitutively active MMP-13 in 
cartilage resulted in OA-like changes, due to collagen type II and proteoglycan 
degradation (Neuhold et al., 2001). Mice null for ADAMTS-5 showed protection 
from injury-induced OA, whilst a line null for ADAMTS-4 did not (Glasson et al., 
2005). These results suggest that ADAMTS-5 is required for cartilage degeneration in 
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mice. Alternatively, cartilage developmental abnormalities in such knock-out mice 
could explain these findings. ADAMTS-4 is probably also important in human 
cartilage physiology, as discussed earlier in section 1.3.1 (Song et al., 2007). In an 
ACL section and medial menisectomy rat model with forced mobilisation, microarray 
analysis at 28 days after surgery showed up-regulation of the proteinases MMP-13 
(2.5 fold) and ADAMTS-5 (1.7 fold) (Appleton et al., 2007). The molecular events 
that might induce such proteinases in vivo, initiating the disease process remain 
unknown. 
1.4.6 Other inflammatory response genes and osteoarthritis 
The role of inflammatory cytokines in rheumatoid arthritis is well-established, but far 
less certain in OA. Ever since IL-1 was isolated and shown to induce rapid depletion 
of proteoglycan in cartilage explant cultures, this molecule has received much 
attention with respect to its potential role in OA (Saklatvala, 1987). There are two 
forms of IL-1, α and β, whose effects, including those on cartilage appear to be 
similar. IL-1 induces transcription of many metalloproteinases and aggrecanases in 
chondrocyte and cartilage explant cultures (Flannery et al., 1999; Gebauer et al., 
2005; Vincenti and Brinckerhoff, 2002). There is evidence that IL-1 is produced in 
cartilage in animal models of OA (Chambers et al., 1997; Pelletier et al., 1993). 
Although the conditional expression of IL-1β in temporomandibular joints of 
transgenic mice led to degeneration of these joints, another group found that deletion 
of IL-1β in mice caused accelerated development of OA following partial medial 
meniscectomy (Clements et al., 2003; Lai et al., 2006). The grade of osteoarthritis was 
reported in another study to be inversely proportional to the intensity of IL-1 staining 
(Towle et al., 1997). IL-1 is mainly produced by macrophages, and whether 
significant amounts are made by and released from chondrocytes has always been 
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uncertain. It is of note that although IL-1 activity can be detected in lysates of cultured 
porcine cartilage, the cytokine is intracellular and does not appear to be secreted 
(Gruber et al., 2004). An autocrine role for IL-1 in cartilage is unproven.  
TNFα is similar to IL-1 in its action on cartilage (Hui et al., 2003; Saklatvala, 1987). 
It is a pivotal cytokine in inflammatory diseases such as rheumatoid arthritis and 
psoriatic arthritis, and its blockade ameliorates the disease in a majority of patients. 
Although its mRNA is reported to be up-regulated in osteoarthritis (Amin, 1999), 
TNFα does not appear to be released by cartilage, and whether it plays any role in the 
pathogenesis of OA is also unclear. 
There have been reports of increased cyclooxygenase (COX)-2 mRNA and protein in 
OA cartilage (Amin et al., 1997). COX-2 is inducible and typically rapidly up-
regulated at sites of inflammation, forming pro-inflammatory prostanoids by the 
conversion of arachidonic acid to prostaglandin (PG)H2. Inducible nitric oxide 
synthase (iNOS) is also overproduced by chondrocytes isolated from osteoarthritic 
cartilage (Amin et al., 1995). Induction of all of these inflammatory response genes 
depends upon inflammatory signalling. 
1.5 Inflammatory signalling pathways 
Inflammation is the response of tissues to sublethal injury, to infection or to an 
immune reaction. It is an important effector of both innate and adaptive immune 
responses (Delves and Roitt, 2000a, b). Inflammation classically causes pain, redness, 
swelling and warmth of the tissue due to vasodilatation and local mediator production. 
Blood vessels become more permeable to leucocytes which migrate to the site of 
damage or infection. The inflammatory response also initiates repair of the tissue via 
cell proliferation and the formation of granulation tissue. At the molecular level, the 
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inflammatory response can be thought of as a defined signalling and gene response 
which is particular to the cell and tissue. 
The inflammatory response is mediated by intracellular inflammatory signalling 
pathways. The core of inflammatory signalling is the three MAP kinase pathways, and 
NFκB. Following their activation, these pathways regulate inflammatory response 
gene expression of cytokines, matrix metalloproteinases, chemokines, adhesion 
molecules and mediator generating enzymes (e.g. COX-2 and iNOS). This gene 
regulation is via direct activation of transcription by the pathways and via stabilisation 
of mRNAs by post-transcriptional regulation (Fig 1.2)(Kracht and Saklatvala, 2002). 
Inflammatory signalling also has effects on processes as diverse as differentiation and 
apoptosis. In excess of 100 inflammatory response genes exist, and their control is 
elaborate, depending on stimulus and cell type.  
Inflammatory signalling pathways are typically activated by pro-inflammatory 
cytokines such as IL-1 and TNFα, or by microbial products such as 
lipopolysaccharide (LPS) (Kracht and Saklatvala, 2002). The mechanism by which 
sterile tissue injury activates inflammatory signalling is obscure. There is evidence 
that these pathways may be activated by endogenous ligands via Toll-like receptors 
(TLRs). For example, TLR-4 (the LPS recognition receptor) can be activated by heat 
shock proteins 60 and 70, and fragments of hyaluronic acid or fibronectin (Termeer et 
al., 2002; Tsan and Gao, 2004). Any of these substances might be released or 
generated upon tissue injury, or cell death. Supernatants of necrotic cells have been 
shown to activate dendritic cells in a similar manner to LPS, and therefore probably 
via the inflammatory signalling pathways (Matzinger, 2002). Her ‘danger model’ 
suggests that an alarm signal from distressed or injured cells is needed to activate 
antigen presenting cells and generate an immune response.  
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Figure 1.2. Inflammatory signalling in mammalian cells. 
Pro-inflammatory cytokines such as interleukin-1 (IL-1), tumour necrosis 
factor (TNF)α or bacterial lipopolysaccharide (LPS) signal via cell surface 
receptors causing activation of mitogen activated protein kinase kinase
kinases (MKKKs),  which in turn phosphorylate mitogen activated protein 
kinase kinases (MKKs). Specific MKKs are responsible for the activation of 
the MAP kinases (MAPKs) p38 MAP kinase, extracellularly regulated 
kinase (ERK) and c-jun N terminal kinase (JNK). The MAPKs and nuclear 
factor kappa B (NFκB) regulate inflammatory response gene transcription.
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1.5.1 The MAP kinases 
The MAPKs are defined by their TXY motifs which require dual phosphorylation for 
activation. There are three types: ERK, JNK and p38 MAPK. There are two closely 
related genes coding for ERKs 1 and 2 (p44 and p42), there are three JNK genes 
expressed as two predominant forms, p46 and p54, which arise from alternative 
splicing, and there are four genes (α,β,γ and δ) for p38 MAPK (Kracht and Saklatvala, 
2002). All three types of MAPK are generally strongly activated by inflammatory 
cytokines or LPS (see Fig 1.2). The ERK pathway is also strongly activated by growth 
factors including IGF-1, epidermal growth factor (EGF) and FGF (Starkman et al., 
2005; Vincent et al., 2002). JNK and p38 MAPK may also be activated by cellular 
stresses such as hyperosmolarity, UV light and protein synthesis inhibitors, although 
the underlying mechanisms are poorly understood (Duzgun et al., 2000; Liu et al., 
2006; Yujiri et al., 1999). MAPKs are activated by MAPK kinases (MKKs) which in 
turn are activated by phosphorylation of serine residues by MAPK kinase kinases 
(MKKKs) (Hagemann and Blank, 2001), (see section 1.5.3 & Fig 1.2).  
Important substrates of the MAPKs include downstream protein kinases and 
transcription factors. The latter include Ets (all three MAPKs) and the activating 
protein (AP)-1 transcription factors c-jun and activating transcription factor-2 (ATF-
2)(JNK). The downstream kinases are MAPK activating protein kinase (MAPKAP-
K)-1 and -2, MAPK stimulated kinase (MSK)-1 and -2 and MAPK integrating kinase 
(MnK) (Kracht and Saklatvala, 2002). The ERK pathway has effects on mitosis and 
on inflammatory gene transcription. JNK induces and activates early response genes 
such as the AP-1 binding proteins, and may also be pro-apoptotic (Liu and Lin, 2005; 
Morton et al., 2004). p38 MAPK regulates gene transcription but is also necessary for 
the stabilisation of inflammatory response mRNAs. Substrates of the p38 MAPK 
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pathway such as tristetraprolin which bind to AU rich elements in the 3’untranslated 
region of inflammatory mRNAs mediate this control (Clark et al., 2003). The MAPKs 
are inactivated by dual specificity phosphatases (DUSPs), particularly DUSP-1, which 
is induced by inflammatory signalling and serves as an important negative feedback 
(Tanoue et al., 2000).  
1.5.2 NFκB 
NFκB is a primary controller of inflammatory response gene expression (Barnes and 
Karin, 1997). NFκB signalling is required for inflammatory and immune responses 
and is also anti-apoptotic. NFκB is typically activated by pro-inflammatory cytokines 
or microbial products: engagement of all known TLRs leads to NFκB activation 
(Bonizzi and Karin, 2004; Doyle and O'Neill, 2006). The NFκB proteins are a family 
of five homologous Rel transcription factors (RelA (p65), RelB, c-rel, p50 and p52). 
These form hetero-and homo-dimers and are sequestered in the cytoplasm as latent 
complexes via non-covalent interactions with NFκB inhibitory proteins, the inhibitors 
of κB (IκBs).  
The canonical pathway: The common form of NFκB is a heterodimer of NFκB1 
(p50) and RelA (p65). This is inactive in the cytoplasm when bound to the 
prototypical IκB, IκBα (Fig 1.3). NFκB activation is classically mediated by the 
phosphorylation of IκBα, which becomes ubiquitinated and is then degraded in the 
26S proteasome. The removal of IκBα exposes a nuclear localisation sequence on 
p50/p65 NFκB which targets it to the nucleus. Here it promotes transcription of 
inflammatory response genes by binding to NFκB binding sites within their promoters 
(Bonizzi and Karin, 2004).  
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Figure 1.3. Activation of nuclear factor kappa B (NFκB) by canonical and 
atypical pathways. 
The canonical pathway is activated by agonists such as interleukin (IL)-1 and 
tumour necrosis factor (TNF)α which stimulate IκB kinase (IKK) to phosphorylate
Inhibitor of kappa B alpha (IkBα), inducing its degradation. The atypical 
pathways involve proteolysis of p100 (the non-canonical pathway) and p105 
precursor proteins.
Abbreviations: lipopolysaccharide (LPS), lymphotoxin (LT), B cell activating factor (BAFF), 
TGFβ activating kinase (TAK), NFκB inducing kinase (NIK)
Figure reproduced  from Sun & Ley (2008), Trends in Immunology, 29 (10),  p472  
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IκB kinases: Signal-induced IκB phosphorylation is mediated by a high molecular 
weight IκB kinase (IKK) complex. This tripartite complex consists of α, β and γ 
subunits. IKKα and β (also known as IKK1 and 2) are related molecules which are 
active kinases, both capable of independently phosphorylating IκB (Zandi et al., 
1998). In contrast, IKKγ (also known as NFκB essential modulator [NEMO]) has no 
catalytic activity, but plays a key regulatory role as an adaptor and is obligatory for 
NFκB signalling (Krappmann et al., 2000). Dissociation of NEMO from the IKK 
complex using a cell permeable peptide spanning the NEMO binding domains of 
IKKα and β blocks cytokine-induced NFκB activation (May et al., 2000). Knockout 
of IKKβ is embryonically lethal because of massive liver apoptosis. This is mediated 
by TNFα, which fails to activate the anti-apoptotic mechanisms dependent upon 
NFκB (Bonizzi and Karin, 2004). The canonical pathway, which leads to activation of 
NFκB following cytokine (e.g. IL-1, TNFα), LPS or antigen-receptor engagement is 
considered to be predominantly dependent on IKKβ and NEMO (Li et al., 1999). 
However, a recent report suggests that the presence of IKKα and NEMO alone are 
sufficient for activation of the canonical pathway by IL-1 (Solt et al., 2007). There is 
also some evidence that activation of IKKα may contribute to suppression of NFκB 
activity by accelerating the turnover of p65 and c-Rel and their detachment from pro-
inflammatory gene promoters, thereby exerting an anti-inflammatory effect 
(Lawrence et al., 2005). 
The atypical pathways: Other pathways involving p105 (the NFκB1 precursor) and 
p100 (the NFκB2 precursor) can also lead to NFκB activation (see Fig 1.3),(Sun and 
Ley, 2008). The p100 pathway, also called the non-canonical pathway, is triggered by 
a subset of TNF receptor family members such as lymphotoxin-β receptor, CD40 and 
B cell-activating factor receptor. Upon ligation, NFκB inducing kinase (NIK) causes 
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activation of this pathway. NIK levels are usually low because it is continually 
degraded following TRAF-3-dependent ubiquitination. Ligand stimulation induces 
TRAF-3 degradation, allowing the accumulation of newly synthesised NIK and IKKα 
activation (Wallach and Kovalenko, 2008). Studies in IKK deficient cells have 
demonstrated that IKKα is the critical kinase for this pathway: it can be activated in 
the absence of both IKKβ and NEMO: (Bonizzi and Karin, 2004). IKKα 
phosphorylates p100, triggering its polyubiquitination and partial proteolysis. This 
gives rise to the p52 subunit (NFκB2) which can homodimerise, or associate with 
RelB. This dimer translocates to the nucleus and regulates several lymphoid 
chemokine genes. The major function of this pathway is the development and 
organisation of lymphoid tissues, and the maturation of B cells (Bonizzi and Karin, 
2004).  
A further ‘atypical’ pathway leading to NFκB activation involves processing of p105 
to produce p50 (NFκB1) following its phosphorylation by IKKα/β. p105 is associated 
with the MKKK Tpl-2 in the cytoplasm. Proteolysis of p105 releases Tpl-2, which 
phosphorylates and activates MKKs and subsequently MAPKs (Beinke et al., 2004). 
p50 subunits dimerise and translocate to the nucleus (Fig 1.3). 
1.5.3 Regulation of MAPKs and IKK 
MKKs are specific: MKK (MEK)1 and 2 activate ERK, MKK4 and 7 activate JNKs 
and MKK3 and 6 activate p38 MAPK. MKKKs can activate multiple signalling 
pathways simultaneously. Some have been shown to activate JNK, p38 and IKKs. 
These include MEKK1, 2 and 3, Tpl-2 (also known as Cot) and TGF-β activated 
kinase (TAK)-1 (Kracht and Saklatvala, 2002).  
How MKKKs are coupled to receptor signalling complexes in a stimulus-specific 
manner is not well understood. Most of our knowledge comes from the TLR/IL-1 
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receptor (TIR) and TNF receptor (TNFR) families (Fig 1.4). In the case of TLR/ IL-1 
signalling, the adaptor proteins are MyD88 and Mal, which bind IL-1 receptor 
associated kinases (IRAKs). Phosphorylated IRAK-1 then binds to TNF receptor 
associated family (TRAF)-6. TRAF-6 is an E3 ligase and undergoes self-
ubiquitination, recruiting TAK-1 via the ubiquitin binding domain of a TAK binding 
protein, TAB-2, in association with TAB-1. Phosphorylated activated TAK-1 
subsequently phosphorylates downstream targets including IKKs and MKKs (Doyle 
and O'Neill, 2006) (Fig 1.4).  
In TNF signalling, the TNFR associates with the TNFR-associated death domain 
protein (TRADD) which in turn recruits (TRAF)-2 and the receptor interacting protein 
(RIP)-1 kinase. TRAF-2 and polyubiquitinated RIP-1 recruit the TAK-1-TAB-2 
complex and IKK complex, resulting in phosphorylation and activation of IKK, 
leading to activation of NFκB and MAPKs (Fig 1.4) (Ea et al., 2006; Hacker and 
Karin, 2006). MEKK3 also appears to be important for TNF-induced IKK signalling 
(Blonska et al., 2005). 
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Figure 1.4. The IL-1R/TLR and TNF signalling pathways.
IL-1 or LPS bound to LPS binding protein (LBP) bind to related receptors with 
a TLR/IL-1R (TIR) intracellular domain. Liganded receptors bind the adaptor 
protein MyD88, which recruits IL-1 receptor associated kinases (IRAKs). Some 
TLRs also recruit a related adaptor Mal (not shown). Phosphorylated IRAK-1 
then binds to TNF receptor associated family (TRAF)-6 which ubiquitinates
itself. TAB-2, which is bound to TGFβ associated kinase (TAK)-1, is an 
ubiquitin-binding protein. TAK-1 thus oligermises and is activated by 
transphosphorylation. Activated TAK-1 phosphorylates and activates IKKs and 
MKKs. TNF binding to its receptor causes binding of TNFR associated via 
death domain (TRADD) to the receptor complex. This allows recruitment of 
TRAF-2 and receptor associated protein (RIP)-1 kinase. The IKK complex is 
subsequently activated following recruitment of TAK-1 and ubiquitinated
NEMO. In addition to RIP-1, MEKK3 also appears to be required for TNF-
induced IKK signalling.
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1.6 Fibroblast growth factor signalling 
As described earlier, FGF-2 is present in the chondrocyte pericellular matrix and is 
released upon cartilage injury (Vincent et al., 2002; Vincent et al., 2004). It ligates 
FGF receptors, which are receptor tyrosine kinases, and activates a number of 
signalling pathways (Fig 1.1).  
ERK: Growth factors such as FGF activate the ERK MAPK pathway. This is via 
activation of the small GTPase Ras, which recruits Raf to the cell membrane. Raf 
subsequently phosphorylates MEK-1 and -2 (also known as MKK-1 and -2), 
activating ERK. The activation of Ras is classically via the adaptor protein Grb-2 and 
the GTP exchange factor SOS interacting with the receptor tyrosine kinase (Ramos, 
2008). 
Phosphatidylinositol-3 kinase: The phosphatidylinositol (PI)-3 kinase pathway is 
also activated by growth factors such as FGF and IGF and, to a lesser extent, by 
inflammatory stimuli such as LPS and TNFα. Activation of PI3 kinase leads to 
activation of Akt and p70S6 kinase, downstream serine threonine protein kinases 
involved in cell survival and protein synthesis respectively. In chondrocytes in vitro, 
IGF-I stimulates proteoglycan synthesis via the PI3 kinase pathway (Starkman et al., 
2005). 
Protein kinase C (PKC): This is the name given to a group of lipid-dependent serine-
threonine kinases involved in cell proliferation, differentiation and apoptosis. They 
include classical (both diacylglycerol [DAG] and calcium-dependent), novel 
(calcium-dependent) and atypical (neither DAG nor calcium-dependent) enzymes. 
Growth factors such as FGF activate PKC by activating phospholipase C, which 
hydrolyses phosphoinositides in the cell membrane. In chondrocytes in vitro, 
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inhibitors of PKC were found to inhibit IL-1 induced aggrecanase transcription and 
glycosaminoglycan release in one study (LaVallie et al., 2006). 
1.6.1 Non receptor protein tyrosine kinases  
The non-receptor protein tyrosine kinases (PTKs) include the Src family kinases 
(SFKs), the Syk family, the focal adhesion kinase (FAK) family (such as Pyk2) and 
the Tec family kinases (such as Btk). FGF is reported to activate some of these 
kinases in vitro. For example, c-src appears to be necessary for FGF-induced 
proliferation of cultured fibroblasts (Kilkenny et al., 2003). FAK appears to be 
required for some FGF-induced responses in myofibroblasts (Greenberg et al., 2006).  
During the course of my work, I discovered that protein tyrosine phosphorylation was 
an early event following cartilage injury, implying activation of tyrosine kinases. 
PTKs are also implicated in the inflammatory response: following LPS stimulation of 
monocytes, tyrosine phosphorylation is an early event (Beaty et al., 1994). Over-
expression of PTKs has been implicated in oncogenesis. Tyrosine phosphorylation 
can activate or inactivate protein tyrosine kinases and autophosphorylation can also 
occur. As well as a tyrosine kinase domain, non receptor PTKs such as SFKs contain 
a src homology (SH)2 and a SH3 domain (Okutani et al., 2006). These domains are 
recruited to tyrosine-phosphorylated sites and proline-rich motifs on other molecules 
respectively. In this way, protein tyrosine kinases can induce binding and localisation 
of other signalling molecules. PTKs are tightly regulated by protein tyrosine 
phosphatases (Ostman et al., 2006).  
Src family kinases: The src family consists of nine members: c-src, fyn, yes and yrk, 
which are ubiquitous, and hck, lyn fgr, lck and blk, which are found mainly in cells of 
haematopoietic lineage (Bromann et al., 2004; Parsons and Parsons, 2004). Much is 
known about the critical role of SFKs in T cell receptor transduction. Lck and fyn are 
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the first signalling molecules to be activated downstream of the T cell receptor 
(Barber et al., 1989). Hck, lyn and fgr are activated by many inflammatory stimuli in 
monocytes and macrophages (Okutani et al., 2006). Triple mutation of src, yes and 
fyn in mouse embryonic ‘SYF’ cells has allowed some study of the roles of SFKs 
(which have been previously hampered by redundancy between family members) 
(Klinghoffer et al., 1999). In cells of mesenchymal origin such as fibroblasts, there is 
expression of c-src, yes, fyn, hck and lyn (Kilkenny et al., 2003). 
1.7 The response of articular cartilage to injury 
1.7.1 Histological changes after cartilage injury 
It was noted in the nineteenth century that damaged articular cartilage does not repair 
(Redfern, 1851). Further work throughout the twentieth century confirmed that 
following superficial injury (not breaching bone), the cartilage does not usually repair 
(Mankin, 1962). A possible exception may be in fetal, or very young animals 
(Calandruccio and Gilmer, 1962; Namba et al., 1998). Direct cartilage injuries not 
only fail to heal, but lead to degeneration. Superficial cutting or scarification of the 
articular surface in rabbit knees leads after six weeks to degeneration characterised by 
fibrillation, progressive matrix loss and clustering of chondrocytes, similar to the 
histological changes seen in human OA (Meachim, 1963). Deep injuries, involving 
bone (which is vascularised) lead to healing of defects by formation of granulation 
tissue and fibrocartilaginous repair (Key, 1931; Mankin, 1962; Shapiro et al., 1993). 
This mechanism is exploited in the orthopaedic technique of drilling localised 
cartilage defects. However, fibrocartilage lacks the mechanical properties of hyaline 
cartilage and can subsequently degenerate (Key, 1931; Shapiro et al., 1993). It is not 
clear from these studies if lack of healing and degeneration following cartilage injury 
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are primarily due to decreased cartilage anabolism, increased catabolism or a 
combination of the two.  
1.7.2 Molecular responses of articular cartilage to injury 
To investigate the molecular and cellular responses of cartilage to injury, different in 
vitro methods can be employed. Rested cartilage explants can be exposed to supra-
physiological impact loads (Lee et al., 2005). Blunt trephine injuries to cultured 
cartilage have also been employed (Redman et al., 2004). Our group has studied the 
effects of scoring or dissection of cartilage on the intact articular surface, and of 
cutting explants adapted to culture conditions (Gruber et al., 2004; Vincent et al., 
2002).  
Cell death: Injury to cartilage can lead to chondrocyte death. Whilst low frequency 
and low energy loads may have anabolic effects on cartilage, supra-physiological 
loads lead to increased cell death, with a large proportion of this being apoptotic 
(Chen et al., 2001; Patwari et al., 2004). Trephine injury to cartilage explants causes a 
band of chondrocyte death (both necrosis and apoptosis) along the cut edge, 
irrespective of age. The cell death is greater following blunt trauma compared with 
sharp injury with a scalpel (Redman et al., 2004; Tew et al., 2000). Apoptosis of 
chondrocytes also occurs in in vivo models of acute osteochondral injury and 
experimentally-induced osteoarthritis (Costouros et al., 2004; Hashimoto et al., 1998). 
The cause of the apoptosis is not understood. It may be due to soluble factors and be 
mediated by Fas (Hashimoto et al., 1997; Levin et al., 2001). 
Proteinase expression: Few in vivo studies examining the molecular responses to 
direct cartilage injury have been reported. Up-regulation of MMP-3 and ADAMTS-5 
was reported after a single injurious load to cultured explants (Lee et al., 2005). 
Another study showed increased MMP-13 staining and increased MMP activity 
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(presence of the VDIPEN neoepitope of aggrecan) around partial thickness cartilage 
defects in pigs (Hembry et al., 2001). That proteinases and other inflammatory 
response genes are involved in the subsequent degeneration of cartilage after injury 
seems very likely, but their mechanism of induction remains unclear. 
1.7.3 Signalling in articular cartilage after injury 
Some years ago, our laboratory noted that dissecting articular cartilage from the joint 
surface (explantation), or scoring it in situ activated the three MAPK pathways ERK, 
JNK and p38 MAPK. Explantation also caused some degradation of IκBα, implying 
the possible activation of NFκB (Gruber et al., 2004). The activation of NFκB by 
cartilage injury has since been shown by confocal microscopy. Translocation to the 
nucleus of the p65 subunit of NFκB can be visualised 30 minutes after explantation 
(Fig 1.5, A. Didangelos, Ph.D. thesis, 2008). How these pathways, typically activated 
by inflammatory cytokines or microbial products, were activated by injury was 
unknown. 
In the search for an activating factor for the MAPKs, a soluble factor which activated 
ERK was found to be released from cartilage following explantation or re-cutting of 
cartilage explants. This was purified from conditioned medium and identified by mass 
spectrometry as FGF-2 (Vincent et al., 2002). FGF-2 was subsequently shown to be 
bound to perlecan in the pericellular matrix (Vincent et al., 2007). It was also 
responsible for ERK activation which followed loading of cartilage explants and 
alginate-embedded chondocytes, because the activation was prevented by an FGF 
receptor inhibitor (Vincent and Saklatvala, 2006; Vincent et al., 2004). p38 MAPK in 
cultured chondrocytes was also activated by FGF-2 and its activation on explantation 
may therefore also be FGF-dependent (A. Didangelos, Ph.D. thesis, 2008). However, 
he found that FGF-2 did not activate JNK in cultured chondrocytes or resting cartilage 
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explants. Despite an extensive search, there was no evidence of any other soluble 
factor released following dissection and fine chopping of cartilage which could 
activate JNK. The activation was not simply due to direct mechanical stress, because 
if dissected cartilage was rested in culture overnight or longer, then re-cut, JNK 
activation did not recur, although there was release of FGF-2 and ERK activation. The 
dissection of cartilage and placing into culture medium allows for some tissue 
swelling and deformation of the cartilage pieces, which could cause fluid flow and 
shear of cells within the matrix and subsequent activation of cell signalling. To try to 
control for such tissue swelling, the intact cartilage of the articular surface was scored 
in situ, or the cartilage was dissected into a culture dish without medium. JNK 
activation was still seen (A. Didangelos, Ph.D. thesis, 2008). The mechanism of 
activation of JNK and NFκB pathways in cartilage following injury remains 
unknown.  
The activation of inflammatory signalling following explantation is sufficient to 
induce IL-1α mRNA, and the magnitude of induction is proportional to the amount of 
cartilage injury (Gruber et al., 2004). Activation of JNK and NFκB following sharp 
injury to cartilage is therefore likely to induce other inflammatory response genes 
including proteinases, and this could initiate catabolism of the extracellular matrix. An 
understanding of the mechanism of activation of these pathways, and their effect on 
cartilage is likely to improve our understanding of cartilage biology and processes 
which may lead to OA. 
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Figure 1.5. Localisation of NFκB in dissected cartilage explants  
immediately ex vivo (0) and after 30 minutes.
The p65 subunit of NFκB is stained green, and nuclei red. Yellow signal 
indicates p65 translocation in to the nucleus.
Figure from A.Didangelos, Ph.D. Thesis, 2008. 
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1.8 Summary, aims and objectives of the project 
My hypothesis is that the activation of inflammatory signalling pathways in articular 
cartilage by injury may lead to subsequent catabolism of the matrix. In this project, 
the regulation of intracellular signalling pathways and expression of inflammatory 
response genes in the chondrocyte in response to sharp injury of the intact articular 
surface will be further explored in experiments utilising porcine joints. 
 
Chapter 3: Inflammatory signalling and gene expression in injured articular cartilage 
• Whether canonical NFκB is activated following dissection of articular 
cartilage will be investigated by the use of a kinase assay for IKK.  
• Whether the signalling is sufficient to induce a range of typical inflammatory 
response genes including proteinases will be investigated by RT-PCR. 
• Expression of two of these inflammatory response genes will be examined by 
ELISA and western blotting. The signalling necessary for activin A production 
after cartilage injury will be assessed by the use of pharmacological inhibitors 
of candidate pathways.  
Chapter 4: Investigation of tyrosine phosphorylation in cartilage following injury 
• Tyrosine kinases are implicated in the response of cartilage to injury in work 
presented in Chapter 3. Tyrosine phosphorylation occurring after injury will be 
further explored by phosphotyrosine western blotting. 
• Tyrosine-phosphorylated proteins of interest will be purified by 
immunoprecipitation and electrophoresis and silver-stainable bands identified 
by mass spectrometry. 
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Chapter 5: The role of tyrosine kinases in the response of cartilage to injury 
• The tyrosine-phosphorylated proteins identified by mass spectrometry will be 
verified by western blotting and phospho-western blotting. 
• The role of src family kinases in the response of cartilage to injury will be 
explored by western blotting, immunoprecipitation-kinase assay and 
pharmacological inhibition experiments. 
• The role of the FGF receptor tyrosine kinase in the response of cartilage to 
injury will be investigated by pharmacological inhibition of the receptor. 
Chapter 6: The response of synovium to injury 
• Whether the signalling activated by cartilage injury is also activated by injury 
to another connective tissue, synovium, will be explored by the use of 
phospho-western blotting. 
• Whether inhibition of src and FGF-induced pathways in synovium has similar 
effects to inhibition of these pathways in cartilage will be explored. 
• The localisation of cellular activation in response to tissue injury will be 
explored by immunolocalisation of phospho-paxillin, a src substrate shown to 
be activated in both tissues by injury. 
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2.1 Reagents 
General laboratory reagents were the best available grade from either Sigma-Aldrich 
(Dorset, UK) or BDH (Dorset, UK) unless otherwise stated. Bovine serum albumin, 
electrophoresis grade (BSA) was from PAA Laboratories, Pasching, Austria. 
2.1.1 General buffers 
A 10x stock solution of phosphate buffered saline (PBS) (43mM Na2HPO4, 14mM 
KH2CO3, 14mM KCl and 1.37M NaCl at pH 7.3) was from VWR (Lutterworth, UK). 
A 1x PBS solution was made by diluting the 10x stock solution with ddH2O.  
A 10x solution of tris-buffered saline (TBS) was prepared (50 mM Tris-HCl, pH 7.4, 
150 mM NaCl). A 1x TBS solution was made by diluting the 10x solution with 
ddH2O. 
2.1.2 Antibodies 
Primary and secondary antibodies for western blotting, immunoprecipitation and 
immunohistochemistry used in experiments are listed in Table 2.1 below. Mouse 
purified immunoglobulin for non-immune controls in immunoprecipitation 
experiments was mouse IgG1 isotype from murine myeloma (M5284, Sigma-Aldrich, 
Dorset, UK).  
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 Table 2.1. Primary and secondary antibodies. 
Antibody specificity Activity Antibody type Source 
Phospho-ATF-2 (9221) Western blotting Rabbit polyclonal Cell Signaling Technology, 
Beverly, USA 
Phospho-p38 MAPK 
(9211) 
Western blotting Rabbit polyclonal Cell Signaling Technology, 
Beverly, USA 
Phospho-ERK (M8159) Western blotting Mouse monoclonal Sigma-Aldrich, Dorset, UK 
ERK (sc-154) Western blotting Rabbit polyclonal Santa Cruz Biotechnology, USA 
ERK (SAK-2) Western blotting  Rabbit polyclonal Laboratory’s own 
IKKγ (559675) Immunoprecipitation Mouse monoclonal BD biosciences, Bedford, USA 
IKKα (556532) Western blotting Mouse monoclonal BD biosciences, Bedford, USA 
Phospho-Akt (9271) Western blotting Rabbit polyclonal Cell Signaling Technology, 
Beverly, USA 
IκBα (sc-203) Western blotting Rabbit polyclonal Santa Cruz Biotechnology, USA 
COX-2 (210-712-1) Western blotting Rabbit polyclonal Alexis biochemicals, Lausen, 
Switzerland 
Phosphotyrosine (4G10) 
(05-321) 
Western blotting Mouse monoclonal Upstate, Lake Placid, USA 
4G10 agarose conjugate 
(16-101) 
Immunoprecipitation Mouse monoclonal Upstate, Lake Placid, USA 
4G10 HRP conjugate (16-
105) 
Western blotting  Mouse monoclonal Upstate, Lake Placid, USA 
FAK (2A7) (05-182) Immunoprecipitation Mouse monoclonal Upstate, Lake Placid, USA 
FAK (06-543) Western blotting Rabbit polyclonal Upstate, Lake Placid, USA 
Phospho tyr-576 FAK (07-
157) 
Western blotting Rabbit polyclonal Upstate, Lake Placid, USA 
Phospho tyr-397 FAK (44-
624G) 
Western blotting Rabbit polyclonal Biosource International, 
Camarillo, USA 
Phospho-paxillin (2541) Western blotting/IHC Rabbit polyclonal Cell Signaling Technology, 
Beverly, USA 
Paxillin (5H11) (05-417) Western blotting Mouse monoclonal Upstate, Lake Placid, USA 
c-src (D1306) Western blotting Rabbit polyclonal Santa Cruz Biotechnology, USA 
c-src (GD11) (05-184) Western blotting/ 
Immunoprecipitation 
Mouse monoclonal Upstate, Lake Placid, USA 
Yes (06-514) Western blotting Mouse monoclonal Upstate, Lake Placid, USA 
Fyn (sc-16) Western blotting Rabbit polyclonal Santa Cruz Biotechnology, USA  
Hck (06-833) Western blotting Rabbit polyclonal Upstate, Lake Placid, USA 
Cortactin (4F11) (05-180) Western blotting Mouse monoclonal Upstate, Lake Placid, USA 
Phospho-tyr 215 src (07-
791) 
Western blotting Rabbit polyclonal Upstate, Lake Placid, USA 
Phospho-tyr 416 src (2101) Western blotting Rabbit polyclonal Cell Signaling Technology, 
Beverly, USA 
Phospho-tyr 418 src (07-
909) 
Western blotting Rabbit polyclonal Upstate, Lake Placid, USA 
Phospho-EGF receptor 
(Tyr 845) (2231) 
Western blotting Rabbit polyclonal Cell Signaling Technology, 
Beverly, USA 
Phospho-EGF receptor 
(Tyr 1068) (2236) 
Western blotting Rabbit polyclonal Cell Signaling Technology, 
Beverly, USA 
EGF receptor (sc-03) Western blotting Rabbit polyclonal Santa Cruz Biotechnology, USA 
Tubulin (T9026) Immunoprecipitation Mouse monoclonal Sigma-Aldrich, Dorset, UK 
Rabbit IgG HRP (P0217) Western blotting (secondary 
antibody) 
Swine IgG DAKO Cytomation,  
A/S, Denmark 
Mouse IgG HRP (P0218) Western blotting (secondary 
antibody) 
Rabbit IgG DAKO Cytomation, A/S, 
Denmark 
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2.1.3 Cytokines and growth factors 
Primary chondrocytes and cartilage explants were stimulated with various factors. 
Reagents used are listed in Table 2.2 below. 
 Table 2.2. Recombinant cytokines and growth factors. 
Cytokine/growth factor Species Source 
Interleukin-1 α Human Professor J. Saklatvala 
Fibroblast growth factor-2 Human Peprotech EC, London, 
UK 
Transforming growth 
factorβ 
Human R&D systems, MN, USA 
2.1.4 Signalling pathway inhibitors 
A number of pharmacological inhibitors of signalling pathways were employed for 
experiments in chondrocytes and cartilage explants. These are listed in Table 2.3 
below. The concentrations used in certain experiments are given in the results 
sections. 
Sodium pervanadate: Sodium orthovanadate and pervanadate are potent tyrosine 
phosphatase inhibitors. They were therefore both used to up-regulate tyrosine 
phosphorylations in cell and tissue culture experiments. Pervanadate involves the 
creation of oxyvanadium ions in various states of oxidation, which probably improves 
its tissue penetration compared to sodium orthovanadate. Solutions of sodium 
pervanadate for cell culture were prepared by the addition of 500μl of a solution 
containing 10μl of 30% hydrogen peroxide and 870μl DMEM to 9.5ml of 10 mM 
sodium orthovanadate in serum-free DMEM, immediately prior to the experiment. 
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 Table 2.3. Signalling pathway inhibitors. 
Inhibitor Specificity Source Vehicle 
U0126 MEK inhibitor Promega, Madison, USA 
(V1121) 
DMSO 
PD173074 FGF receptor 
inhibitor 
Gift from GSK DMSO 
SB202190 p38 MAP kinase 
inhibitor 
Calbiochem 
(559388) 
DMSO 
LY294002 PI3 kinase inhibitor Calbiochem 
(440204) 
DMSO 
Gö6976 Protein kinase C 
inhibitor  
Calbiochem 
(365253) 
DMSO 
Gö6983 Protein kinase C 
inhibitor  
Calbiochem 
(365251) 
DMSO 
PP2 Src family kinase 
inhibitor 
Calbiochem 
(529576) 
DMSO 
PP1 Src family kinase 
inhibitor 
Biomol International 
(EI-275) 
DMSO 
Genistein Tyrosine kinase 
inhibitor 
Biomol International 
(EI-147) 
DMSO 
SP600125 JNK inhibitor Calbiochem 
(420119) 
DMSO 
L-JNKI JNK inhibitor Calbiochem 
(420116) 
Water 
MG132 Proteasome inhibitor Biomol International 
(PI-102) 
DMSO 
BMS345541 IKK inhibitor Calbiochem 
(401480) 
DMSO 
PF573228 FAK inhibitor Gift from Pfizer DMSO 
cycloheximide Protein synthesis 
inhibitor 
Sigma-Aldrich, Dorset, 
UK (C-6255) 
Absolute 
ethanol 
Sodium 
orthovanadate 
Tyrosine phosphatase 
inhibitor 
Sigma-Aldrich, Dorset, 
UK (S6508) 
Water 
Chapter 2                                                                                                                Materials and Methods 
 
 63
2.2  Cell and tissue culture 
Dulbecco’s Modified Eagle’s Medium (DMEM) was obtained as a 1x endotoxin-free 
solution from PAA Laboratories, Pasching, Austria). This was supplemented with 
25nM sterile HEPES buffer (PAA Laboratories, Pasching, Austria). For cell culture, 
medium was also supplemented with 10% Foetal Calf Serum (FCS) and penicillin-
streptomycin (100U/ml) (PAA Laboratories, Pasching, Austria). Aliquots were stored 
at -20°C and diluted into medium at appropriate concentrations. All tissue culture 
plastics were from Beckton-Dickinson (Franklin Lakes, USA). 
Porcine trotters and knees were obtained from a local abattoir within 12h of slaughter. 
Before use, porcine trotters were soaked in 1% virkon solution (Dupont Relyon 
Prevention Solutions, Sudbury, UK). Most of the experiments presented in this thesis 
were performed on cartilage dissected from the articular surface of the fused 2nd-3rd 
porcine metacarpophalangeal (MCP) joint (Fig 2.1). After skinning the trotter, the 
MCP joint was opened carefully in a biological safety cabinet, using a size 10 
disposable scalpel (Fig 2.1A). Cartilage was then dissected from the articular surface 
(Fig 2.1B), using a size 15 disposable scalpel (all scalpels were sterile, and from 
Swann Morton, Sheffield, UK). Cartilage was used mainly as explants. However, 
some experiments used porcine chondrocytes, which were prepared from this cartilage 
(see below).  
Synovium was dissected from the anterior surface of the opened porcine 
metacarpophalangeal joint. 
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distal articular surface
proximal articular surface
synovium
A
B
Figure 2.1. The porcine compound metacarpophalangeal joint.
A. Porcine trotters were immersed in 1% Virkon for 20min, then skinned, 
and carefully opened using a size 10 scalpel. 
B. ~0.5g cartilage was dissected from the articular surfaces, using a size 
15 scalpel (see also Fig 2.2). 0.1g synovium was trimmed from the cut 
edge of the anterior side of the joint.  
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B                     C                       D
n MCP joints e.g. 3
Mix in culture dish
A
2n cultures e.g. 6
Figure 2.2. Experimental design for cartilage experiments.
A. Rested cartilage explants. All cartilage from n MCPJs was dissected into a culture dish 
containing serum-free medium and washed, prior to transferring equal numbers of cartilage 
explants to 2n bijous to rest for 24 hours prior to treatment with stimulus.
B.-D. Explant time courses. The metacarpphalangeal joint surface is shown. B. For long 
experiments (hours) e.g. for activin A ELISA Ch. 3, half of the distal and proximal surfaces 
were dissected per point. 3-4 biological replicates per point from different joints were used. 
C. For medium time course experiments (10 minutes +) e.g. signalling time courses Ch. 3, 6 
pieces of cartilage were dissected  from the distal surface (marked with ovals). Lysates from 
2 different joints were later pooled for each point prior to electrophoresis. D. For short time 
course experiments (15 seconds +) e.g. phosphotyrosine signalling Ch. 4, 2 pieces of 
cartilage were dissected from the distal surface (marked with ovals) and placed in culture 
medium for the appropriate time prior to snap freezing. This procedure was repeated 3 times 
and cartilage from each short culture then lysed together for each point (total of 6 pieces).  
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2.2.1 Primary porcine chondrocytes  
Freshly dissected cartilage explants were digested with collagenase IA from 
Clostridrium histolyticum (Sigma-Aldrich, Dorset, UK) (1mg/ml) in 10% FCS-
containing DMEM for 4-5h at 37°C. The digest was passed through a cell strainer 
(BD Falcon, BD Biosciences, Bedford, USA), then centrifuged at 1,800 r.p.m for 
5min. Pellets were washed twice with serum-free DMEM to remove collagenase, and 
then re-suspended in 10% FCS containing DMEM. Cells were counted using a 
standard haemocytometer, and plated on 12 well plates at a density of 2 million cells 
per well (90% confluent). Cells were then incubated at 37°C /5% CO2 for 48h prior to 
use. Before use, cells were serum-starved for 3h. 
2.2.2 Cartilage explants 
Approximately 0.5g cartilage (half of the cartilage from a porcine trotter from the 
distal and proximal surfaces) was dissected and cultured for each point for most 
experiments. For some experiments, approximately 0.2g cartilage (6 pieces) from the 
distal articular surface only was used (see Fig 2.2). Unless stated cartilage explants 
were cultured in 2-4ml serum-free medium. 
Rested cartilage explants: Porcine trotters were skinned, opened in a tissue culture 
hood, and cartilage dissected using aseptic technique into serum-free medium 
containing antibiotics and cut into pieces about 3 x 3mm in size. Explants were then 
washed three times in serum-free DMEM without antibiotics and cultured for 24 or 
48h at 37°C, 5% CO2 prior to use (Fig 2.2A). 
Explant time course experiments: Porcine trotters were soaked in 1% Virkon then 
rinsed briefly in 70% ethanol. Trotters were skinned, MCP joints opened, then closed 
and equilibrated at 37°C, 5% CO2 for 4h prior to explantation. Freshly dissected 
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cartilage explants were cultured in serum-free, antibiotic free DMEM at 37°C, 5% 
CO2 for increasing times prior to snap freezing or lysis. For ‘0’ time points, the joint 
was opened and the surface rapidly washed with 250ml 1x PBS, prior to immediate 
dissection of the cartilage into a tube on dry ice (Fig 2.2B).  
Scoring of the articular surface: Trotters were skinned, MCP joints opened, then 
closed and equilibrated at 37°C, 5% CO2 for 4h. Joints were then opened in the tissue 
culture hood, and the distal articular surface was scored to a depth of 1-2mm using a 
sterile blade (#15, Swann Morton, Sheffield, UK), at 1mm intervals in both coronal 
and sagittal planes. The joint was then closed and returned to the incubator for the 
appropriate time, prior to washing the surface rapidly in ice cold 1x PBS and 
immediate dissection of the cartilage into a tube on dry ice. 
Injection of whole joint experiments: Porcine trotters were soaked in 1% Virkon 
then rinsed briefly in 70% ethanol. Trotters were equilibrated at 37°C, 5% CO2 for 4h. 
After 3h, 3ml serum-free DMEM +/- appropriate concentrations of inhibitor or 
vehicle were injected via a dorsal approach into the MCP joint with a 25G needle 
(BD, Drogheda, Ireland). Following this, trotters were skinned, opened and cartilage 
dissected immediately into serum-free medium +/- inhibitor and cultured for the 
appropriate time. 
Freeze-thawed cartilage: In some experiments, the generation of freeze-thawed 
cartilage was necessary. Explants were snap frozen in liquid nitrogen, defrosted in a 
waterbath for 5min at 37°C and these steps were repeated twice more.  
Conditioned medium: Conditioned medium was generated by dissecting 0.5g 
cartilage in 1ml serum-free medium. The explants were then chopped into 1 x 1mm 
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pieces with a scalpel, prior to culture for the indicated time and removal of the 
medium. 
2.3 Preparation of cell and tissue lysates  
Unless otherwise stated, monolayer chondrocytes and cartilage explants were lysed 
using a dissociative lysis buffer (RIPA). Lysis buffer was supplemented with fresh 
2mM DTT. For serine phospho-western blotting, the buffer was also supplemented 
with proteinase inhibitor cocktail, microcystin and fresh β glycerophosphate. For 
tyrosine phospho-western blotting, the buffer was supplemented in addition with fresh 
sodium fluoride and sodium orthovanadate (see Table 2.4). 
2x RIPA buffer        
100mM Tris/HCl pH 7.4      
300mM sodium chloride       
20mM sodium pyrophosphate    
20mM sodium Fluoride      
2mM EDTA       
200μM β glycerophosphate    
2% sodium orthovanadate      
0.2% sodium deoxycholate 
1% NP-40/ Igepal 
0.4% SDS 
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2.3.1 Chondrocytes 
350μl of lysis buffer was added to each well and agitated at 4°C for 20min. Wells 
were then scraped and lysates aspirated and clarified by centrifugation at 13,000 r.p.m 
for 20min. 
2.3.2 Cartilage Explants 
700μl of lysis buffer was added to ~0.5g tissue. Samples were vigorously shaken at 
4°C for 2h. Lysates were aspirated and clarified at 13,000 r.p.m for 20min. 
2.3.3 Synovium  
400μl of lysis buffer was added to ~0.2g tissue. Samples were vigorously shaken at 
4°C for 1.5h. Lysates were aspirated and clarified at 13,000 r.p.m for 20min. 
2.3.4 Protein determination by the Bradford Assay 
This assay was used to assess protein concentration in cellular lysates (the presence of 
matrix as well as cellular proteins meant that a meaningful assessment of cellular 
protein content in tissue lysates was not possible using this method). 1μl sample was 
mixed with 99μl 1x PBS and 900μl Bradford reagent (0.01% (w/v) Coomassie 
Brilliant Blue G-250, 4.7% (v/v) ethanol and 8.5% (v/v) H3PO4). The A595 of the 
sample was determined using a digital spectrophotometer (Cecil Instruments, 
Cambridge, UK). Protein concentration was estimated by comparison of the A595 of 
the sample to a standard curve from known concentrations of BSA.  
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 Table 2.4. Protease and phosphatase inhibitors used during lysis. 
Reagent Dilution Target Source 
100x Protease inhibitor 
cocktail, containing: 
1: 100  Sigma-Aldrich, 
Dorset, UK 
AEBSF 104 μM  Serine proteases  
Aprotinin 80μM  Serine proteases  
Leupeptin 2.1mM  Serine/cystine proteases  
Bestatin 3.6 mM  aminopeptidases  
Pepstatin A 1.5mM  Aspartic proteases  
E-64 1.4mM  Thiol/cysteine protease, 
chymase & trypsin 
 
    
Phenyl methyl sulphonyl 
fluoride (PMSF) 200mM 
1:200 Serine proteases Sigma-Aldrich, 
Dorset, UK 
Microcystin 1 mg/ml 1:500 Serine proteases Alexis, Lausen, 
Switzerland 
Para-nitrophenyl 
phosphate 
(PNPP) 1M 
1:500 General phosphatase 
inhibitor 
Calbiochem, La 
Jolla, USA 
β glycerophosphate 1M 1:500 General phosphatase 
inhibitor 
Sigma-Aldrich, 
Dorset, UK 
Sodium fluoride 200 mM 1:100 Tyrosine phosphatases Sigma-Aldrich, 
Dorset, UK 
Sodium orthorvanadate 
100 mM 
1:100 Tyrosine phosphatases Sigma-Aldrich, 
Dorset, UK 
Sodium iodoacetate in 
methanol 200mM 
1:200 Tyrosine phosphatases Sigma-Aldrich, 
Dorset, UK 
EDTA  Metal chelator Sigma-Aldrich, 
Dorset, UK 
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2.4 SDS-PAGE 
2.4.1 Buffers and reagents 
Separating buffer   380mM Tris/HCl pH 8.8 
    8% or 11% (w/v) acrylamide  
    0.1% (w/v) SDS 
    0.07% (w/v) ammonium persulphate 
    0.07% (v/v) TEMED 
 
Stacking buffer  125mM Tris/HCl pH 6.8 
    5% (w/v) acrylamide 
    0.1% SDS 
    0.1% (w/v) ammonium persulphate 
    0.1% (v/v) TEMED 
 
4x SDS sample buffer  0.4M Tris/HCl pH 6.8 
    0.4% (w/v) SDS 
    40% (v/v) glycerol 
    1% (v/v) β-mercaptoethanol or DTT 
    0.02% (w/v) bromophenol blue 
 
Running buffer   25mM Tris base 
    190mM glycine 
    0.1% (w/v) SDS 
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2.4.2 Preparation of samples 
Chondrocytes: 250μl of clarified lysate was mixed with 100μl 4x SDS sample buffer, 
vortexed, boiled for 7min and sonicated for 10min prior to electrophoresis. 
Cartilage explants: 500μl of clarified lysate was mixed with 200μl of 4x SDS sample 
buffer, vortexed, boiled for 7min and sonicated for 10min prior to electrophoresis. 
Synovium: 300μl of clarified lysate was mixed with 150μl of 4x SDS sample buffer, 
vortexed, boiled for 7min and sonicated for 10min prior to electrophoresis. 
2.4.3 Electrophoresis 
Proteins from cell or tissue lysates were separated by 1.5mm gel electrophoresis 
(Laemmli, 1970) using Cambridge electrophoresis apparatus (Cambridge 
Electrophoresis Ltd, Cambridge, UK). 8% SDS-acrylamide gels were run for western 
blotting of phospho-tyrosines and 11% gels for all other purposes, using 
Tris/glycine/SDS running buffer (National Diagnostics, USA). Usually 180μl of each 
sample was loaded into one of 15 pre-cast wells of the stacking gel. Pre-stained 
molecular weight markers were run alongside the samples to allow approximate sizing 
of proteins (SeeBlue markers, Invitrogen, UK). Gels were run for 5h at 38mA or 
overnight at 10 mA.  
Alternatively, particularly where multiple bands were being analysed, such as analysis 
of 4G10 immunoprecipitates and for silver staining, a pre-cast mini-gel system was 
employed. The NuPAGE Bis-Tris discontinuous pre-cast 1.5mm polyacrylamide gels 
were from Novex (Invitrogen, UK). The gels have a 4% acrylamide stacking gel and a 
4-12% acrylamide gradient separating gel. 40μl of the cell/tissue lysate was loaded 
into the wells of the stacking gel. The gels were then run at 100V for 2h, using 
NuPAGE MOPS-SDS running buffer, in the bespoke XCell SureLock Mini-Cell 
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electrophoresis apparatus (both by Novex, Invitrogen, UK). After separation of the 
proteins, gels were either silver stained or western blotting was carried out. 
2.5 Western blotting 
Transfer buffer  25mM Tris base 
    192mM Glycine 
    20% (v/v) methanol 
Blocking solution  5% dried milk (w/v) 
    1x TBS, or 1x PBS 
    0.1% Tween (v/v) 
Western blotting was carried out to identify proteins from cellular or tissue lysates or 
immunoprecipitates. Proteins from SDS-PAGE were transferred on to pre-hydrated 
PVDF membranes (Millipore, Bedford, USA) in a Trans-blot chamber (Biorad, 
Hercules, USA) at 100V for 70min at 4°C. Membranes were stained with Coomassie 
Brilliant Blue stain to determine efficiency of transfer and equal protein loading, then 
de-stained with 50% methanol. Membranes were gently agitated in blocking solution 
for 1.5h, and then incubated with the primary antibody for 3h at room temperature or 
overnight at 4°C (see Table 2.1). Antibodies were diluted as per manufacturer’s 
guidelines in blocking solution. Phospho-antibodies were generally diluted in 5% 
BSA in TBS. The membrane was then washed 3 times in PBS or TBS-tween and 
incubated with secondary horseradish peroxidase-conjugated antibody (1:2000) for 1h 
at room temperature. The membrane was washed a further 3 times in PBS/TBS-tween 
and signal developed by enhanced chemiluminescence (ECL, Amersham, UK). 
Protein bands were visualised by autoradiography (Fuji Super RX x-ray film, Fuji 
Photo Film, Dusseldorf, Germany). Films were developed using a Curix 60 film 
processor from AGFA-GEVAERT Ltd, Brentford, UK. 
4G10 western blotting: 4G10 western blotting was optimal when the following steps 
were incorporated. Proteins from SDS-PAGE were transferred on to a pre-hydrated 
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nitrocellulose membrane (NitroBind, Osmonics, USA) at 100V for 90min. 
Membranes were then washed briefly in TBS and blocked overnight in a solution of 
5% BSA in TBS-tween. The membrane was incubated with primary antibody at a 
concentration of 1:20,000 (and latterly an antibody-HRP conjugate was used). Both 
the primary and secondary antibodies were in 5% BSA in TBS-tween. After the 
secondary antibody incubation, the membrane was washed extensively with TBS-
0.1% tween for 1.5h prior to chemiluminescence. 
Stripping proteins from membranes: To re-probe membranes with a further 
antibody where necessary, membranes were washed in PBS, then incubated with 1x 
stripping buffer (Re-Blot Plus Strong Solution, Chemicon, Temecula, USA) for 
10min at RT, prior to washing again for 5min in PBS, prior to blocking and 
subsequent western blotting analysis. 
2.6 Immunoprecipitation kinase assays 
[γ-32P]Adenosine 5-triphosphate (ATP) was ‘Easy Tides’ [γ-32P]ATP from Perkin-
Elmer, Boston, USA.  
2.6.1 In vitro IKK assay 
To assay the activity of IKKα/β within chondrocyte or cartilage lysates, the tripartite 
IKK complex was immunoprecipitated from the lysates using an antibody to IKKγ, 
and the ability of this complex to phosphorylate the substrate IκBα assessed using a 
kinase assay. This protocol has been adapted from a protocol kindly provided by M. 
Bebien, Kennedy Institute of Rheumatology.  
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Buffers for IKK kinase assay 
1x Non-dissociative kinase assay lysis buffer 
50mM Tris/HCl pH 7.5 
250mM NaCl 
3mM EDTA 
3mM EGTA 
1% Triton X-100 
0.5% Igepal 
10% glycerol 
 
1x Immunoprecipitation buffer 
As lysis buffer, but 400mM NaCl 
 
10x kinase wash buffer 
200mM Hepes/HCl pH 7.5 
100mM MgCl2 
 
Reaction mix     μl 
10x kinase wash buffer   2.5 
ATP 200μM    2.5 
β glycerophosphate 1M  0.6 
PNPP 1M    0.3 
DTT 200mM    0.3 
GST-IκBα    0.35 (i.e. 1-2 μg per reaction) 
ddH2O     18 
[γ-32P]ATP    0.4 (at activity date) 
Total     25 
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Non-dissociative lysis buffer, immunoprecipitation buffer and 1x kinase wash buffer 
were supplemented immediately prior to use with proteinase inhibitor cocktail, DTT, 
microcystin, PNPP, β glycerophosphate, sodium orthovanadate and PMSF at the 
appropriate concentration (see Table 2.4), and the solutions kept on ice until use. 
Chondrocytes: For a 12 well plate, 120μl per well of non-dissociative kinase assay 
lysis buffer was added per well, and the plate agitated on ice for 20min. The wells 
were then scraped with a cell scraper (Corning Inc, NY, USA) and the lysate aspirated 
and transferred to a 1.5ml Eppendorf tube. Lysates were clarified at 13,000 r.p.m at 
4°C for 20min, and the supernatant stored at -80°C until later use, or kept on ice if 
used immediately. Bradford assay was carried out on the lysates. 40μg of protein per 
sample was added to 400μl immunoprecipitation buffer in a 1.5ml Eppendorf tube.  
Cartilage: ~0.5g cartilage was lysed in 700μl lysis non-dissociative kinase assay 
buffer. Alternatively, 6 pieces of cartilage were lysed in 400μl lysis buffer. Samples 
were vigorously shaken at 4°C for 2h. Lysates were aspirated and clarified at 13,000 
r.p.m at 4°C for 20min. The supernatant was stored at -80°C until later use, or kept on 
ice. 150μl lysate was added to 250μl immunoprecipitation buffer in a 1.5ml 
Eppendorf tube. 
Immunoprecipitation: For either chondrocyte or cartilage lysates in 
immunoprecipitation buffer, 1μl IKKγ antibody (BD-Pharmingen, Bedford, USA) and 
25μl of a 50:50 mix of re-suspended 1:1 slurry of protein G agarose and Protein A 
agarose in PBS (both from Sigma, Dorset, UK) were added to each sample, and 
incubated overnight, rotating at 4°C.  
Kinase assay: The following day, samples were centrifuged at 13,000 r.p.m for 1min 
and the supernatant discarded. Immunoprecipitates on ice were washed twice in 600μl 
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immunoprecipitation buffer and once in 600μl 1x kinase wash buffer (after the 
addition of each wash, samples were shaken for 6sec, then centrifuged at 13,000 r.p.m 
for 1min and the supernatant aspirated). 
The reaction mix for n+1 samples was prepared on ice (see above). Prior to addition 
of [γ-32P]ATP, the mix was vortexed and pulsed in a centrifuge. Using a gel loading 
tip, all remaining kinase wash buffer was aspirated from the immunoprecipitates. The 
[γ-32P]ATP was then added to the reaction mix and the mixture pipetted repeatedly to 
mix thoroughly. 25μl reaction mix was added to each immunoprecipitate, prior to 
incubation at 30°C for 30min. The kinase reaction was terminated by the addition of 
10μl 4x SDS sample buffer and boiling for 10min. Samples were then centrifuged at 
13,000 r.p.m for 1min, and the whole supernatant (35μl) loaded on to a 11% 
polyacrylamide gel. Following electrophoresis, proteins were transferred on to a 
PVDF membrane at 100V for 1.5h. Autoradiography of the membrane was carried out 
by exposing overnight to x-ray film. Subsequent quantification of phosphorylation of 
the substrate was carried out, using a phosphorimager (see section 2.6.4). Western 
blotting of the membrane with antibodies to IKKα (BD-pharmingen, Bedford, USA) 
was then carried out to ensure equivalent immunoprecipitation of the IKK complex 
between samples. 
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2.6.2 In vitro c-src kinase assay 
The c-src kinase assay performed in these studies assessed activity of c-src both by 
way of its auto-kinase activity (the ability to phosphorylate itself) and its ability to 
phosphorylate a substrate, enolase. The protocols for these experiments have been 
adapted from protocols kindly provided by M. Smolinska-Bylanska and T. Page, 
Kennedy Institute of Rheumatology.  
Buffers for c-src kinase assay 
2x kinase buffer  μl 
ddH2O    900 
1M Hepes pH 7.5  40 
0.1M MnCl2   40 
0.1M DTT   20 
Total    1000 
 
Reaction mix    μl 
2x kinase buffer  5 
100 μM ATP   0.1 
Denatured enolase  1 
ddH2O    2.9 
[γ-32P]ATP   1 (at activity date) 
Total    10 
 
Immunoprecipitation: Cartilage lysates were prepared by lysis of 0.5g cartilage in 
700μl RIPA buffer supplemented with proteinase inhibitor cocktail, DTT, β 
glycerophosphate, sodium orthovanadate, sodium iodoacetate, microcystin and 
sodium fluoride. Samples were clarified by centrifugation at 13,000 r.p.m for 20min. 
Lysates were pre-cleared by addition of 40μl re-suspended 1:1 slurry of Protein G 
agarose in PBS, with rotation at 4°C for 45min. The supernatant was recovered 
following centrifugation at 4°C for 1min. c-src was immunoprecipitated from the 
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lysates by the addition of 4μl GD11 c-src antibodies (Upstate) and 30μl protein G 
agarose bead slurry to the whole supernatant (approximately 600μl), and rotation at 
4°C for 1h. Following centrifugation for 1min, the supernatant was discarded and 
beads were washed four times in RIPA buffer and once in 1x TBS (both 
supplemented with proteinase inhibitor cocktail, sodium orthovanadate, sodium 
fluoride, β glycerophosphate and DTT). 
Preparation of enolase: 100μg (28.6μl) rabbit muscle enolase (EO379, Sigma 
Aldrich, Dorset, UK) was centrifuged at 13,000 r.p.m for 5min at 4°C. Supernatant 
was discarded using a gel loading tip and 10μl of 1mM DTT/50mM Hepes pH 7.5 
was added. The enolase suspension was incubated on ice for 60min, and then 10μl 
glycerol was added. Just prior to the kinase assay, 20μl of 100mM acetic acid was 
added to the enolase suspension, and the mixture incubated at 30°C for 5min to 
denature the enolase. 
Kinase assay: Using a gel loading tip, all remaining kinase wash buffer was aspirated 
from the immunoprecipitates. 10μl 1x kinase buffer was added to each sample. The 
reaction mix for n+1 samples was prepared on ice (see above). Prior to addition of [γ-
32P]ATP, the mix was vortexed and pulsed in a centrifuge. The [γ-32P]ATP was then 
added to the reaction mix and the mixture pipetted repeatedly to mix thoroughly. 10μl 
of reaction mix was added to each sample. Samples were vortexed gently and 
incubated at 30°C for 10min. The kinase reaction was terminated by addition of 15μl 
4x SDS sample buffer and boiling for 10min. Samples were then centrifuged at 
13,000 r.pm for 1min, and the whole supernatant (35μl) loaded on to a 4-12% 
minigel. Following electrophoresis, the gel was dried on to paper using a gel dryer 
(model 583 Geldryer, Biorad, Hercules, USA). Activity of the kinase was assessed by 
autoradiography of the gel, which showed two bands, one relating to phosphorylated 
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c-src and one relating to phosphorylated enolase. Subsequent quantification of 
autophosphorylation and phosphorylation of the substrate was carried out, using a 
phosphorimager (see section 2.6.4). 
2.6.3 Autoradiography 
Dried gels or membranes were subjected to autoradiography using x-ray film 
(Hyperfilm ECL, Amersham biosciences or Fuji Super RX x-ray film, Fuji Photo 
film, Dusseldorf, Germany). After a few hours, or overnight, the films were developed 
with a Curix 60 film processor from AGFA-GEVAERT Ltd, Brentford, UK. 
2.6.4 Quantification of phosphorylation 
Protein phosphorylation data was acquired with a phosphorimager (FLA5100, 
Fujifilm). Phosphorimager data was quantified and analysed using Advanced Image 
Data Analyser Software (AIDA version 4.10, Raytest, Straubenhardt, Germany). 
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2.7 Reverse Transcriptase-PCR from cartilage 
To investigate whether inflammatory response gene mRNA was induced in cartilage, 
total RNA was extracted from cartilage explants, using techniques adapted from 
published protocols (Martin et al., 2001). 
2.7.1 RNA extraction from cartilage explants  
RNA was isolated from ~0.2g freshly dissected cartilage explants (approximately 20 
pieces of cartilage chopped into 3 x 3mm squares, cultured in a 15ml polypropylene 
tube). Culture medium was removed from each sample and 3ml Tri Reagent (Helena 
Biosciences, Sunderland, UK) was added. Samples were kept on ice whilst 
homogenised using a Polytron PT1600 rotor-stator homogenizer (Kinematica AG, 
Littau-Luzern, Switzerland) for 1min, and the homogenate clarified by centrifugation 
at 4°C for 10min. 2ml supernatant was aspirated and allowed to stand at room 
temperature for 5min to allow complete dissociation of nucleoprotein complexes. 
200μl chloroform was then added per 1ml supernatant and the samples vortexed for 
15sec prior to resting at room temperature for 5min. Samples were then centrifuged at 
4°C for 15min. Following centrifugation, the mixture separated into a lower red, 
phenol-chloroform phase, a white interphase (containing DNA), and a colourless 
RNA-containing upper aqueous phase. This upper phase was carefully aspirated and 
mixed with the same volume of 70% ethanol, prior to binding to a QIAmp spin 
column and washing once with RW1 buffer and twice with RPE buffer, as per 
manufacturer’s protocol (QIAmp RNA Blood Mini kit, Qiagen, Chatsworth, USA). 
Following the second wash with RPE buffer, the spin column was transferred into a 
fresh collection tube and centrifuged again at 13,000 r.p.m for 3min. RNA was eluted 
in 30μl of RNAase free water. UV absorbance was measured at 260nm, and samples 
were stored at -80°C until use.  
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2.7.2 Reverse Transcription of RNA (First strand synthesis) 
Reverse transcriptase (RT)-polymerase chain reaction (PCR) was carried out. 1μg 
RNA in a total volume of 10μl RNAase free water was incubated at 65°C for 10min 
with 1μl of random hexamers and 1μl 10mM dNTP mix (Invitrogen). Samples were 
then kept on ice for a further 5min. RT mix (see below) contained an engineered 
version of M-MLV reverse transcriptase, Superscript II (Invitrogen, UK) and the 
RNAase inhibitor RNAguard (Amersham biosciences, Little Chalfont, UK). 8μl RT 
mix was added to the denatured RNA on ice, and the reverse transcription reaction 
carried out at 30°C for 10min, 42°C for 50min and 70°C for 15min. cDNA was then 
stored at -20°C until use. 
RT mix  per sample μl 
5x First-Strand buffer   4 
0.1M DTT    1 
SuperScript II    2 
RNAguard    1 
 
2.7.3 PCR 
PCR of cDNA for inflammatory response genes was then carried out.  
Primers: Some primers were from published studies using porcine/bovine material, 
and these are indicated below. Others where possible were designed from Genbank 
porcine sequences, using Vector NTI (Invitrogen, UK); (see Table 2.5). Where 
insufficient porcine sequence was available, bovine, ovine and human sequences were 
aligned using Vector NTI and primers designed from consensus sequences. Primers 
for ADAMTS-4, ADAMTS-5 and GAPDH were designed by Y. Sawaji in our group. 
Primers were for a variety of inflammatory response genes: proteinases (MMP-1,-13 
and -3, ADAMTS-4 and -5), TIMP-1 (known to be regulated by FGF-2), COX-2, 
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iNOS (inflammatory mediators), cytokines (IL-1,-6 and -8) and growth factors 
important to cartilage metabolism (activin A).  
22μl RNAase free water and 1μl each of sense primer, anti-sense primer and cDNA 
were added to PuReTaq Ready-to-go PCR Beads (Amersham Biosciences, Little 
Chalfont, UK) and PCR carried out using a T3 thermocycler (Biometra, Göttingen, 
Germany). The beads contained 2.5 units of Taq DNA polymerase, 10mM Tris-HCl, 
50mM KCl, 1.5mM MgCl2, 200μM dATP, dCTP, dGTP, dTTP and stabilisers 
including BSA. PCR included three distinct stages; denaturation, primer annealing 
and primer extension. The denaturation for each PCR reaction was an intial incubation 
at 95°C for 5min, then 95°C for 30sec per cycle. The annealing stage allows 
hybridisation of primers to complementary target sites on the DNA molecule. The 
annealing temperature for individual PCRs was estimated by calculation of the 
melting temperatures (Tm) for each primer within the pair (using a Tm calculator, 
Vector NTI). Initial experiments to optimise the reaction, using temperatures at or 
above the estimated Tm were carried out. Annealing temperatures for each PCR are 
shown in Table 2.5. The final primer extension stage was 72°C for 45sec per cycle. 
Following the specified number of cycles, there was a final phase of incubation at 
72°C for 5min. GAPDH was used as a housekeeping control, to confirm equal 
amounts of mRNA between samples. Samples were mixed with 6x bromophenol blue 
buffer and electrophoresed on a 1.2% agarose-TAE gel, and stained with either SYBR 
green (Molecular Probes Inc, USA) or 0.5μg/ml ethidium bromide. A 1Kb Plus DNA 
ladder (Invitrogen, UK) was electrophoresed alongside to allow approximate sizing of 
PCR products. Products were visualised with ultraviolet light (254nm) and recorded 
using a camera and transilluminator (UVP inc, San Gabriel, USA). 
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IL-1α stimulated cartilage was used as a positive control for these experiments, as it 
induces all these inflammatory response genes in chondrocytes (Gebauer et al., 2005). 
For each primer pair, a cycle number within the linear amplification phase was 
selected, which optimally detected regulation of the PCR product by IL-1 (see Table 
2.5).  
50x TAE Buffer 
2M Tris/HCl pH 8.5 
50mM EDTA 
5.7% (v/v) Glacial acetic acid  
 
Bromophenol Blue buffer 
0.25% bromophenol blue 
0.25% xylene cyanol FF 
30% glycerol in H2O 
 
 
 Table 2.5. Primers used for RT-PCR. 
(See following page) 
a (Goodstone and Hardingham, 2002) 
b (Schubert et al., 2001) 
c (Lo et al., 2003) 
d (Kanaki et al., 2002) 
e (Li et al., 1997) 
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Target Accession 
number 
Orientatn Primer sequence 5’-3’ Product 
size 
Annealing 
temperature °C 
Cycle 
number 
GAPDH NM002046 sense CATGGAGAAGGCTGGGGCTC 671 58 22 
  antisense ATGAGGTCCACCACCCTGTT    
COX-2 U68486 sense  GCTCTTCCTCCTGTGCCTGATGAC  449 58 22 
  antisense CATCATCAGACCAGGCACCAGAC    
iNOSa U59390 sense TTCGAGCACATCTGCAGG 302        53 25 
  antisense GTCAGGAGGGATTTCGAA    
 IL-1α X60167 sense GAGGCAGTGAAATTTGACATGG 245 58 34 
  antisense GGCAATGAACAACTTTGGATGGG    
 IL-1β X56972 sense GCTGAAGGCTCTCCACCTCC 330 63 40 
  antisense TCCCAGGAAGACGGGCTTT    
 IL-6 X68723 sense GAACCCAGCTATGAACTCCCTCT 331 58 27 
  antisense GATTGAACCCAGATTGGAAGC    
IL-8 AB057440 sense GGCTCCCAAGAATTTCTCAGTA  318 58 33 
  antisense CAGCAGCCTAGGGTTGCAAG    
MMP-1b AF267156 sense CCGTTTGTTCTTACTCCAGGGAA 416               58 29 
  antisense GGGTACATCAGAGCCCCAATGTC    
MMP-13c AY091604 sense GTGACAGGCAGACTTGATGA  331            58 29 
  antisense AAGCGTGAGCCAACAGACCA     
MMP-3d AF201725 sense GGAGTTCCTGATGTTGGTTACTTC 266 63 30 
  antisense CAAAACTTTTCCAGGTCCGTCAAA    
ADAMTS-4 AF148213 sense ACCACTTTGACACAGCCATTCTG 691 63 35 
  antisense ACCCCCACAGGTCCGAGAGCAG    
ADAMTS-5 NM007038 sense TGTGCTGTGATTGAAGACGAT 672 61 32 
  antisense GACTGCAGGAGCGGTGAGTGG    
TIMP-1 AF156029 sense GCGTTATGAGATCAAGATGACC 212 53 40 
  antisense CTGTTCCAGGGAGCCACAA    
Inhibin βAe NM214028 sense GACATCCGGACTGCCTGCGAGCAG 
 
315 65 30 
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2.8 ELISA  
An ELISA kit specific for quantification of Activin A was used (Duoset, R&D 
systems, Minneapolis, USA). The manufacturer’s protocol for the kit was followed. 
Supernatants from cell or explant culture were clarified by centrifugation and stored at 
-20°C until use. 96 well ELISA plates (NUNC, Roskilde, Denmark) were coated with 
1μg/ml capture antibody diluted in PBS. 100μl of the capture antibody solution was 
added to each well and incubated overnight at room temperature. The following day, 
wells were aspirated and washed 3 times with wash buffer (1x PBS, 0.05% tween). 
Wells were blocked with 1% BSA in PBS for 2h, and then washed again in wash 
buffer. Activin A standards were prepared by 2 fold serial dilution in DMEM from 
8ng/ml to 0.125ng/ml. Where necessary, samples were diluted in DMEM so that the 
activin A concentration in the sample was within the linear range for the assay. 100μl 
of either standards or samples were added to wells. 100μl 6M urea in PBS was then 
immediately added to each well and mixed with the standards and samples. After 2h 
incubation at room temperature, wells were aspirated and washed 3 times with wash 
buffer. 100μl 0.5μg/ml biotinylated detection antibody diluted in 1% BSA in PBS was 
added to each well and left for a further 2h at room temperature, with gentle agitation. 
Wells were aspirated and washed 3 times with wash buffer. 100μl of streptavidin 
solution diluted to 1:200 in 1x PBS was added to the wells for 40min. The 
aspiration/wash step was repeated and 100μl substrate solution (1:1 mixture of 
hydrogen peroxide and tetramethylbenzidine, KPL, Gaithersburg, USA) was added to 
each well for 20min incubation with mild agitation. The reaction was stopped by 
adding 50μl of 2M sulphuric acid. Plates were read immediately using a 
spectrophotometric plate reader (Multiskan Biochromatic, Labsystems, Finland) set to 
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a wavelength of 450nm, and analysed using Ascent software, Thermo Fisher 
Scientific, Waltham, USA. 
2.9 Purification of tyrosine-phosphorylated proteins from 
cartilage lysates 
For all procedures involving preparation of samples for mass spectrometry, the utmost 
care was taken to avoid contamination. All reagents were of ultra-pure analytical 
grade, and H2O was double distilled (ddH2O), free from protein and microbial 
products. Cleaned and baked glassware was used where possible. Surfaces and all 
plasticware were cleaned with 50% methanol, 0.1% TFA prior to use. 
2.9.1 Standard 4G10 immunoprecipitation and elution of 
phosphorylated proteins 
This protocol for purification of tyrosine phosphorylated proteins from lysates was 
adapted from methods described by M. Peirce, Kennedy Institute of Rheumatology 
(Peirce et al., 2005). The methods were optimised and validated for tissue lysates (See 
Ch 4, section 4.5.2) and are summarised in Figure 2.3. 600μl clarifed RIPA lysate was 
added to a 1.5ml Eppendorf and incubated with 20μl of a re-suspended 1:1 slurry of 
Protein A agarose beads in PBS (Sigma-aldrich, Dorset, UK), rotating at 4°C for 
30min-1h. The supernant was then recovered by centrifugation at 13,000 r.p.m for 
1min at 4°C. The pre-cleared lysate was then incubated with 10μl protein A agarose 
beads, covalently linked to 4G10, in PBS (Upstate, USA), rotating overnight at 4°C. 
The next day, beads were precipitated by centrifugation at 13,000 r.p.m for 1min at 
4°C and the supernatant was discarded. The beads were washed 5 times with 600μl 
RIPA buffer (including proteinase and phosphatase inhibitors [see Table 2.4]). After 
the addition of each wash, samples were shaken for 6sec, then centrifuged at 13,000 
r.p.m for 1min and the supernatant aspirated. After the last wash, all remaining RIPA 
buffer was aspirated from the beads with a gel loading tip. A solution of 0.2M phenyl 
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phosphate in RIPA was freshly prepared. The beads were incubated with 20μl of 
phenyl phosphate, shaking gently for 2h at 4°C. The tube was pulsed briefly in the 
centrifuge. Using a cut-off 200μl pipette tip, the phenyl phosphate-bead slurry was 
carefully transferred to a 0.2μm cellulose acetate spin column (Spin-X, Corning 
Costar Inc., NY, USA). (Several eluates from like samples were pooled in one 
column). Columns were then centrifuged at 8,000 r.p.m for 2min. The recovered 
eluate was then either concentrated further (see below, section 2.9.2), or boiled 
immediately with 20μl SDS sample buffer for 7min, sonicated for 10min and boiled 
again for 2min, prior to electrophoresis for either western blotting or silver staining. 
In some experiments, Cibacron Blue Sepharose beads were used (Blue Sepharose 6 
Fast Flow, GE healthcare, New Jersey, USA). 
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Figure 2.3. Standard 4G10 immunoprecipitation protocol.
A summary is shown of the optimised methods used for 
immunoprecipitation of tyrosine-phosphorylated proteins from tissue 
lysates, and their selective elution prior to electrophoresis.
1. Tissue lysis: shaking
2. Clarification: 13,000 r.p.m, 20 min
3. Pre-clearing: 20μl Protein A agarose 1h
4. Immunoprecipitation: 10μl 4G10-agarose beads O/N
5. Washing: x 5 in RIPA 
6. Elution: 20μl 0.2M phenyl phosphate in RIPA
7. Filtration: slurry through Spin-X column 8,000 r.p.m, 2min
8. Concentration (optional): GE clean-up kit
8. Boiling: 4x SDS sample buffer 10min
9. Sonication: 10min
10. Reboiling and over-running 4-12% bis-tris minigel
Cartilage
0.5g in 700μl RIPA
synovium
0.2g in 400μl RIPA
2h 1.5h
4G10 western blotting     silver staining
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2.9.2 Concentration of proteins 
Acetone precipitation: To purify and concentrate proteins, acetone precipitation was 
employed. Acetone was cooled to -20°C in advance of the procedure. 4 times the 
volume of cold acetone was added to the protein solution. The contents were then 
vortexed for 10sec and the solution incubated for 60min at -20°C. Following this, the 
sample was centrifuged at 13,000 r.p.m for 10min at 4°C. The supernatant was then 
removed using a gel loading tip, taking care not to disturb the protein pellet. 4x SDS 
sample buffer was added to the pellet and the sample vortexed, boiled and sonicated 
to assist in solubilising the pellet prior to electrophoresis. 
SDS PAGE clean-up kit: This kit (GE healthcare, New Jersey, USA) involved a two-
stage modified acetone precipitation protocol, and included buffers to assist re-
solubilisation of the protein pellet. The kit was used to concentrate phenyl phosphate 
eluates following 4G10 immunoprecipitation, prior to electrophoresis and subsequent 
identification of proteins by mass spectrometry. The manufacturer’s protocol was 
followed. For samples under 100μl, 300μl precipitant and 300μl co-precipitant 
solutions were added. For samples over 100μl (during scale-up) 3 volumes of 
precipitant and co-precipitant were added. The samples were centrifuged at 13,000 
r.p.m for 5min and then the supernatant removed carefully from the pellet, which was 
then re-suspended in H2O with extensive vortexing. 1ml wash buffer (acetone, pre-
cooled to -20°C) and 5μl wash additive were added and the sample vortexed until the 
pellet was completely dispersed. The samples were then incubated at -20°C for at 
least 1h, with vortexing every 10min for the first 30min. The samples were then 
centrifuged at 13,000 r.p.m for 5min at 4°C. The supernatant was carefully discarded 
and the pellet air dried for 2min. The pellet was re-suspended in two buffers, with 
incubation at room temperature for 5min, and sonication for 10min to assist re-
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solubilisation. Finally, 4x SDS sample buffer was added and the sample vortexed, 
incubated at room temperature for 5min, then boiled for 10min, prior to 
electrophoresis. 
2.9.3 Staining of protein bands 
Some gels were stained to visualise protein bands, either by Coomassie Brilliant Blue 
staining or silver staining.  
Coomassie Brilliant Blue staining: The gel was incubated in Coomassie Brilliant 
Blue G solution for 1h at room temperature. The gel was then washed in repeated 
changes of de-stain solution (50% (v/v) methanol) for 1h, and then left overnight in 
de-stain solution. The next morning the gel was washed with ddH2O, and left in 
ddH2O until further analysis. 
Coomasie Brilliant Blue Stain 
50% (v/v) methanol 
20% (v/v) acetic acid 
0.1% (w/v) Coomasie Brilliant Blue G 
 
Silver staining: For silver staining of gels, the EMBL protocol was employed, which 
was compatible with detection of proteins in the low femtomole range and 
identification by mass spectromety (Mortz et al., 2001; Shevchenko et al., 1996). The 
gel was fixed in a solution containing 50% methanol and 5% acetic acid for 20min, 
and then washed in a 50% methanol solution for 10min. The gel was then placed in 
ddH2O overnight at 4°C. The next morning, the gel was equilibrated to room 
temperature whilst fresh sensitiser, silver and developing solutions were made. The 
gel was incubated in the sensitiser solution (0.02% (w/v) sodium thiosulphate) for 
1min, washed for 2min in 4 changes of ddH2O and then incubated at 4°C for 20min 
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with pre-cooled 0.1% (w/v) silver nitrate solution. The gel was then washed with 
ddH2O for 1min, and the gel chamber changed. It was then washed in two changes of 
ddH2O for a further minute. The gel was placed in the developing solution of 2% 
(w/v) sodium carbonate and 0.04% (v/v) formalin, the latter added immediately 
before use. To reduce background staining, the developing solution was changed 
twice within the first 2min of incubation, and then subsequently once the colour of the 
developing solution started to change to yellow. The developing reaction was stopped 
with 5% acetic acid solution, once the staining of the protein bands of interest was 
sufficient. The gel was then washed with ddH2O and stored at 4°C until further 
analysis. 
2.9.4 Protein identification by mass spectrometry 
Background to the technique: Protein bands from gel electrophoresis were identified 
by mass spectrometry in collaboration with Dr. Robin Wait, Proteomics Unit, 
Kennedy Institute of Rheumatology. Mass spectrometry measures the relative 
molecular masses of ionised molecules and is reliant on the principle that ions of 
different masses can be resolved according to their response to electric (and magnetic) 
fields. Various methods can be used to ionise sample molecules and transfer them to 
the gas phase prior to mass analysis. In electrospray ionisation, the sample solution is 
passed through a needle at high electrical potential which is positioned near a small 
orifice leading into the mass spectrometer vacuum system. The solution is thus 
dispersed into extremely fine, highly charged droplets which contain protonated 
sample molecules. Evaporation of the solvent reduces the size of the droplets, 
increasing the charge density to the point where electrostatic repulsion causes droplet 
fission, which is followed by further solvent evaporation and fission, until only gas 
phase, protonated sample molecules remain. These are accelerated towards the orifice 
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plate of the spectrometer, which is maintained at an opposite electrical potential. Thus 
the sample molecules enter the vacuum system of the spectrometer for mass analysis.  
Electrospray is a so called soft ionisation technique, which means that little excess 
energy is imparted, so that predominantly protonated molecules (possibly of varying 
charge states) are produced. This enables determination of the mass of the intact 
sample, but does not in itself provide further structural information (such as amino 
acid sequence in the cases of peptides). It is therefore necessary to force the molecule 
to fragment after ionisation, usually by collision with a neutral gas such as argon or 
nitrogen. In the case of peptides, fragmentation occurs predominantly at the peptide 
bonds, resulting in a series of truncated peptide cations, differing by the masses of 
whole amino acids, which enables the sequence to be determined. These types of 
experiments are performed using tandem MS (MS-MS), in which two mass analysers 
are connected in series, with a region containing the collision gas between them. The 
first analyser then selects a precursor peptide ion (possibly present in a complex 
mixture) which is fragmented in the collision region, and the second mass analyser 
measures the masses of resulting fragments. Time-of-flight (Tof) analysis means that 
ions are boosted to the same kinetic energy, and the time taken for the ion to reach the 
detector measured. 
The peptide sequence can then be determined either by manual interpretation of the 
spectra, or more usually now, by computerised comparison of the fragment masses 
observed to the pattern of fragments calculated from a database of proteins with 
known sequence, which also enables a statistical assessment of the likelihood of a 
correct identification. For successful identification, the target sequence has to be 
present in the database used. For organisms where the complete genome sequence is 
available this is usually the case. However my studies used porcine material, and 
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unfortunately sequencing of the porcine genome is currently incomplete (though full 
expressed sequence tag (EST) coverage is now available), so protein identification 
sometimes required the presence in the database of the corresponding homologues 
from other mammalian species. 
In-gel digestion: Silver-stained protein bands were manually cut out of the gels for 
digestion with trypsin, as previously described (Shevchenko et al., 1996). Methods 
were adapted so that excised pieces of gel could be digested in specialised plates, 
carried out using a robotic digestion system (Investigator ProGest, Genomic 
Solutions, Huntingdon, UK) (Wait et al., 2001). The gel pieces were destained with a 
mixture of potassium ferricyanide and sodium thiosulphate washed with 50mM 
ammonium hydrogen carbonate buffer and dehydrated with acetonitrile, prior to 
reduction with DTT and blocking of SH groups with iodoacetamide. Gel pieces were 
then digested with modified trypsin (10μl at 6.5ng/ml in 25mM ammonium hydrogen 
carbonate) for 8h at 37°C, and peptides recovered by sequential extraction with 
25mM ammonium carbonate, 5% formic acid and acetonitrile. The pooled extracts 
were lyophilized and then dissolved in 0.1% formic acid prior to electrospray.  
Electrospray mass spectrometry: Tandem mass spectra were recorded with a 
quadrupole/orthogonal acceleration time-of-flight (q-Tof) mass spectrometer (Waters, 
Manchester, UK) interfaced to a Waters CapLC capillary chromatograph. Samples 
were dissolved in 0.1% (v/v) formic acid in ddH2O, injected onto a Pepmap C18 
column (LC Packings, Amsterdam, Netherlands) and eluted into the electrospray 
source with an acetonitrile/ 0.1% formic acid gradient. The capillary voltage was set 
to 3,500V and data-dependent MS/MS acquisitions were performed on precursors 
with charge states of 2, 3, or 4 over a survey mass range of 400-1400. Precursor ions 
were fragmented by collision with argon and the collision voltage was varied between 
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18-45V depending on the charge and mass of the precursor, using an empirically 
determined lookup table for each charge state. Proteins were identified by correlation 
of un-interpreted tandem mass spectra with entries in SwissProt/TREMBL, using 
ProteinLynx Global Server (Version 1.1, Micromass). No taxonomic, mass or pI 
constraints were applied. Two missed cleavages per peptide were allowed, and the 
fragment ion tolerance window was set to 100p.p.m. Carbamidomethylation of 
cysteine was set as a fixed modification, but other potential modifications were not 
considered in the first pass search. All matching database hits were manually 
reviewed, and if the reported score (ProteinLynx Global Server) was less than 100, 
additional searches were performed against the NCBI database using MASCOT, 
which utilises a robust probabilistic scoring algorithm. Measured parent and fragment 
masses were typically within 0.03Da of their theoretical values. 
2.10   Immunohistochemistry 
The phosphorylation of paxillin in synovium was assessed using 
immunohistochemical methods involving an avidin-biotin cascade technique. This 
was carried out in collaboration with D. Essex, senior histopathology technician, 
Kennedy Institute. Synovial samples were fixed in formalin for a minimum of 24h. 
Samples were then paraffin-embedded, and 4μm sections cut and placed on slides. 
Sections were incubated at 60°C for 1h, and then de-waxed in xylene for 2x 2min, 
rehydrated in 2 changes of absolute alcohol, and then washed in H2O. Sections were 
placed in citrate buffer (0.01M, pH 6.0) at room temperature, then warmed to 99°C 
and boiled for 10min (to aid in unmasking antigen), before cooling for 30min. 
Sections were washed in TBS, and then placed in 3% hydrogen peroxide in 30% 
methanol for 10min at room temperature, to block endogenous peroxidase activity. 
Sections were washed again in H2O, then blocked in 10% normal goat serum for 
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10min at room temperature. Sections were then incubated in rabbit anti-phospho-
paxillin antibody (1:50 dilution) for 1h at room temperature. Sections were washed 
twice in TBS, then incubated with secondary antibody (goat anti-rabbit 1:400) for 
35min at room temperature. After further washing in TBS, slides were incubated in 1 
in 100 dilution of Avidin Biotin Complex (ABC) for 35min at room temperature. 
3,3’-diaminobenzidine tetrahydrochloride (DAB, Vector Laboratories, Peterborough, 
UK) was used as a substrate for peroxidase. The DAB-hydrogen peroxide mixture 
was prepared immediately prior to use. The sections were incubated in this for 5min, 
then counterstained with Haematoxylin for 1min, differentiated in 0.5% acid alcohol 
and then washed extensively in running water. Sections were dehydrated in alchohol, 
cleared with xylene and mounted in Pertex. DAB formed a brown reaction product at 
the site of the antigen, which if present, was visible by light microscopy. Sections 
were visualized with a Leitz Dialux 22EB light microscope and representative images 
recorded using Spot software, Diagnostic Instruments Inc., Michigan, USA. 
2.11 Statistics 
Unpaired t-tests were employed to compare samples, with a P value <0.05 considered 
significant. Data was analysed using Graphpad Prism and Microsoft Excel software, 
2003. 
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3 Inflammatory signalling and gene expression in 
injured articular cartilage 
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3.1 Introduction 
Our laboratory studies wounding of cartilage as a simple, reproducible, scaleable 
model of injury. It is essential to study injury of intact cartilage on the articular 
surface because its response differs from that of cartilage adapted to culture. For 
example, re-cutting cultured explants does not re-activate JNK. We have not 
attempted injurious loading, because it is technically difficult to deliver to an intact 
articular surface. 
Although it had been shown that the three MAPK pathways were activated rapidly 
upon explantation, and that there was also some degradation of IκBα, activation of 
IKKs had not been investigated (Gruber et al., 2004). In this chapter, I further 
examined activation of intracellular signalling mechanisms in cartilage by injury, and 
in particular IKK. I also investigated to what extent the signalling induced genes 
characteristic of an inflammatory response and, by the use of pharmacological 
inhibitors, the importance of individual pathways for expression of two such genes. 
3.2 The MAPKs are rapidly activated by explantation of 
articular cartilage 
The published experiments showing activation of p38 MAPK and JNK following 
explantation employed immunoprecipitation kinase assays (Gruber et al., 2004). Since 
that time, the laboratory has used antibodies to the phosphorylated forms of these 
kinases to assess their activation state by western blotting of cartilage lysates. These 
western blotting assays use less tissue than the kinase assays which make them 
preferable. In the case of phospho-JNK, only one antibody (mouse monoclonal #9255, 
Cell Signaling Technology, Beverly, USA) had proved successful with cartilage 
samples, but different batches behaved variably. An additional problem encountered 
with cartilage extracts was that the porcine IgG heavy chain (present in the tissue) 
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stained with the secondary antibody and obscured the larger JNK isoform. JNK 
phosphorylates the AP-1 transcription factor ATF-2. ATF-2 may also be a substrate 
for p38 MAPK (Morton et al., 2004). There is evidence in other tissues that there are 
negative regulators of ATF-2 such as Kruppel-like factor 2 (KLF-2) (Fledderus et al., 
2007). ATF-2 is abundant in cartilage and can be detected with antibodies to 
phosphorylated ATF-2.  Prior studies by members of our group using these antibodies 
have shown that IL-1 induction of phospho-ATF-2 was not inhibited by a p38 
inhibitor or the MEK inhibitor U0126, and that FGF-2, which strongly activates ERK, 
did not induce phosphorylation of ATF-2 (A. Didangelos, Ph.D. thesis, 2008). This 
suggested that in cartilage ATF-2 may be an indicator of JNK activation. Figure 3.1 
shows that when cartilage was explanted into medium and left for 10min there was 
induction of ATF-2 phosphorylation, compared with cartilage dissected immediately 
from the articular surface into lysis buffer (0min). However, if cartilage was explanted 
immediately into a solution of p38 MAPK inhibitor SB202190 and cultured for 
10min, there was no inhibition of phospho-ATF-2 (Fig 3.1). (It appeared that 
phosphorylation of ATF-2 was enhanced). This experiment suggested that ATF-2 was 
not being phosphorylated by p38 MAPK upon cartilage dissection. Given that the 
phospho-ATF-2 antibody was sensitive and reliable in western blotting of porcine 
cartilage lysates, I have used this as an indicator of JNK activation.  
To investigate how rapidly the MAPK pathways were activated by explantation, 
cartilage pieces (about 0.2g of tissue) were dissected from the surface of the porcine 
compound MCP joint into serum-free medium and cultured for the increasing times 
indicated prior to lysis in ice cold RIPA buffer (Fig 3.2). (Trotters were equilibrated at 
37°C prior to the experiment).  
 
Chapter 3                             Inflammatory signalling and gene expression in injured articular cartilage 
 100
 
 
 
 
- SB      DM      Agent in medium
0       10       10 Time after dissection (min)    
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Figure 3.1. The p38 inhibitor SB202190 does not reduce the phosphorylation of 
ATF-2 which is caused by explantation of articular cartilage.
Trotters were equilibrated at 37°C for 4h. ~0.2g cartilage was dissected either 
immediately into ice cold lysis buffer (-,0), or into medium containing 10μM 
SB202190 (SB) and cultured for 10min, or dissected into medium containing 
0.1%DMSO alone (DM) and cultured for 10min prior to lysis. Cartilage lysates
were assayed for phospho-ATF-2 by western blotting. The membrane was stripped 
and re-probed with ERK to ensure equal cellular protein loading. This is 
representative of 2 experiments.
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Figure 3.2. The mitogen activated protein kinases are activated following 
explantation of articular cartilage.
Trotters were equilibrated at 37°C prior to dissecting ~0.2g cartilage from separate 
joints for each point immediately into lysis buffer (0) or into serum-free medium 
and cultured for increasing times indicated prior to lysis. Cartilage lysates were 
assayed for phospho-ATF-2, phospho-p38 and phospho-ERK by western blotting. 
The membrane was stripped and re-probed for ERK to ensure equal cellular protein 
loading. 
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As a control, cartilage was dissected immediately from the articular surface into lysis 
buffer, to detect the baseline phosphorylation of kinases in the tissue (0min). 
Increased phosphorylation of ERK, p38 MAPK and ATF-2 could be seen within one 
minute of dissection (Fig 3.2). Activation of ATF-2 and p38 was maximal by 5-10min 
and had returned almost to baseline by 60min (Fig 3.2). This was comparable with the 
response of cartilage to IL-1 (not shown). The activation of ERK was more sustained, 
which was in-keeping with previous results (Vincent et al., 2002). To check for equal 
loading of cellular protein, the membrane was stripped and re-probed with an 
antibody to ERK 1 and 2 proteins.  
3.3 IKK activity is increased following injury to articular 
cartilage 
To test the possibility that the canonical NFκB pathway was activated by cartilage 
explantation, an immunoprecipitation kinase assay for IKK was employed (see 
Materials & Methods, section 2.6.1). Initial experiments were performed on primary 
porcine chondrocytes. Confluent monolayers were serum starved for 2h and then 
stimulated with IL-1α, a known activator of IKK, for the times indicated prior to lysis 
in non-dissociative kinase assay lysis buffer. The chondrocyte lysates were incubated 
overnight with agarose beads coated with antibody to IKKγ, and the ability of the 
immunoprecipitated IKK heterotrimeric complex (α,β,γ) to phosphorylate the 
substrate GST-IκBα was assessed by incubation with [γ-32P]ATP. The 
phosphorylation reaction was terminated by boiling the reaction mixture with SDS 
sample buffer prior to electrophoresis of the supernatant. Proteins were transferred on 
to a PVDF membrane which was exposed to film overnight, and also quantified using 
a phosphorimager. IKK activity in lysates from IL-1 stimulated chondrocytes was 
increased at 5min and reached a peak at 30-60min (Fig 3.3A). 
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Figure 3.3. IL-1α induces IKK activity in (A) isolated chondrocytes and 
(B) cartilage explants.
A. Porcine primary chondrocytes (2 million cells per point) were serum 
starved for 3h, then stimulated for increasing times indicated with serum-free 
medium containing 10ng/ml IL-1α (IL-1) or the medium changed (0). The 
medium was then aspirated and 120μl kinase assay lysis buffer added per 
well. IKK was immunoprecipitated from the chondrocyte lysates and IKK 
activity assayed on the substrate GST-IκBα. 
B. Porcine cartilage explants were rested for 24h in serum-free medium, then 
stimulated with serum-free medium containing 100ng/ml IL-1α for the times 
indicated. The medium was then aspirated and the explants lysed in 600μl 
kinase assay lysis buffer for 2h. IKK was immunoprecipitated from the 
lysates and IKK activity assayed on the substrate GST-IκBα. 
For both experiments, quantitation of phosphorylation of the substrate is 
shown as a % of a 0 measurement. The membrane was stripped and re-
probed for IKKα to ensure equal immunoprecipitation of the IKK complex 
from samples. 
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Some baseline IKK activity at 0min was evident (cells serum starved and not 
stimulated by IL-1). The membranes were probed for IKKα, another member of the 
complex, to ensure equal loading of the lanes. A similar assay was carried out using 
rested cartilage explants.  
Approximately 0.5g cartilage was dissected and rested in serum-free medium for 24h 
prior to stimulation with IL-1α for increasing times prior to lysis and 
immunoprecipitation kinase assay. IL-1 stimulation caused over 10 fold increase in 
the ability of the precipitates to phosphorylate IκBα, again peaking at 30min (Fig 
3.3B). 24h after stimulation, IKK activity was undetectable (below that in 
unstimulated explants, 0min).  
To assess whether there was increased IKK activity after explantation of articular 
cartilage, porcine trotters were equilibrated at 37°C prior to ~0.2g cartilage from each 
of 2 MCP joints being dissected into serum-free medium and left for increasing times 
prior to lysis and assay. To detect baseline activity, cartilage was dissected 
immediately from the articular surface into a tube on dry ice, prior to lysis. Some IKK 
activity was detected in these ex vivo samples. In response to explantation, there was 
increased IKK activity that was maximal at 5min (Fig 3.4). This peak of IKK activity 
was earlier than the peak seen following IL-1 stimulation of either cartilage explants 
or isolated chondrocytes (Fig 3.3A&B). In three separate experiments there was on 
average an 8 fold increase in IKK activity at 5 min after explantation compared with 
ex vivo cartilage (Fig 3.4B). By 30min, there was a 3 fold increase over baseline 
activity. 
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Figure 3.4. Explantation of cartilage rapidly induces IKK activity.
A. Trotters were equilibrated at 37°C prior to dissection of ~0.2g 
cartilage from each of two MCP joints either immediately into lysis
buffer (0) or into serum-free medium and culture for increasing times 
indicated prior to lysis. IKK was immunoprecipitated from the cartilage 
lysates and IKK activity assayed on the substrate GST-IκBα. 
Autoradiography of the membrane is shown (upper panel). Quantitation
of phosphorylation of the substrate is shown as a % of the 0 
measurement. The membrane was stripped and re-probed for IKKα to 
ensure equal immunoprecipitation of the IKK complex from samples. 
B. The results from 3 similar experiments were pooled. The 
measurement of IKK activity from 0 points from individual 
experiments was normalised to 100%, and quantitation of IKK activity 
of other samples expressed as a % of this. The bars show the mean % 
integral and the error bar shows the standard deviation of these
measurements. ***=P=0.0006 vs. 0min, by unpaired t-test.
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The activation of IKK in these experiments could have been due to an effect of 
culture medium on the cartilage. To investigate this possibility, the response of the 
intact articular surface to scoring was investigated. Trotters were equilibrated at 37°C 
prior to opening the joint and scoring with a scalpel (see Materials & Methods for 
details, section 2.2.2). Cartilage was dissected either immediately after scoring into 
lysis buffer or after 5 min. As a control, cartilage which had not been scored was 
dissected into medium and cultured for 5min. The lysates were assayed for IKK 
activity. The IKKα western blot suggested that the scored lane was somewhat 
overloaded compared with the control, and so quantitation of these bands was 
performed. Normalising for IKKα, a 4 fold increase was seen in response to scoring 
(Fig 3.5). 
It was possible that the activation of IKK following cartilage injury was due to release 
of a soluble mediator, perhaps from cells upon damage, or from the matrix. If this was 
the case, re-cutting rested cartilage, or stimulating rested explants with conditioned 
medium from finely cut fresh cartilage should cause re-activation of the pathway. 
Cartilage explants were rested for 48h in serum-free medium prior to stimulation with 
IL-1, or cutting the cartilage finely, and culturing for a further 30min (the peak of 
IKK activity following IL-1 stimulation), or stimulating the cartilage for 30min with 
medium conditioned for 30min by finely chopped cartilage. I also tested the effect of 
FGF-2, since it is known to be released from cartilage on cutting, although it would 
not be expected to activate NFκB. None of these stimuli other than IL-1 increased 
IKK activity in the explants (Fig 3.6).  
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Figure 3.5. Scoring the intact articular surface activates IKK.
Trotters were equilibrated at 37°C prior to: fine scoring with a scalpel 
of the articular surface and immediate dissection of the cartilage 
immediately into lysis buffer (0), or dissection of the cartilage into 
serum-free medium and culture for 5min prior to lysis (Ex), or fine 
scoring of the articular surface and incubation at 37°C for a further 
5min, prior to rapid dissection of the scored cartilage into lysis buffer 
(Score). IKK was immunoprecipitated from the cartilage lysates and 
IKK activity assayed on the substrate GST-IκBα. Autoradiography is 
shown. Quantitation of phosphorylation of the substrate is shown as a 
% of the 0 measurement, normalised for IKKα staining. The 
membrane was stripped and re-probed for IKKα to ensure equal 
immunoprecipitation of the IKK complex from samples. This is 
representative of 2 experiments.
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Figure 3.6. Re-cutting cartilage, treatment with conditioned medium or 
treatment with FGF-2 does not re-activate IKK in cartilage explants.
Cartilage explants (~0.5g per point) were rested for 48h in serum-free 
medium and then treated in the following ways: cut into 2 x 2mm squares 
and cultured for 30min (recut), incubated with medium which had been 
conditioned with freshly re-cut explants for 30min (CM), incubated with 
50ng/ml FGF-2 for 30min (FGF) or incubated with 100ng/ml IL-1α for 
30min (IL-1) prior to lysis, or immediately placed in lysis buffer (0). IKK 
was immunoprecipitated from the explant lysates and IKK activity assayed 
on the substrate GST-IκBα. Quantitation of phosphorylation of the substrate 
is shown as a % of a 0 measurement. The membrane was stripped and re-
probed for IKKα to ensure equal immunoprecipitation of the IKK complex 
from samples. This is representative of 2 experiments.
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3.4 PI3 kinase is activated by explantation of cartilage 
It was possible that other signalling pathways known to be activated by growth factors 
or cytokines might be activated by cartilage explantation. Phosphorylation of Akt, a 
downstream substrate of PI3 kinase, is conventionally used as a read-out for 
activation of the PI3 kinase pathway. Cartilage explants were rested for 48h prior to 
stimulation with FGF-2 for increasing times prior to lysis, or left unstimulated. 
Phosphorylation of Akt was strongly induced within 10min of stimulation with FGF-2 
(Fig 3.7). IL-1α was also used as a stimulus since there is little literature on the 
actions of inflammatory stimuli on this pathway. IL-1 was a weaker inducer of 
phosphorylation of Akt than the growth factor. The membrane was stripped and re-
probed with antibodies to phosphorylated ERK. ERK phosphorylation was also seen 
with both stimuli, and again, the activation was stronger with FGF. To check for equal 
loading of cellular protein, the membranes were stripped and re-probed for total ERK. 
The effect of explantation was then tested. Figure 3.8 shows there was strong increase 
of phosphorylation of Akt by 5min which was sustained for 1h, but had declined to 
basal level after 20h.  
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Figure 3.7. Akt is phosphorylated in response to stimulation of 
cartilage explants with either FGF-2 or IL-1α. 
~0.5g cartilage explants were rested in serum-containing medium for 24h, 
and then serum starved for a further 24h prior to immediate lysis (0) or 
stimulation with 250ng/ml FGF-2 (FGF) or 100ng/ml IL-1α (IL-1) for 
increasing times prior to lysis. Lysates were assayed for phospho-Akt by 
western blotting. The membrane was stripped and re-probed for 
phosphorylated and total ERK.
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Figure 3.8. PI3 kinase is activated following explantation of cartilage.
~0.5g cartilage was dissected either directly into lysis buffer (0) or into 
serum-free medium and cultured for increasing times indicated prior to lysis. 
Cartilage lysates were assayed for phospho-Akt by western blotting. The 
membrane was stripped and re-probed for ERK to ensure equal cellular 
protein loading.
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3.5 Inflammatory response gene induction in articular 
cartilage 
It was apparent that various signalling pathways were activated by articular cartilage 
injury, some that were probably due at least in part to release of FGF-2 (ERK, p38 
MAPK and perhaps PI3 kinase) and some possibly FGF-independent (JNK, NFκB). I 
next investigated to what extent such signalling induced expression of inflammatory 
response genes.  
A panel of 12 inflammatory response genes was selected. This included typical 
inflammatory response genes such as COX-2 and iNOS, cytokines (IL-1, IL-6), 
chemokines (IL-8) and proteinases relevant to cartilage physiology (ADAMTS-4,-5, 
MMP-1,-3 and -13). TIMP-1 was included as it was known to be induced by FGF 
stimulation of chondrocytes (Vincent et al., 2002). Activin A was included because 
the laboratory had previously identified it on proteomic analysis of cultured human 
cartilage. It is induced in cell culture by inflammatory cytokines and growth factors 
(Hubner and Werner, 1996). The PCR identifies the mRNA for inhibin βA, the 
subunit of activin A.  
In order to establish the method for extracting RNA from cartilage, preliminary 
experiments were carried out on IL-1 stimulated tissue. GAPDH was selected as a 
house-keeping gene. In some experiments, GAPDH appeared to be regulated by IL-1 
or FGF, particularly after prolonged stimulation e.g. 20h. Because of this, 4h or 
shorter time points were used where possible. Since these experiments were 
performed, there has been increased discussion of this issue in the literature. 
Alternative house-keeping genes were not tested, as GAPDH was felt to be adequate 
for the purpose of looking for strong regulation of genes. As expected, mRNAs of all 
of these genes were up-regulated in cartilage after 4h of IL-1 treatment (Fig 3.9).  
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Figure 3.9. IL-1 induces inflammatory response gene mRNAs in rested 
cartilage explants. 
Porcine articular cartilage was dissected into serum-free culture medium, washed 
3 times and rested for 24h. Explants were then stimulated for 4h with culture 
medium alone (-) or culture medium containing 20ng/ml IL-1α (+). Cartilage was 
immediately homogenised in ice cold TRI reagent prior to RNA extraction and 
RT-PCR for various inflammatory response genes. PCR products were 
electrophoresed on a 1.2% agarose gel and stained with SYBR Green. GAPDH is 
shown as a house-keeping control. The results shown are representative of 3 
similar experiments.
Abbreviations: Glyceraldehyde 3 phosphate dehydrogenase (GAPDH); interleukin (IL); 
cyclooxygenase (COX)-2; matrix metalloproteinase (MMP); A Disintegrin And 
Metalloproteinase with ThomboSpondin Motif (ADAMTS); inducible nitric oxide synthase
(iNOS); Tissue Inhibitor of Metalloproteinases (TIMP)
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The optimum cycle number to detect a difference between control and IL-1 stimulated 
explants for all PCRs was recorded. This meant that future RT-PCR for inflammatory 
response genes could be semi-quantitative. The SYBR Green dye used in these initial 
experiments caused differences in the migration of PCR products. This is a well-
recognised phenomenon when pre-staining cDNA with SYBR Green. Higher DNA 
concentrations (over 50ng/band) cause a significant alteration of mobility (Miller et 
al., 1999). To prevent this, ethidium bromide was added to gels in further 
experiments.  
3.6 Inflammatory response genes are regulated by 
explantation of articular cartilage 
Experiments were then performed to find out which of these genes were induced by 
injury. Cartilage was dissected either directly into ice cold TRI reagent for RNA 
extraction, or cultured in serum-free culture medium for 4 or 20h. Some cartilage was 
cultured for 4h in medium containing IL-1 as a positive control. GAPDH again served 
as the house-keeping gene. 8 out of the 12 mRNAs were induced at 4h after 
explantation (Fig 3.10A, Expt 1). These were COX-2, IL-1α, IL-6, the three MMPs, 
ADAMTS-4 and inhibin βA. Induction of these genes was stronger when the cartilage 
was explanted into IL-1 (n.b. the strength of the GAPDH band suggests the IL-1-
treated samples may be underloaded). Some genes (iNOS, IL-8, ADAMTS-5) which 
were not induced at 4h by explantation alone, were induced when IL-1 was present. 
Additional data from a separate experiment is shown in support of some of these 
findings (Fig 3.10A, Expt 2).  
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Figure 3.10A. Inflammatory response gene induction is seen 4 hours after 
explantation of articular cartilage. 
Porcine articular cartilage was dissected directly into ice cold TRI reagent and 
homogenised prior to RNA extraction (0) or cultured in serum-free medium for either 4 or 
20h +/- 10 ng/ml IL-1α prior to homogenisation and RNA extraction. RT-PCR products 
were electrophoresed on a 1.2% agarose gel and stained with ethidium bromide. GAPDH 
is shown as a house-keeping gene control. The results shown are representative of 4 
separate experiments. Results from 2 separate experiments are shown.
Time after dissection (h)
Time after dissection into IL-1 (h)
0    4   20   - 0     4   20    -
- - - 4          - - - 4
COX-2
MMP1
ADAMTS-4
iNOS
IL-8
GAPDH
ADAMTS-5
IL-1α
IL-6
MMP13
MMP3
TIMP1
Inhibin βA
Expt 1                       Expt 2
 
 
Chapter 3                             Inflammatory signalling and gene expression in injured articular cartilage 
 116
It was possible that there was induction of iNOS, IL-8, ADAMTS-5 or TIMP-1 before 
4h. The RNA extraction was therefore carried out at earlier times (Fig 3.10B). 
GAPDH in this experiment is apparently regulated by IL-1. IL-8 mRNA was not 
induced at any time. There was only convincing induction of COX-2, MMPs and 
ADAMTS-4 at 2h after explantation.  
3.7 FGF-2 induces some of the inflammatory response 
genes seen following cartilage injury 
The induction of inflammatory response mRNAs on explantation could perhaps be 
due in part to the release of FGF-2. Five of the mRNAs were reproducibly induced by 
FGF-2 stimulation of cultured explants: COX-2, MMP-1, MMP-3, TIMP-1 and 
inhibin βA (Fig 3.11). The induction of these mRNAs by FGF-2 was in keeping with 
published data (Hermansson et al., 2004; Vincent et al., 2002). These experiments do 
support the hypothesis that the signalling following cartilage injury is sufficient to 
induce a range of inflammatory response genes, including proteinases, in cartilage. To 
what extent the induction is due to FGF-dependent and FGF-independent signalling 
pathways is unclear. 
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Figure 3.10B. Inflammatory response gene induction is seen 2 hours after 
explantation of articular cartilage. 
Porcine articular cartilage was dissected directly into ice cold TRI reagent and 
homogenised prior to RNA extraction (0 h) or cultured in serum-free culture 
medium for either 0.5, 1 or 2h +/- 10ng/ml IL-1α prior to homogenisation and 
RNA extraction. RT-PCR products were electrophoresed on a 1.2% agarose gel 
and stained with ethidium bromide. GAPDH is shown as a house-keeping gene 
control. The results shown are representative of 2 similar experiments.
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Figure 3.11. FGF-2 induces some inflammatory response mRNAs in 
rested cartilage explants.
Porcine articular cartilage was dissected into serum-free culture medium, 
washed 3 times and rested for 24h. Explants were then stimulated for 4h 
with culture medium alone (-), or medium containing 20ng/ml FGF-2 (+). 
Cartilage was immediately homogenised in ice cold TRI reagent prior to 
RNA extraction and RT-PCR for various inflammatory response genes. 
PCR products were electrophoresed on a 1.2% agarose gel and stained 
with ethidium bromide. GAPDH is shown as a house-keeping control. 
Results from 2 separate experiments are shown.
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3.8 Measurement of activin A and COX-2 protein production 
in cartilage following injury  
Explantation of cartilage was sufficient to induce mRNA of a number of 
inflammatory response genes. It was important to establish whether there was 
increased protein expression for any of these genes. There were no quantitative assays 
available for porcine MMPs or IL-6. I decided to study activin A since we had 
previously measured the protein by ELISA in cartilage cultures (S. Alexander, Ph.D. 
thesis, 2005). It was possible that the release of activin A by articular cartilage was 
partly by passive leaching from the tissue of previously synthesised protein. If this 
was the case, its production would not be affected by inhibition of protein synthesis, 
or by killing the cells. However, the production of activin A following explantation 
was largely prevented by either dissecting the cartilage into the protein synthesis 
inhibitor cycloheximide, or by freeze-thawing the cartilage before culture (Fig 3.12). 
Thus the production of activin A was due to synthesis during culture. This and the 
observation that the secretion of activin A by cartilage following injury was partially 
FGF-dependent, had been previously made within our group (S. Alexander, Ph.D. 
thesis, 2005).  
COX-2 protein production was also investigated. It was seen at 4h following 
explantation by western blotting cartilage lysates. Its expression was strong at 8 and 
16h, and was maintained at 24h (Fig 3.13).  
The signalling following explantation was therefore sufficient to induce expression of 
inflammatory response genes at the level of both mRNA and protein. I wanted to use 
pharmacological inhibitors to find out which signalling pathways mediated the 
expression of particular genes. To do this, I needed to study a strongly regulated gene 
whose protein could be measured accurately. Activin A fulfilled these criteria. 
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Figure 3.12. Secretion of activin A by dissected cartilage is an active 
cellular process.
Porcine cartilage was dissected and cultured for 16h in 1g/ml serum-free 
culture medium. Some explants were cultured with 10μg/ml 
cycloheximide, some were frozen and thawed 3 times before culture, and 
some were left untreated. Activin A in the medium was measured by 
ELISA. Bars show the mean +/- S.D. of triplicate cultures. ***=P<0.0001 
vs. untreated cultures, by unpaired t-test.
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0          4          6          8          16         24   Time after dissection
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74 kD
Figure 3.13. COX-2 protein is seen 4 hours after dissection of cartilage 
from the articular surface. 
Porcine articular cartilage was either dissected immediately into ice cold 
lysis buffer (0) or into serum-free medium and cultured for the times 
specified (h) prior to lysis. Cartilage lysates were assayed for COX-2 by 
western blotting. The blot was stripped and re-probed for ERK to ensure 
equal loading of cellular protein. This is representative of 3 similar 
experiments.
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3.9 Testing the efficacy of pharmacological inhibitors of 
signalling pathways 
Pharmacological inhibitors of signalling pathways were selected, many of which are 
well-characterised and have been widely used (see Materials & Methods, Table 2.3). 
However, the inhibitors of JNK and IKK were less well-characterised and were first 
tested in cell-based assays. 
3.9.1 JNK inhibitors 
The anthrapyrazolone compound SP600125 is reported to be a selective JNK inhibitor 
(Bennett et al., 2001). Cultured porcine chondrocytes were incubated with increasing 
concentrations of this inhibitor, and then stimulated with IL-1α. The cell lysates were 
assayed for phospho-ATF-2 by western blotting. As previously discussed, 
phosphorylation of ATF-2 is an indicator of JNK activity in this system (Fig 3.1). The 
vehicle DMSO, when added to the culture medium did not cause phosphorylation of 
ATF-2. Increasing concentrations of SP600125 from 1-100μM did not inhibit IL-1 
induced phosphorylation of ATF-2 in chondrocytes, and even appeared to enhance 
phosphorylation (Fig 3.14A).  
L-JNKI is a cell permeable peptide which is reported to inhibit the phosphorylation of 
c-jun by JNK in neuronal cells (Borsello et al., 2003). This compound was tested and 
also failed to inhibit IL-1-induced ATF-2 phosphorylation in chondrocytes (Fig 
3.14B). It was decided to abandon use of putative JNK inhibitors, since no validated 
convincing inhibitor for use in cell experiments is available. 
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A
B
L-JNKI (μM)        - - 10      1      10     20      - -
phospho-ATF-2
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DMSO (%) - - - - - - - 0.005 0.05  0.5    - - -
IL-1 IL-1
phospho-ATF-2
IL-1
Figure 3.14. The JNK inhibitors (A) SP600125 and (B) L-JNKI are not 
effective when tested on IL-1 stimulated porcine primary chondrocytes.
For both A.& B., porcine primary chondrocytes (2 million cells per well) were 
serum starved for 3h, then pre-incubated for 30min with medium alone (-) or 
medium containing increasing concentrations of either A. SP600125 or B. L-
JNKI, or equivalent concentrations of the vehicle DMSO. Chondrocytes were 
then stimulated for 20min with serum-free medium alone (first 2 lanes), 
medium +/- fresh inhibitor plus IL-1α 10ng/ml (IL-1) or medium +/- fresh 
DMSO. The medium was then aspirated and 250μl dissociative lysis buffer 
added per well. Chondrocyte lysates were assayed for phosphorylated ATF-2 
by western blotting. For B., the membrane was stripped and re-probed for 
ERK to ensure equal loading.
Both A. and B. are each  representative of 2 experiments.
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3.9.2 NFκB and PI3 kinase inhibitors 
BMS345541 (4-(2’aminoethyl)amino-1,8-dimethylimidazo[1,2-a]quinoxaline) is an 
inhibitor of IKK (Burke et al., 2003). Its effects were tested on primary porcine 
chondrocytes stimulated with 20ng/ml IL-1, and the lysates were western blotted for 
IκBα. IL-1 caused degradation of IκBα as predicted (Fig 3.15A). This degradation 
was partially inhibited by 10μM BMS345541. The membrane was stripped and re-
probed with ERK to ensure equivalent cellular protein loading. Quantitation of the 
western indicated a 30% reduction in IL-1-induced IκBα degradation in response to 
10μM of this inhibitor. A similar effect was seen in a separate experiment. Whether 
this effect of BMS345541 is sufficient to affect subsequent translocation and 
activation of NFκB was not assessed. An alternative inhibitor of NFκB signalling is 
MG132. This small peptide aldehyde proteasome inhibitor prevents proteasomal 
degradation of phosphorylated, ubiquitinated IκBα and thus inhibits NFκB activation 
(Jiang et al., 2004). It has been widely used for this purpose, and was therefore 
employed in addition to BMS345541 in subsequent experiments.  
LY294002 is a widely used inhibitor of PI3 kinase. Its effectiveness at inhibiting 
phosphorylation of Akt was tested in chondrocytes. LY294002 prevented FGF-
induced phosphorylation of Akt in chondrocytes at 1 and 10 μM (Fig 3.15B). 
3.9.3 Inhibitors of MEK and of the FGF receptor tyrosine kinase 
U0126 is an inhibitor of activation of MEK, the kinase kinase of the ERK pathway, 
and is well-characterised and specific for this kinase when tested in vitro (Davies et 
al., 2000).  
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Figure 3.15. Testing inhibitors of (A) IKK and (B) PI3 kinase pathway on primary 
chondrocytes.
A. Porcine primary chondrocytes (2 million cells per point) were serum starved for 3h, 
then pre-incubated for 30min with medium alone (-) or medium containing increasing 
concentrations of the diluent DMSO or the IKK inhibitor BMS345541. Chondrocytes
were then stimulated for 20min with serum-free mdium alone, the inhibitor alone, or 
medium +/- DMSO or fresh inhibitor containing 20ng/ml IL-1α. The medium was then 
aspirated and 250μl lysis buffer added per well. Chondrocyte lysates were assayed for 
IkBα by western blotting. 2 different experiments are shown. Quantitation of the blots are 
shown as a % of a 0 measurement. The membranes were stripped and re-probed for ERK. 
B. Porcine primary chondrocytes (2 million cells per point) were serum starved for 3h, 
then pre-incubated for 30min with medium alone (-) or medium containing the vehicle 
DMSO, or medium containing the PI3 kinase inhibitor LY294002 1μM or LY294002 
10μM. Chondrocytes were then stimulated for 30min with serum-free medium alone +/-
DMSO (lanes 1-3), or medium +/- fresh inhibitor plus FGF-2 20ng/ml (FGF). The 
medium was then aspirated and 250μl dissociative lysis buffer added per well. 
Chondrocyte lysates were assayed for phosphorylated Akt by western blotting. 
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PD173074 (also known as SB402451) is in the pyrido[2,3-d]pyrimidine class of 
tyrosine kinase inhibitors (Hamby et al., 1997). It is an ATP-competitive inhibitor of 
FGF receptor 1, and also has a weaker effect on the vascular endothelial growth factor 
receptor. It poorly inhibits other tyrosine kinases such as srcs, and receptors of IGF, 
EGF and PDGF, and other protein kinases such as protein kinase C and MEK 
(Mohammadi et al., 1998). It was initially obtained from GlaxoSmithKline, who had 
shown that it inhibited FGF induced ERK activation with an IC50 of about 10nM 
(Skaper et al., 2000). Both inhibitors had been tested previously by our group on 
porcine chondrocytes. PD173074 inhibited FGF-2 induced ERK activation in 
chondrocytes. It also inhibited PDGF induced ERK activation at a similar IC50, but 
did not inhibit activation of ERK by IGF-1 (T. Vincent, Ph.D. thesis, 2002). 
PD173074 at a concentration of 50nM was also shown to prevent the re-activation of 
ERK by re-cutting of cartilage explants (Vincent et al., 2002). Effectiveness of 
PD173074 and U0126 at inhibiting ERK activation following cartilage explantation is 
shown later in Figure 3.18. 
3.10  Activin A production in chondrocyte and explant 
culture 
I wanted to investigate firstly, which of the FGF-induced pathways was involved in 
the expression of activin A following explantation, and secondly, whether 
inflammatory signalling was also involved (see Ch 1, Figs 1.1 & 1.2).  
Cultured primary chondrocyte monolayers should provide the simplest way to test the 
effects of signalling pathway inhibitors. Chondrocytes were therefore isolated and 
rested for 48h, prior to serum starvation and stimulation with FGF-2 for 18h. I also 
tested the effects of TGFβ and IL-1α for purposes of comparison. Activin A levels 
were measured by ELISA in the medium. FGF-2 stimulation of chondrocytes caused 
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only a doubling of activin A production compared with control (Fig 3.16A). This was 
far less marked than the response to IL-1α, or the response to explantation (Fig 3.12).  
It was possible that cartilage explants would behave differently to cultured 
chondrocytes. Rested cartilage explants were stimulated with FGF-2, TGFβ or IL-1α, 
or left untreated. Untreated cartilage explants produced moderate amounts of activin 
A and none of the agents significantly increased this (Fig 3.16B). The rested explant 
cultures responded differently to IL-1 compared with chondrocyte monolayers with 
respect to activin A production, despite the IKK response to IL-1 in chondrocytes and 
explants being similar (Fig 3.3). This was surprising and perhaps suggested that IL-1 
might activate different pathways in chondrocytes and explants, and that more than 
one pathway may be required for the response. Re-cutting is known to cause FGF-2 
release and ERK activation. Re-cutting of rested explants caused an increase in 
activin A production (Fig 3.17). However, the magnitude of the response was not as 
great as that seen in freshly dissected tissue. This may be related to the fact that the 
signalling response of cultured cartilage and the intact articular surface differ: JNK is 
known to be refractory to re-cutting, for example (A. Didangelos, Ph.D. thesis, 2008) 
and I have also shown that IKK is not re-activated by re-cutting (Fig 3.6). Given that I 
could not reproduce the strength of induction of activin A caused by injury using 
defined stimuli or re-cutting in culture, I returned to study the effects of 
pharmacological inhibitors on the production of activin A following explantation, as 
in Figure 3.12. 
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Figure 3.16. Secretion of activin A by (A) cultured primary chondrocytes
and (B) cartilage explants in response to FGF-2, IL-1α and TGFβ.
A. Porcine primary chondrocytes (2 million cells per point) were serum starved 
for 5h and then stimulated with serum-free medium containing 20ng/ml FGF-2, 
10ng/ml IL-1α or 20ng/ml TGFβ, or medium alone (-) for 18h. The medium 
was then aspirated, clarified and assayed for activin A by ELISA. 
B. ~0.5g porcine cartilage explants were rested in serum-containing medium for 
24h, and then serum starved for a further 24h. Explants were then stimulated 
with 1ml serum-free medium/g tissue containing FGF-2 250ng/ml, IL-1α
100ng/ml or TGFβ 100ng/ml, or medium alone (-) for 16h. The medium was 
then aspirated, clarified and assayed for activin A by ELISA. 
Bars show mean +/- S.D. from triplicate cultures. **=P=0.0004 vs. untreated 
chondrocytes (-), by unpaired t-test. Both A. and B. are representative of 2 
experiments. 
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Figure 3.17. Activin A release following the re-cutting of cartilage 
explants.
~0.5g cartilage explants were rested for 24h in serum-free culture medium 
prior to re-cutting the cartilage into 2 x 2mm pieces (recut), or leaving the 
cartilage untreated (-). Cartilage was then cultured for 17h prior to 
clarification of medium and assay for activin A by ELISA. Bars show 
mean +/- S.D. of triplicate cultures. *=P<0.04 vs. untreated cultures, by 
unpaired t-test. These results are representative of 2 separate experiments.
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Given that activation of inflammatory signalling caused by explantation is very rapid, 
it was suspected that to achieve maximal inhibition of signalling with pharmacologic 
agents in tissues it would be better, rather than simply dissecting the cartilage into a 
solution containing the inhibitor, also to inject the inhibitor into the joint, so that it 
could diffuse through the cartilage before injury occurred. To test the effectiveness of 
PD173074 and U0126 in inhibiting the activation of ERK following explantation, the 
inhibitors were injected into porcine MCP joints. After 2h the joints were opened and 
articular cartilage dissected either immediately into lysis buffer, or into medium with, 
or without, the inhibitor and cultured for 30min prior to lysis. The lysates were 
examined for phosphorylated ERK by western blotting. The membrane was stripped 
and re-probed for total ERK. As predicted, ERK was strongly activated by 
explantation (Fig 3.18). This activation was markedly reduced by either the FGF 
receptor inhibitor or the MEK inhibitor. There was some residual ERK activation 
remaining in the presence of the FGF receptor inhibitor and this was reproducible (Fig 
3.18, left hand panel). This could have been because the inhibitor was not fully 
effective, or that there were FGF-independent signalling pathways also activating 
ERK.  
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Agent used for injection     - - veh PD        - - veh U
phospho-ERK
ERK
Time after dissn (min)      0   30   30 30 0    30  30 30
Figure 3.18. Efficient blockade of explantation-induced ERK activation 
by intra-articular injection of inhibitors.
Porcine MCP joints were initially injected with 3ml serum-free culture 
medium containing vehicle (0.1% DMSO) (veh), 250nM FGF receptor 
inhibitor PD173074 (PD, left hand panel), 20μM MEK inhibitor U0126 (U, 
right hand panel), or left untreated (-). Following equilibration at 37°C for 2h, 
~0.5g cartilage was dissected either immediately into ice cold lysis buffer (0) 
or cultured for 30min in serum-free medium +/- respective inhibitor/vehicle 
prior to lysis. Phosphorylated ERK was assayed by western blotting. The 
membrane was stripped and re-probed for ERK to ensure equal loading. 
These results are representative of 2 similar experiments.
&  incubation
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3.11  The production of activin A on explantation is FGF- and 
ERK-dependent 
Partial inhibition of activin A production after explantation had been seen previously 
when the cartilage was dissected into medium containing PD173074 (S. Alexander, 
Ph.D. thesis, 2005). It was possible that the inhibition was incomplete because the 
inhibitor did not have adequate time to diffuse into the cartilage to prevent rapid cell 
activation by FGF. In view of the strong inhibition of ERK activation achieved by 
injection of the inhibitor in the previous section, the experiment was carried out using 
this procedure. Prior injection gave significantly better inhibition of activin A 
production (around 80%), compared with dissection of cartilage directly into inhibitor 
without prior injection (Fig 3.19). In contrast, injection of medium alone into the joint 
(the vehicle) did not significantly perturb the production of activin A by the cartilage. 
Therefore, in all further experiments, intact porcine MCP joints were first injected 
with medium containing the inhibitors prior to dissection into medium containing the 
inhibitor.  
To test whether MAPKs were necessary for activin A production after explantation, 
porcine trotters were injected with the FGF receptor inhibitor PD173074, the MEK 
inhibitor U0126 or the p38 MAPK inhibitor SB202190 and equilibrated at 37°C, prior 
to dissection and culture in medium containing the respective inhibitors. As controls, 
cycloheximide or 0.1% DMSO (the vehicle) were injected. Activin A was measured 
in the medium after 16h (the time of its maximal production following injury). 
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Figure 3.19. The effect on activin A production by cartilage of injection of 
pharmacological inhibitors into joints prior to explantation.
Intact porcine MCP joints were injected (+) with 3ml serum-free medium 
(veh) or medium containing 10μg/ml cycloheximide (cyclo), the FGF receptor 
inhibitor PD173074 250nM (PD) or not injected (-) and equilibrated at 37°C 
for 2h. ~0.5g cartilage per point was then explanted into 2ml medium/g tissue 
containing fresh inhibitor (cycloheximide, PD) or medium alone (veh, 
untreated) and cultured for 16h prior to collection of the medium. This was 
clarified by centrifugation and assayed for activin A by ELISA. % activin A 
production was calculated for each sample, compared with untreated cartilage. 
2 different experiments are shown. Bars show mean +/- S.D. from 4 cultures in 
Expt 1 and 3 cultures in Expt 2. 
Expt 1: ***=P<0.0001 vs. untreated and P=0.005 vs. PD (not injected), by 
unpaired t-test. Expt 2: **=P<0.0001 vs. untreated and P=0.018 vs. PD (not 
injected), by unpaired t-test
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 Injection of the joints with 0.1% DMSO in medium did not affect the production of 
activin A following explantation. (After this finding was replicated on 3 occasions, 
this control was not included in further experiments) (Fig 3.20A). PD173074 inhibited 
activin A production on explantation. In 4 similar experiments, the mean inhibition 
with PD173074 was 82% (Table 3.1). Some variation in efficacy was seen in initial 
experiments because an old batch of inhibitor had been used. The partial inhibition by 
the FGFR inhibitor suggested that FGF-independent signalling pathways might also 
be involved in the induction of activin A on explantation. The p38 MAPK inhibitor 
SB202190 did not significantly inhibit activin A secretion after explantation, whereas 
the MEK inhibitor U0126 (20μM) did cause inhibition (Fig 3.20A). U0126 was also 
effective at a lower concentration of 10μM (Fig 3.20B). This suggested that the ERK 
pathway was required for the production of activin A following injury. This was 
likely to be downstream of FGF-2. Although the experiment shown in Figure 3.20A 
suggests that the effects of U0126 are comparable to PD173074, the mean inhibition 
over 6 experiments was lower at 51% (Table 3.1). 
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Figure 3.20. ERK inhibition and FGF receptor inhibition both reduce activin
A production following explantation. (A) & (B) show 2 independent 
experiments.
A. Intact porcine MCP joints were injected with 3ml of serum-free medium 
containing cycloheximide 10μg/ml (cyclo), the FGF receptor inhibitor PD173074 
250nM (PD), the MEK inhibitor U0126 20μM (U), the p38 inhibitor SB202190 
20μM (SB), the vehicle (medium + 0.2% DMSO) (veh) or were not injected (-) and 
equilibrated at 37°C for 2h. ~0.5g cartilage per point was then explanted into 2ml 
medium/g tissue containing fresh inhibitors, vehicle, or medium alone (-) and 
cultured for 16h prior to collection of the medium. This was clarified by 
centrifugation and assayed for activin A by ELISA. 
B. Intact porcine MCP joints were injected with 3ml serum-free medium plus 
cycloheximide 10μg/ml (cyclo), the MEK inhibitor U0126 10μM (U), the vehicle 
medium + 0.1% DMSO (veh) or not injected (-) and equilibrated at 37°C for 2h. 
Cartilage was then explanted into 2ml medium/g tissue +/- fresh inhibitors and 
cultured for 16h prior to collection of medium. This was clarified by centrifugation 
and assayed for activin A by ELISA. 
Bars show mean +/- S.D. from triplicate cultures. *=P=0.03 & **=P=0.006, vs. 
untreated cultures (-), by unpaired t-test.
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 Table 3.1. Effects of signalling inhibitors on activin A production after 
explantation. 
Inhibitor Target pathway Concentration n % inhibition, 
mean (range) 
S.E.M 
PD173074 FGFR 250nM 4 82 (79-84) 1.44 
U0126 MEK(ERK) 10μM 6 51 (34-66) 5.71 
MG132 NFκB (proteasome) 10μM 7 49 (28-70) 5.10 
BMS345541 NFκB (IKK) 10μM 4 71 (63-78) 3.58 
PP2 Src family kinases  10μM 3 60 (52-66) 4.22 
      
For each experiment with a particular inhibitor, a % inhibition of activin A production 
compared with untreated samples was calculated. The mean % inhibition, range of % 
inhibition and standard error of the mean (S.E.M) for a number of experiments (n) is 
shown. 
 
The inhibition of activin A by U0126 or PD173074 was never to baseline levels, 
despite these inhibitors effectively preventing ERK activation following explantation 
(Fig 3.18). This suggested that additional signalling pathways activated by injury also 
contributed to the regulation of expression of the cytokine. One candidate was NFκB, 
so I therefore tested the effects of inhibitors of this pathway. 
3.12  NFκB is also required for activin A production after 
explantation of cartilage 
The effects of the proteasome inhibitor MG132 and the IKK inhibitor BMS345541 on 
activin A production following cartilage injury were investigated. Porcine MCP joints 
were injected with inhibitors and equilibrated, prior to dissection and culture for 16h 
in medium with and without inhibitor. MG132 inhibited activin A production (Fig 
3.21A). This effect could have been due to NFκB inhibition or non-specific effects: 
blocking the proteasome must affect many cellular processes. However, BMS345541 
also inhibited activin A production to a similar degree (Fig 3.21A). The extent of 
inhibition was similar to that seen with PD173074 (Table 3.1).  
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Figure 3.21. NFkB pathway inhibitors reduce activin A production on 
explantation.
A. Intact porcine MCP joints were injected with 3ml serum-free medium plus 
10μg/ml cycloheximide (cyclo), the proteasome inhibitor MG132 (MG) 10μM, 
the IKK inhibitor BMS345541 (BMS) 20μM or not injected (-) and equilibrated 
at 37°C for 2h. 
B. Intact porcine MCP joints were injected with 3ml serum-free medium plus 
10μg/ml cycloheximide (cyclo), the proteasome inhibitor MG132 (MG) 10μM, 
the FGF recpeptor inhibitor PD173074 (PD) 250nM, a combination of both 
inhibitors (MG+PD) or not injected (-) and equilibrated at 37°C for 2h. 
In both A. and B. ~0.5g cartilage per point was then explanted into 2ml medium/g 
tissue containing fresh inhibitors or medium alone (-) and cultured for 16h prior 
to collection of the medium. Medium was clarified by centrifugation and assayed 
for activin A by ELISA. Bars show mean +/- S.D. from quadruplicate cultures.  
For both A. and B. 2 different experiments are shown.
A. Expt 1 **=P=0.002; Expt 2 **=P=0.015, ***=P=0.003 all vs. untreated 
cultures (-), by unpaired t-test 
B. Expt 1 *=P=0.03; **=P=0.008;***=P=0.0005; Expt 2, **=P=0.0008, 
*=P=0.004, ***=P=0.0001 all vs. untreated cultures (-), by unpaired t-test. 
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The effect of inflammatory signalling (NFκB) and FGF-dependent signalling seemed 
likely to be additive. This possibility was tested by treating porcine joints with both 
PD173074 and MG132 compared with each inhibitor in isolation. The combination of 
FGF receptor inhibition and proteasome inhibition reduced the production of activin 
A on injury to baseline levels (Fig 3.21B). This suggested that NFκB, in addition to 
FGF-dependent pathways, was required for maximal activin A production upon 
injury.  
The experiment was repeated using PD173074 and the alternative NFκB inhibitor 
BMS345541 both alone, and in combination. Combining the IKK inhibitor with the 
FGFR inhibitor did not have a significantly greater effect than either agent alone, 
although there was already marked suppression in these experiments with the 
individual inhibitors (Fig 3.22A). Since NFκB is anti-apoptotic, it was possible that 
the reduction in activin A production caused by inhibitors of NFκB over a period of 
16h was due to cell death. The effect of these inhibitors on mRNA levels of inhibin 
βA (the subunit of activin A) following the dissection was therefore studied. Cartilage 
was either dissected immediately into TRI reagent, or into medium in the presence or 
absence of inhibitors for 4h prior to RNA extraction. Some inhibition of inhibin βA 
mRNA was seen at 4h after dissection into PD173074 or the IKK inhibitor 
BMS345541, compared with dissection into medium alone (Fig 3.22B). The 
combination of these two inhibitors suppressed activin A mRNA to low levels. It 
therefore appeared that the IKK inhibitor was probably not toxic to the chondrocytes, 
and that the FGF pathway and NFκB pathways were both necessary for the 
production of activin A mRNA and protein following injury. 
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Figure 3.22. The effect of a combination of FGF receptor and NFκB 
pathway inhibitors on activin A (A) protein and (B) mRNA following 
explantation.
Porcine MCP joints were initially injected with 3ml of serum-free medium 
containing the vehicle medium + 0.1% DMSO (veh), cycloheximide 10μg/ml 
(cyclo), 250nM FGF receptor inhibitor PD173074 (PD), 10μM IKK inhibitor 
BMS345541 (BMS) or a combination of both inhibitors (PD+BMS), or left 
untreated (-). Following equilibration at 37°C for 2h:
A. Cartilage was dissected into 1g/ml culture medium +/- fresh inhibitor and 
cultured for 16h. Activin A in the medium was measured by ELISA. Bars 
show mean +/- S.D. from quadruplicate cultures. ***=P=0.0001 vs. untreated 
cultures (-), by unpaired t-test. 
B. Cartilage was either dissected directly into ice cold TRI Reagent, or 
dissected and cultured for 4h in serum-free medium +/- fresh inhibitor, prior 
to homogenisation of cartilage explants, RNA extraction and RT-PCR for 
inhibin βA and GAPDH. 
A. and B. are each  representative of 2 experiments.
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3.13  Src family kinases are implicated in activin A 
production after explantation of cartilage 
The FGF receptor inhibitor was highly efficient at reducing activin A levels following 
explantation by on average 80% (Fig 3.19, Fig 3.22A & Table 3.1). It was possible 
that ERK was not the only FGF-dependent pathway involved in the regulation of this 
cytokine. Stimulation of the FGFR activates several signalling pathways. In addition 
to the ERK MAPK pathway, protein kinase C (PKC), PI3 kinase and src family 
kinases are all likely to be activated by FGF (Ch 1, Fig 1.1). The effects of inhibitors 
of these pathways on activin A production were tested. The protein kinase C (PKC) 
inhibitors Gö6976 and Gö6983 inhibit the classical, novel and atypical PKC enzymes 
differentially. However, neither reduced activin A production following explantation 
(Fig 3.23A).  
To investigate whether tyrosine kinases such as the src family are involved in the 
response, genistein, a broad inhibitor of tyrosine kinases was used, as well as PP1 and 
PP2 (closely related pyrazolopyrimidine compounds which have been widely used as 
inhibitors of src family kinases). They are specific (having significantly lower 
efficacy against the related kinase csk), but do not discriminate between src family 
members (Bain et al., 2003). Genistein and PP1 both caused inhibition of activin A 
secretion when tested in the explantation system (Fig 3.23B). PP2 caused on average 
a 60% inhibition of activin A production which was highly reproducible at 10 μM 
(Fig 3.24 & Table 3.1). This was in contrast to the PI3 kinase inhibitor LY294002, 
which had no effect on activin A production. PP2 did not inhibit the FGF-induced 
activation of ERK in chondrocytes (Fig 3.25).  
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Figure 3.23. The effect of inhibiting PKC and tyrosine kinase pathways on 
activin A production.
A. Intact porcine MCP joints were injected with 3ml serum-free medium plus 
cycloheximide 10μg/ml (cyclo), the PKC inhibitors Gö6983 100nM (Go6983) or 
Gö6976 100nM (Go6976) or left untreated (-) and equilibrated at 37°C for 2h. 
B. Intact porcine MCP joints were injected with 3ml serum-free medium plus 
cycloheximide 10μg/ml (cyclo), the src kinase inhibitor PP1 10μM (PP1), the 
tyrosine kinase inhibitor genistein 100μM (Gen) or left untreated (-) and 
equilibrated at 37°C for 2h. 
For both A. & B., ~0.5g cartilage per point was then explanted into 2ml 
medium/ g tissue containing fresh inhibitors or medium alone (-) and cultured 
for 16h prior to collection of the medium. This was clarified by centrifugation 
and assayed for activin A by ELISA. Bars show mean +/- S.D. from 
quadruplicate cultures. *=P=0.04; **=P=0.001; P=0.0001, all vs. untreated 
cultures (-), by unpaired t-test. A. and B. are each representative of 2 
experiments. 
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Figure 3.24. Src family kinase inhibition reduces activin A secretion 
following explantation whereas PI3 kinase inhibition has no effect.
A. Intact porcine MCP joints were injected with 3ml serum-free medium plus 
10μg/ml cycloheximide (cyclo), the src kinase inhibitor PP2 10μM (PP2), the 
PI3 kinase inhibitor LY294002 10μM (LY) or left untreated (-) and 
equilibrated at 37°C for 2h. 
B. Intact porcine MCP joints were injected with 3 ml serum-free medium 
plus10μg/ml cycloheximide (cyclo), the src kinase inhibitor PP2 10μM or 
5μM, or left untreated (-) and equilibrated at 37°C for 2h. 
In both A. and B., ~0.5g cartilage per point was then explanted into 2ml/g 
culture medium containing fresh inhibitors or medium alone (-) and cultured 
for 16h prior to collection of the medium. This was clarified, and assayed for 
activin A by ELISA. Bars show mean +/- S.D. from quadruplicate cultures. 
A. ***=P=0.001 vs. untreated cultures (-), by unpaired t-test. 
B. **=P=0.002 and *=P=0.003 vs. untreated cultures (-), by unpaired t-test.
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Figure 3.25. The src family kinase inhibitor PP2 does not inhibit FGF-
induced activation of ERK in chondrocytes.
Porcine primary chondrocytes (2 million cells per point) were serum starved 
for 3h, then pre-incubated for 30min with medium alone (-) or medium 
containing 0.1% DMSO (D), the MEK inhibitor U0126 1μM (U1), U0126 
10μM (U10) or the src family kinase inhbitor PP2 10μM (PP2) and then 
treated for 30min with serum-free medium alone +/- 0.1% DMSO (D), 
medium +/- fresh inhibitors plus FGF-2 20ng/ml (FGF). The medium was then 
aspirated and 250μl dissociative lysis buffer added per well. Chondrocyte
lysates were assayed for phosphorylated ERK by western blotting. The 
membrane was stripped and re-probed for total ERK. This is representative of 
2 experiments using different batches of chondrocytes.
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These experiments suggested that non-receptor tyrosine kinases such as the src family 
kinases may also be important pathways in the response to articular cartilage injury. It 
was not clear whether these pathways were FGF-dependent or independent, or how 
they might relate to other inflammatory signalling pathway activation. Certain 
members of the src family are known to be activated by FGF-2 in other tissues, 
although little is known about their regulation in articular cartilage (Bromann et al., 
2004; Kilkenny et al., 2003).  
3.14   COX-2 protein expression following explantation is 
mediated by NFkB and FGF, and depends upon ERK and 
p38 MAPK 
COX-2 protein had also been shown to be induced in articular cartilage following 
explantation (Fig 3.13). It was possible that its induction following the insult would 
be mediated by different pathways to activin A. To test whether FGF-dependent 
pathways or NFκB were necessary for COX-2 expression following explantation, the 
FGF receptor inhibitor PD173074 or the IKK inhibitor BMS345541 were injected 
into porcine MCP joints prior to dissection of cartilage into medium containing fresh 
inhibitor and culture for 16h (the time of maximal COX-2 expression, Fig 3.13). The 
FGF receptor inhibitor prevented COX-2 expression (Fig 3.26, Expt 1). In 
comparison, the IKK inhibitor BMS345541 reduced COX-2 expression after 
explantation by around 50%. The combination of the two inhibitors was not more 
potent than the PD173074 alone. A second similar experiment is shown. Both FGF-
dependent pathways and NFκB appeared to be important in the regulation of COX-2 
production after cartilage injury.  
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Figure 3.26. The effect of the FGF receptor inhibitor PD173074 and 
the IKK inhibitor BMS345541 on the production of COX-2 protein 
by cartilage following explantation.
Porcine MCP joints were initially injected with 3ml serum-free culture 
medium containing 10μg/ml cycloheximide (cyclo), 250nM FGF receptor 
inhibitor PD173074 (PD), 10μM IKK inhibitor BMS345541 (BMS), a 
combination of the two inhibitors, or left untreated (-). Following 
equilibration at 37°C for 2h, ~0.5g cartilage was dissected and cultured 
for 16h in serum-free medium +/- respective inhibitors prior to lysis. 
COX-2 in the cartilage lysates was assayed by western blotting. The 
membrane was stripped and re-probed for ERK to ensure equal loading. 
The results of two separate experiments are shown.
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The two MAPK pathways regulated in chondrocytes by FGF-2 are ERK and p38 
MAPK. We therefore investigated whether either of these pathways was required for 
COX-2 expression. Both U0126 (Fig 3.27A) and SB202190 (Fig 3.27B) markedly 
reduced COX-2 protein levels after explantation, but not quite to baseline 
(cycloheximide). NFκB and FGF-2-induced pathways (ERK and p38 MAPK) were 
therefore likely to be responsible for induction of COX-2 expression after cartilage 
injury.  
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Figure 3.27. The effect of inhibitors of (A) MEK and (B) p38 MAPK on 
the production of COX-2 protein by cartilage following explantation.
Porcine MCP joints were left untreated (-) or injected with 3ml serum-free 
culture medium containing 10μg/ml cycloheximide (cyclo), the vehicle alone 
0.1% DMSO (veh) or either (A) 10μM MEK inhibitor U0126 (U) or (B)
10μM p38 MAPK inhbitor SB202190 (SB). Following equilibration at 37°C 
for 2h, ~0.5g cartilage was dissected and cultured overnight in serum-free 
medium +/- inhibitors prior to lysis. COX-2 in the cartilage lysates was 
assayed by western blotting. The membrane was stripped and re-probed for 
ERK to ensure equal loading.
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3.15   Discussion 
These experiments show that in addition to MAPKs, other intracellular signalling 
pathways including PI3 kinase and IKK are activated by dissection of cartilage. The 
induction of IKK activity is strong and rapid (within 30sec). Re-cutting rested 
cartilage does not re-activate this pathway although the tissue responded to IL-1. 
Given this, and the lack of response to medium conditioned with freshly dissected 
extensively diced tissue, or to exogenous FGF, it was not possible to attribute the 
activation of IKK by injury to a soluble mediator released from the cartilage.  
IKK is the most upstream kinase that I have investigated. It is not clear whether IKKα 
or β, or both, is the active kinase, because the assay detects both enzymes. Although 
IKKβ is considered to be the main kinase in the canonical activation of NFκB by 
inflammatory stimuli, IKKα may be equally important in the activation of the 
pathway by some stimuli such as IL-1 (Solt et al., 2007). This could be investigated 
by western blotting the phosphorylated forms of the kinases in cartilage lysates 
(Muddasani et al., 2007). The activation of IKK is not well understood. TAK-1 is the 
major kinase activated by inflammatory stimuli that phosphorylates IKK, but 
preliminary experiments suggest that TAK-1 activity is not increased in response to 
explantation (experiments carried out in collaboration with B. Brennan & J. Dean at 
the Kennedy Institute). Understanding the mechanism of this IKK activation would 
give insight into how cells detect tissue injury. 
Fewer inflammatory response genes are induced following cartilage injury than by IL-
1 (8 out of 12 tested). These include COX-2, activin A and IL-6, as well as 
collagenases such as MMP-1 and -13 and the aggrecanase ADAMTS-4. Induction of 
proteinases could be catabolic for the extracellular matrix, and therefore provide a 
link between cartilage injury and degeneration. My experiments did not give clear 
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evidence of induction of ADAMTS-5. This proteinase has been implicated as the 
major aggrecanase in murine models of injury-induced osteoarthritis, but it is not 
clear if it has the same importance in other species (Glasson et al., 2005; Stanton et 
al., 2005). ADAMTS-4 or other enzymes may have an equally important role in man 
(Song et al., 2007).  
The increased expression of activin A in cartilage following injury is interesting 
because recent work in our laboratory has shown that it inhibits IL-1-induced 
aggrecan degradation in cartilage in vitro (Alexander et al., 2007), see also Appendix. 
This suggests that activin A may be an anti-catabolic autocrine cytokine produced by 
injured cartilage, and that injury induces anti-catabolic and catabolic (ADAMTS-4, 
IL-1) molecules. In a recent microarray study of a rat model of joint injury, inhibin 
βA mRNA was up-regulated over 8 fold (Appleton et al., 2007). 
In some experiments, the house-keeping gene glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) mRNA was noted to be regulated by explantation or 
stimulation with FGF. Recent reports highlight that regulation of such genes is 
recognised in certain circumstances, causing difficulty with normalisation of 
experiments (Fundel et al., 2008). For a more detailed assessment of absolute changes 
in mRNA levels, quantitative PCR would be necessary. However, normalisation can 
still be an issue. 18S, a ribosomal RNA which is present at high abundance in total 
RNA samples is often used for normalisation of q-PCR. This may have proved a 
better internal control than GAPDH in this setting.  
FGF-dependent signalling is required for induction of two inflammatory response 
genes, activin A and COX-2 in response to cartilage injury. Both genes appear to be 
strongly regulated by FGF, as judged by the effect of the inhibitor of the receptor 
tyrosine kinase. However, in the case of activin A, FGF stimulation (exogenous 
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stimulation with FGF, or re-cutting of rested explants) is not sufficient to induce a 
significant increase in activin A, implying that other pathways must be necessary. 
ERK appears important for induction of both COX-2 and activin A, but is likely to be 
down-stream of FGF. p38 MAPK was not required for activin A production, but is 
important in the induction of COX-2 protein. This p38-dependence may be related to 
the fact that COX-2 mRNA contains AU-rich elements in its 3’-UTR and requires p38 
activity for its stabilisation (Dean et al., 2003). Results with both MG132 and 
BMS345541 suggest that the NFκB pathway may be needed for both activin A and 
COX-2 induction. Interestingly, the effects of FGFR and NFκB inhibition seem to be 
additive. The earlier observation that the NFκB pathway is not activated by re-cutting 
resting explants could explain why re-cutting had a significant but smaller effect on 
increasing activin A production. However, the specificity of these agents is obviously 
important when effects such as these are detected: MG132 may have off-target effects 
because of its action on the proteasome and the specificity of BMS345541 for IKK is 
not well-characterised. 
A further pathway implicated in the injury response in the case of activin A is src. 
PP2 has been found by others to be quite specific for src family kinases (Bain et al., 
2003). Srcs have been shown to be expressed in chondrocytes, but their role in 
cartilage is largely unexplored (Islam et al., 2001; Liu et al., 2004). Although FGF-2 
activates SFKs in many cell lines, whether it does so in primary chondrocytes has not 
been investigated (Bromann et al., 2004). It is not clear from the effect of PP2 on 
activin A production whether src family kinases represent another FGF-dependent 
pathway, or are activated by some other means.  
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4.1 Introduction 
In chapter 3, I have shown that a physical injury to cartilage not only activates several 
intracellular signalling pathways, but also induces a number of inflammatory response 
genes. In the case of production of both activin A and COX-2 after injury, FGF-2 
appears to be necessary, but to work in conjunction with other pathways. The effect of 
PP2 on activin A production strongly suggested that src family kinases were needed. 
It was possible that src kinases mediate in part the effect of FGF. Alternatively, a src 
family member may be involved in the injury response independently of FGF. Non 
receptor tyrosine kinases are commonly involved in surface receptor signalling other 
than that of receptor tyrosine kinases. For example signalling through T and B cell 
receptors, through interferon receptors and the receptors of the IL-6 group of 
cytokines all involve tyrosine kinases.  
Because of our lack of understanding of the mechanism by which chondrocytes detect 
physical injury, and because of the significant effect of PP2 in inhibiting activin A, I 
decided to examine whether there is tyrosine kinase activation in cartilage in response 
to injury and to what extent it is FGF-independent. 
4.2 Tyrosine phosphorylation rapidly follows explantation of 
cartilage  
A common approach to detect changes in protein tyrosine kinase or phosphatase 
activity is to western blot tyrosine-phosphorylated proteins in cell extracts. A number 
of antibodies which recognize tyrosine-phosphorylated proteins have been 
successfully employed, for example see (Hinsby et al., 2003; Zhang et al., 2005). 
4G10 is a mouse IgG kappa monoclonal antibody which has been widely used either 
alone, or in combination with other phosphotyrosine antibodies for 
immunoprecipitation and western blotting. 
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To investigate whether there was change in protein tyrosine phosphorylation in the 
cartilage in response to explantation, porcine trotters were equilibrated at 37°C prior 
to cartilage being dissected either directly into a tube on dry ice or into serum-free 
culture medium for increasing times, prior to lysis in RIPA buffer. Lysates were 
clarified and mixed with sample buffer prior to electrophoresis on an 8% acrylamide 
gel, and western blotting with 4G10 antibody. There was clear induction of a number 
of bands following explantation, in particular at 190 kD, 100 kD, 80 kD, 60 kD and 
55 kD (Fig 4.1). The phosphorylations declined gradually after 20min. The pattern of 
induction of bands was reproducible and rapidly followed the injurious stimulus. In 
another experiment these bands were induced 30sec after injury (Fig 4.2). The 
membrane was stripped and re-probed with antibody to ERK to check loading. This 
showed that the 5min sample was under-loaded, accounting for the weaker 
phosphotyrosine staining at this time. Usually, tyrosine phosphorylation peaked 
between 10-30min and was still present at 60min (Fig 4.1). No temporal separation of 
these bands was possible by western blotting: they were all evident within 20-30sec of 
explantation.  
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Figure 4.1. Tyrosine phosphorylation patterns of articular cartilage lysates
following explantation of the tissue.
Porcine MCP joints were equilibrated at 37°C for 4h. ~0.5g cartilage (from a 
separate joint for each time point) was dissected into serum-free medium for the 
time specified. At the end of the incubation, cartilage was washed 3 times in ice 
cold PBS prior to snap freezing. For 0min samples, cartilage was dissected into 
a tube on dry ice. Cartilage lysates were boiled with SDS sample buffer, 
electrophoresed on an 8% gel and assayed for phosphotyrosine residues by 
western blotting with the 4G10 antibody (upper panel). The membrane was 
stripped and re-probed for ERK (lower panel). The arrows indicate the positions 
of the major induced bands. These results are representative of 4 experiments.
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dissection (min)
Figure 4.2. Tyrosine phosphorylation patterns of explanted articular cartilage.
Porcine MCP joints were equilibrated at 37°C for 4h. ~0.5g cartilage from an 
individual joint was dissected into serum-free medium for the times specified. At 
the end of the incubation, cartilage was washed 3 times in ice cold PBS prior to 
snap freezing. For 0min sample, cartilage was dissected into a tube on dry ice. 
Cartilage lysates were assayed for phosphotyrosine residues by western blotting 
with the 4G10 antibody. The membrane was stripped and re-probed for ERK to 
ensure equal cellular protein loading.
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4.3 Induction of tyrosine-phosphorylated proteins following 
cartilage injury is not affected by culture medium 
All culture medium in these experiments was serum-free, as growth factors present in 
serum could stimulate tyrosine kinases. It was conceivable that the induction of these 
bands was related to contact with culture medium. To test this possibility, cartilage 
was dissected from joints equilibrated at 37°C into a dry tissue culture dish and 
incubated at 37°C without medium for increasing times prior to lysis and western 
blotting for phosphotyrosine residues. Induction of the same bands was evident, 
although in some cases their appearance was delayed until 2min after dissection and 
they were maximal at the later time of 60min (Fig 4.3). Because cartilage was not 
washed prior to lysis in this experiment, serum albumin is present (as well as other 
plasma proteins of synovial fluid) and distorts the pattern in the 55-60 kD region.  
Conceivably, a factor in synovial fluid could have been responsible for inducing 
tyrosine phosphorylation by coming in contact with chondrocytes via the cuts in the 
cartilage. However this possibility was not supported by the observation that the 
activation was reduced neither by increasing washing of cartilage prior to culture nor 
by increasing the volume of medium used for culture (data not shown). It was also 
possible that the removal of cartilage from the articular surface, rather than the sharp 
injury per se caused activation of tyrosine kinases. To investigate this, porcine trotters 
were opened and equilibrated at 37°C prior to scoring the articular surface as 
previously described (see Materials & Methods for details, section 2.2.2). Joints were 
replaced in the incubator for increasing times indicated. The surface was then washed 
rapidly (10 sec) with ice cold PBS prior to rapid dissection and lysis of the cartilage. 
Again, induction of the same bands was evident, particularly a complex of bands 
between 100 and 120 kD and the 60 kD band (Fig 4.4).  
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Figure 4.3. Tyrosine phosphorylation following explantation of articular
cartilage is not dependent on contact with culture medium.
Porcine MCP joints were equilibrated at 37°C for 4h. 3 cartilage pieces from a 
single joint surface were dissected into a dry tissue culture dish and incubated at 
37°C for increasing times specified, and points performed in duplicate. For 0min 
samples, cartilage was dissected directly into a tube on dry ice. Samples were 
pooled for lysis. Cartilage lysates were assayed for phosphotyrosine residues by 
western blotting. This is representative of 2 experiments.
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Figure 4.4. Protein tyrosine phosphorylation is induced in cartilage by 
scoring of the articular surface.
Trotters were opened and equilibrated at 37°C. ~0.2g cartilage was dissected 
from the articular surface directly on to dry ice (01) or scored immediately prior 
to dissection (02), or the articular surface extensively scored (1 x 1mm) and the 
joint closed and incubated at 37°C for the times indicated prior to dissection into 
a tube on dry ice (scoring). As controls, an equal amount of cartilage was 
dissected from the surface into serum-free culture medium and cultured for 
10min prior to snap freezing (dissection). Samples were lysed and western 
blotting with 4G10 antibody carried out. The membrane was re-probed for ERK 
to ensure equal loading. This is representative of 2 experiments.
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The induction of tyrosine phosphorylations by scoring was somewhat weaker than 
that seen following dissection and culture for 10min (shown as a control in the 
experiment, Fig 4.4). This could have been because the surface area of tissue injury 
was proportionately less. In addition, an inducible band at around 190 kD is evident in 
these samples. This was seen faintly in Fig 4.1 and is increasingly apparent in later 
experiments, where samples have not been stored prior to lysis and electrophoresis, 
and where transfer time has been extended to enhance the transfer of larger proteins 
on to the membrane.  
4.4 Induction of tyrosine phosphorylation following cartilage 
injury is not dependent on FGF-2 
Since FGF-2 is released upon cartilage injury, it was entirely possible that the 
inducible protein tyrosine phosphorylations were FGF-dependent. This was 
investigated.  
4.4.1 The FGF receptor inhibitor does not prevent the tyrosine 
phosphorylation following explantation 
To test whether FGF signalling was necessary for the initial explantation-induced 
tyrosine phosphorylation, intact joints were equilibrated at 37°C, having been injected 
with 250nM FGF receptor tyrosine kinase inhibitor PD173074, or vehicle alone, or 
not injected. Cartilage was then dissected either immediately into a tube on dry ice or 
into medium containing PD173074, or medium alone for 5min prior to snap freezing, 
lysis and western blotting with 4G10 antibody. There was strong induction of the 
bands of interest following explantation, and this was unaffected by the presence of 
the FGF receptor inhibitor (Fig 4.5A). The membrane was re-probed for ERK protein 
to ensure equal loading. To ensure that the FGF receptor inhibitor was having an 
effect on the cartilage in this experiment, the samples were re-run, and western 
blotting for phosphorylated ERK was carried out. This showed partial inhibition of 
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ERK activation in response to explantation in the presence of the inhibitor. This was 
consistent with FGF-2 activation of FGFR being responsible for some of the ERK 
activation caused by explantation. The results indicate that the tyrosine 
phosphorylation is likely to be independent of FGF-2.  
Because the src family kinase inhibitor PP2 inhibited activin A production after 
explantation, I investigated whether the tyrosine phosphorylation induced by cartilage 
injury would be suppressed by this compound. In a similar experiment to Fig 4.5A, 
joints were equilibrated at 37°C, having been injected with 10μM PP2, or the vehicle 
0.1% DMSO alone, or not injected. Cartilage was then dissected either immediately 
into lysis buffer (0) or into medium containing PP2, or into medium containing 0.1% 
DMSO for 20min prior to lysis and western blotting with 4G10 antibody. In contrast 
to the FGF receptor inhibitor, PP2 suppressed the induction of essentially all tyrosine 
phosphorylation following explantation (Fig 4.5B). For this experiment the tissue was 
lysed 20min after dissection but the effect of the inhibitor was seen at earlier times in 
other experiments. This suggested (a) that src, or a src-like kinase, was necessary for 
the tyrosine phosphorylation induced by explantation, and (b) that this kinase activity 
was not dependent on the action of the FGF-2 released. 
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Figure 4.5. The FGF receptor inhibitor PD173074 does not prevent
tyrosine phosphorylation following cartilage explantation (A), whereas the 
src family kinase inhibitor PP2 does (B).
A. Porcine MCPJs were injected with 250nM FGF receptor inhibitor 
PD173074 (PD) or the vehicle culture medium alone (veh) or not injected (-) 
and equilibrated at 37°C. ~0.5g cartilage was then dissected either immediately 
into a tube on dry ice (0) or into serum-free medium alone or medium 
containing PD173074 and cultured for 5min prior to washing in ice cold PBS 
and snap freezing. 
B. Porcine MCP joints were injected with medium containing 10μM src family 
kinase inhibitor PP2 (PP2) or the vehicle 0.1% DMSO (veh) or not injected (-) 
and equilibrated at 37°C. ~0.5g cartilage was then dissected either directly into 
lysis buffer (0), or into medium alone, medium containing 0.1% DMSO or PP2 
and cultured for 20min prior to lysis. 
For both A. and B., lysates were assayed for phosphotyrosine content by 
western blotting with 4G10 antibody. The membrane was stripped and re-
probed with antibodies to ERK to ensure equal cellular protein loading. For A.
samples were re-run and western blotting for phospho-ERK was carried out.
A. is representative of 2 experiments and B. is representative of 3 experiments.
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4.4.2 FGF-2 stimulation of cartilage explants or chondrocytes does 
not increase tyrosine phosphorylation 
The effect of stimulation with exogenous FGF-2 on tyrosine phosphorylation in 
cartilage was also examined. Cartilage explants were rested in serum-free medium for 
24h prior to stimulation with 50ng/ml FGF-2 for increasing times prior to lysis. Some 
explants were treated with 10mM pervanadate for 10min as a positive control to 
induce strong tyrosine phosphorylation. As predicted, this phosphatase inhibitor 
strongly up-regulated tyrosine phosphorylation (Fig 4.6A, most right hand lane). This 
is despite this lane being underloaded on blotting with ERK as a loading control. In 
comparison, there was no change in the levels of tyrosine-phosphorylated proteins in 
response to FGF-2, other than the induction of two bands around 40 kD which were 
thought likely to be tyrosine-phosphorylated ERK. Weak constitutive tyrosine 
phosphorylation was seen in all samples. The membrane was re-probed for 
phosphorylated ERK to confirm activation of ERK by FGF-2. As a further test, 
cartilage explants were re-cut. This stimulus also led to ERK activation but did not 
increase levels of tyrosine-phosphorylated proteins above baseline either (data not 
shown).  
The effect of FGF-2 on tyrosine phosphorylation in primary porcine chondrocytes 
was also examined. Chondrocytes were serum starved prior to stimulation with FGF-2 
for increasing times prior to lysis. Lysates were run on a 4-12% bis tris minigel, and 
so the pattern and the relative positions of the markers are different to Fig 4.6A. 
Constitutive tyrosine phosphorylation in the resting serum starved chondrocytes was 
evident (Fig 4.6B). Many bands were present, but no change in their intensity was 
seen in response to FGF-2. In contrast, strong induction of phosphorylated ERK in 
response to this stimulus was noted when the membrane was stripped and re-probed.  
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Figure 4.6. FGF-2 does not induce tyrosine phosphorylations in (A) cartilage 
explants or (B) primary porcine chondrocytes.
A. Cartilage was dissected and rested for 24h in serum-free medium. Then, equal 
amounts of cartilage were either snap frozen (0) or stimulated with medium 
containing 250ng/ml FGF-2 (FGF) for increasing times indicated, or medium 
containing 10mM sodium pervanadate for 10min (v) prior to snap freezing and 
lysis. 
B. Primary porcine chondrocytes were prepared and rested in serum-containing 
medium for 48h. 2 million cells per point were then serum starved for 3h prior to 
immediate lysis (0) or stimulation with 20ng/ml FGF-2 for the times indicated 
prior to lysis.
For both A. and B., lysates were clarified and western blotting with 4G10 
antibody was carried out. Membranes were re-probed with phospho-ERK 
antibodies and then stripped and re-probed with total ERK, to ensure equal 
cellular protein loading. A. is representative of 4 experiments and B. is 
representative of 2 experiments.
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The SAK2 ERK antibodies used in Fig 4.6B only recognised the lower 42 kD isoform 
of ERK and showed equal loading of cellular protein (indicated with arrow). 
However, the secondary antibodies also recognized un-stripped phospho-ERK from 
the previous blot. In Fig 4.6A, the membrane was stripped and re-probed with Santa 
Cruz ERK antibodies (See Materials & Methods, Table 2.1). Here the antibodies 
bound less well where phospho-ERK antibody had previously bound to the 
membrane, giving the impression of under-loading of lanes 3-6. 
4.5 Immunoprecipitation of tyrosine-phosphorylated proteins 
The rapidity and extent of the tyrosine phosphorylation caused by injury, together 
with its apparent independence of FGF-2 was intriguing. The fact that the src inhibitor 
PP2 prevented it and also inhibited activin A expression suggested it may be an 
important factor in the response. I therefore decided to identify the tyrosine-
phosphorylated proteins by mass spectrometry. I immunoprecipitated them from 
lysates with the 4G10 antibody covalently linked via protein A to agarose beads 
(called ‘4G10 beads’). Immunoprecipitation prior to western blotting would purify 
and concentrate tyrosine-phosphorylated proteins in the samples. 
4.5.1 Preliminary experiments 
Immunoprecipitation with 4G10 beads was first tried with porcine primary 
chondrocyte lysates. 10 million chondrocytes per point were either left unstimulated, 
or treated with sodium pervanadate for 20min, prior to lysis in RIPA buffer and 
immunoprecipitation overnight with 4G10 beads. Beads were then washed in RIPA 
buffer, boiled with SDS sample buffer and western blotting of the supernatants for 
phosphotyrosines was carried out with 4G10 antibody. (Gels used to analyse the 
immunoprecipitates were 4-12% bis tris mini gels, and therefore the protein patterns 
are somewhat different to the 8% acrylamide gels shown previously). A number of 
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bands were immunoprecipitated from chondrocyte lysates (Fig 4.7). The phosphatase 
inhibitor sodium pervanadate strongly up-regulated immunoprecipitable tyrosine-
phosphorylated proteins, and therefore served as a good positive control for this 
procedure.  
Next, lysates from cartilage which had either been dissected immediately from the 
articular surface (0), or into serum-free medium and cultured for 2min, were 
incubated overnight with either 4G10 antibody or ‘non-immune’ mouse 
immunoglobulin pre-incubated with protein A agarose beads. A number of bands 
were immunoprecipitated from cartilage lysates only by the 4G10 antibody, some of 
which (notably bands at 60 kD and 100-120 kD) appeared to be regulated by injury 
(Fig 4.8). It was possible that greater regulation would have been seen at longer times 
after explantation, and this was taken in to account in later experiments, where a time 
of 10min was selected (see Figs 4.1& 4.4). Non specific bands at ~27 and ~52 kDa 
present in all samples were likely to represent immunoglobulin light and heavy chains 
respectively. 
4.5.2 Optimisation of methods for 4G10 immunoprecipitation from 
cartilage lysates 
Preparation of lysates: The length of time for lysis of cartilage in order to obtain 
maximum extraction of tyrosine-phosphorylated proteins was assessed. Equal 
amounts of cultured cartilage were lysed in RIPA buffer for increasing times. 
Relatively little phosphotyrosine was detected after 15min of extraction. Markedly 
more was seen after 45min, and 2h extraction showed improved extraction of the 
190kD band (Fig 4.9). I decided to use 2h routinely for extraction. 
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Figure 4.7. Tyrosine-phosphorylated proteins can be 
immunoprecipitated from primary chondrocyte lysates by 4G10 
antibody bound to agarose beads.
Serum starved primary porcine chondrocytes (10 million per point) 
were either left unstimulated (-), or stimulated for 20min with 10mM 
sodium pervanadate (V), prior to lysis with RIPA buffer. Lysates were 
incubated overnight with protein A agarose beads cross-linked to 4G10 
(4G10 beads). Beads were washed 5 times in RIPA buffer, then boiled 
for 10min with SDS sample buffer and the supernatant blotted for
protein phosphotyrosines using conjugated 4G10-HRP antibody. 
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Figure 4.8. Tyrosine-phosphorylated proteins can be 
immunoprecipitated from cartilage lysates.
Intact joints were equilibrated at 37°C. 2g cartilage per point was dissected 
either immediately into a tube on dry ice (0) or into culture medium and 
incubated for 2min, prior to washing 3 times with cold PBS and snap 
freezing. Cartilage was lysed in RIPA and lysates incubated overnight at 4°C 
with either 4G10 beads (4G10) or protein A agarose pre-incubated with 
mouse immunoglobulin (N/I control). Beads were washed 5 times in RIPA 
buffer, then boiled for 10min with SDS sample buffer and the supernatant 
examined for protein tyrosine phosphorylations by western blotting with the 
4G10-HRP antibody. 
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Figure 4.9. Investigating optimal time of cartilage lysis prior to 
phosphotyrosine immunoprecipitation.
~0.5g cartilage was dissected per point into culture medium for 10min, 
prior to lysis in RIPA buffer, shaking at 4°C for the increasing times 
indicated. Lysis buffer was then removed, clarified and western 
blotting of the lysates with 4G10-HRP antibody to detect their protein 
phosphotyrosine content was carried out.
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Selective elution of phosphoproteins from 4G10 beads: There was some evidence 
of non-specific precipitation of proteins from tissue lysates (Fig 4.8). In order to elute 
phosphorylated proteins selectively from the beads 0.2M phenyl phosphate was used 
(Peirce et al., 2005). To recover efficiently all of the phenyl phosphate solution from 
the beads after elution, the slurry was passed through a spin column (0.22 μM 
cellulose acetate). 
To test how selective this elution step was, in an initial experiment 2 aliquots of 600μl 
of cultured cartilage lysate were each incubated with 10μl 4G10 beads overnight, and 
the beads eluted with either RIPA alone, or RIPA containing 0.2M phenyl phosphate 
for 2h. Phosphorylated proteins were only evident in the eluate containing phenyl 
phosphate on 4G10 western blotting (Fig 4.10A).  
It was important to investigate the efficiency of the immunoprecipitation and elution 
step at removing tyrosine-phosphorylated proteins. Lysates prior to 
immunoprecipitation (pre-IP), following immunoprecipitation (post IP) and the 
eluates from immunoprecipitates (IP) were all assessed for phosphotyrosine content 
by 4G10 western blotting. The immunoprecipitation and phenyl phosphate elution 
markedly concentrated the tyrosine phosphorylation within the samples, and marked 
regulation of phosphorylation following injury was still evident (Fig 4.10B ‘IP’). 
Some tyrosine phosphorylation was still present in lysates after immunoprecipitation. 
This could have been because the 4G10 immunoprecipitation was inefficient at 
depleting all tyrosine-phosphorylated proteins from the lysates. Alternatively, the 
avidity of 4G10 antibody binding on western blotting meant that this procedure was 
not able to assess any depletion quantitatively. 
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Figure 4.10. Selective elution of phosphorylated proteins from 4G10 
beads.
A. 2x~0.5g cartilage was dissected into serum-free medium for 10min, prior 
to washing 3 times in ice cold PBS and lysis in RIPA buffer. Lysates were 
pooled, vortexed, pre-cleared with protein A agarose, and then incubated 
overnight with 4G10 beads. Beads were washed 5 times in RIPA, and then 
eluted for 2h in 20μl of either RIPA alone (R) or RIPA containing 0.2M 
phenyl phosphate (P-P). Eluates were boiled with SDS sample buffer and 
western blotting with 4G10-HRP antibody carried out.
B. ~0.5g cartilage from each of 4 MCP joints was either dissected 
immediately into a tube on dry ice (0) or into serum-free medium for 10min 
prior to washing 3 times and lysis (10). Respective lysates were pooled, and 
aliquots either boiled immediately with SDS sample buffer (pre-IP) or 
incubated overnight with 4G10 beads and eluted with phenyl phosphate (IP). 
Further aliquots of lysate which had undergone 4G10 immunoprecipitation
were mixed with sample buffer (post-IP). Western blotting with 4G10-HRP 
antibody was carried out.
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Reduction of serum protein contamination: In Figure 4.8, strong bands at ~27 and 
~52 kD were likely to represent the light and heavy chains of immunoglobulin 
respectively, as they were also precipitated by the non-immune IgG. Contaminating 
serum proteins such as this were likely to hinder identification of proteins of interest, 
which lay between 50 and 190 kDa. By ‘running off’ the samples from the minigel to 
the 39 kD marker, the light chain was removed and spreading of the remaining bands 
was achieved. In addition, cartilage was rapidly washed 4 times to remove as much 
synovial fluid as possible prior to lysis. For ‘0’ time points, the articular surface was 
rapidly washed with 250ml ice cold buffered saline prior to dissection.  
Protein A has a high affinity for immunoglobulin. ‘Pre-clearing’ the lysates with 
protein A agarose beads was therefore likely to deplete immunoglobulin and reduce 
non-specific binding during subsequent immunoprecipitation with 4G10 beads (which 
contained protein A). It was important to check that incubation with protein A agarose 
beads did not reduce the phosphorylated protein content of lysates. Increasing 
volumes of protein A agarose beads or Blue Sepharose beads (which are known to 
bind serum albumin and other serum proteins) were incubated with equal aliquots of 
pooled cartilage lysate prior to 4G10 immunoprecipitation and western blotting. The 
highest volume of the protein A beads (500μl of slurry in PBS) and 100μl Blue 
Sepharose beads caused depletion of tyrosine phosphorylation in the lysates (Fig 
4.11). Up to 100μl protein A agarose beads was subsequently used for pre-clearing 
600μl of lysate. 
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Figure 4.11. Does pre-clearing with protein A agarose or blue sepharose
beads affect phosphotyrosine content of lysates?
~0.5g cartilage per point was dissected and cultured for 10min in serum-free 
culture medium, washed 3 times in PBS, then lysed in RIPA buffer. 600μl of 
clarified, pooled lysate was rotated for 1h at 4°C with increasing volumes of a 
50% slurry of protein A agarose beads (protein A-agarose), or 100μl blue 
sepharose beads (BS). Supernatants were then incubated overnight with 10μl 4G10 
beads. Beads were washed 5 times in RIPA, and then eluted with phenyl 
phosphate. Eluates were boiled with SDS sample buffer. Western blotting with 
4G10-HRP antibody was carried out.
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WB: 4G10
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Stability & concentration of tyrosine-phosphorylated proteins: Some reports 
suggest an immunoprecipitation time of 1-2h for 4G10 antibody is optimal, although 
this clearly depends on the buffer system and the concentration of antigen. Cartilage 
lysates were incubated with 4G10 beads for either 2h or 18h, prior to 4G10 
immunoprecipitation and western blotting. There were stronger bands and greater 
regulation after 18h of immunoprecipitation compared with 2h (Fig 4.12). Future 
immunoprecipitations were therefore carried out overnight (~18h). This optimised 
protocol, using 4G10 immunoprecipitation and phenyl phosphate elution is referred to 
henceforth as “standard 4G10 immunoprecipitation” (see Materials & Methods, Fig 
2.3 for summary). 
To be able to carry out further purification of tyrosine-phosphorylated proteins, it was 
important to ascertain whether they were stable in the eluted material. Following 
4G10 immunoprecipitation from cartilage lysates, aliquots of pooled phenyl 
phosphate eluate were either mixed immediately with sample buffer (Lane 1, Fig 
4.13) or kept at various temperatures for 24h prior to the addition of sample buffer 
and 4G10 western blotting. Compared with freshly prepared samples (Lane 1), those 
kept at room temperature lost their phosphotyrosines (Lane 2), and there was also 
some loss at 4°C (Lane 3, Fig 4.13). 
Given the low relative concentration of tyrosine-phosphorylated proteins, a 
concentration procedure was likely to be necessary to make positive identifications by 
mass spectrometry. Any such procedure needed to conserve as far as possible the 
phosphotyrosine content of the samples. Possibilities were limited because of the 
presence of RIPA (and therefore SDS) in the samples (TCA precipitation was not 
possible). Poor stability made strategies such as freeze drying the samples inadvisable 
(Fig 4.13).  
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Figure 4.12. Investigating the optimal length of phosphotyrosine
immunoprecipitation from cartilage lysates.
~0.5g cartilage was dissected either directly into ice cold lysis buffer 
(0) or into culture medium for 10min (10) prior to lysis. Lysates were 
incubated with 4G10 beads for either 2 or 18h prior to washing the 
beads 5 times in RIPA, eluting in phenyl phosphate and boiling the 
eluate with SDS sample buffer. Samples were electrophoresed and 
assayed for phosphotyrosine content by western blotting with 4G10-
HRP antibody. This is representative of 2 different experiments.
191
64
51
39
0    10    0    10   Time after dissection (min)
2           18   Immunoprecipn (h)
IP: 4G10
WB: 4G10
Markers
(kD)
 
 
Chapter 4                                     Investigation of tyrosine phosphorylation in cartilage following injury 
 175
 
 
Figure 4.13. Stability of protein tyrosine phosphorylation in eluates from 
cartilage immunoprecipitates on storage.
5 x ~0.5g cartilage was dissected into culture medium for 10min prior to 
lysis. Lysates were incubated with 4G10 beads overnight, prior to washing 
the beads 5 times in RIPA and eluting in phenyl phosphate. Eluates were 
pooled, mixed and then aliquoted into 5 samples. The first sample was boiled 
with SDS sample buffer immediately (0). The remaining samples were stored 
for 24h at the various temperatures indicated, prior to boiling with SDS 
sample buffer. Samples were electrophoresed and assayed for 
phosphotyrosine content by western blotting with 4G10-HRP antibody.
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Acetone precipitation carried out on eluates led to significant loss of phosphorylation 
on 4G10 western blotting compared with unconcentrated material (Fig 4.14, Lane 2). 
Using an electrophoresis clean-up kit (GE), there was preservation of tyrosine 
phosphorylation (Fig 4.14, Lane 3). This kit incorporated an acetone precipitation 
step, but also had several buffers to aid re-solubilisation of the pellet in low volumes. 
It took an additional 3-4 hours, with samples kept either on ice or at -20°C. This 
method was selected for the concentration of material in subsequent scale-up 
experiments. 
4.5.3 Rapidity of injury-induced tyrosine phosphorylation 
following immunoprecipitation  
It was important to see if the apparent rapid up-regulation of tyrosine phosphorylation 
after explantation seen on western blotting of cartilage lysates was still evident 
following optimised 4G10 immunoprecipitation. Trotters were equilibrated prior to 
dissection of cartilage either on to dry ice, or into culture medium for the times 
indicated prior to lysis. Standard 4G10 immunoprecipitation and 4G10 western 
blotting was carried out. Tyrosine phosphorylation of proteins was rapidly induced 
within 15-30 sec of injury (Fig 4.15A). The band at 60 kD, the upper bands of the 
complex at 100-120 kD and the 190 kD band were all seen at the earliest time point. 
These bands probably all corresponded to bands of similar sizes noted in earlier 4G10 
western blotting experiments using the large gel system (Figs 4.1 & 4.4).  
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Figure 4.14. Concentration of eluates from 4G10 immunoprecipitates.
6g cartilage was dissected into culture medium for 10min prior to lysis (0.5g 
per sample). Lysates were incubated with 4G10 beads overnight prior to 
washing the beads 5 times in RIPA, and eluting in phenyl phosphate. 
Unconcentrated eluate was pooled (U/C). 40% of this material was 
concentrated by acetone precipitation (Ac). 40% of the material was 
concentrated using an electrophoresis clean up kit (GE). Equal amounts (cf. 
starting material) of unconcentrated and concentrated material (Ac, GE) were 
electrophoresed and phospho-western blotting with 4G10-HRP antibody 
carried out. 
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Figure 4.15. Induction of protein tyrosine phosphorylation in 4G10 
immunoprecipitates of lysates is seen within seconds of cartilage injury. (A) and (B) 
are two separate but similar experiments. 
For both A. & B., trotters were opened and equilibrated at 37°C. 3 cartilage pieces from 
a single joint surface were dissected either directly into a tube on dry ice (0) or into 
serum-free medium for increasing times. Points were performed in duplicate and pooled 
prior to lysis. Lysates were incubated with 4G10 beads overnight prior to washing the 
beads 5 times in RIPA, eluting in phenyl phosphate solution and boiling the eluate with 
SDS sample buffer. Western blotting with 4G10-HRP antibody was carried out. Lysates
were kept and electrophoresed separately and western blotting for ERK carried out to 
ensure equal amounts of cellular protein was used for immunoprecipitation.
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In a separate experiment, cartilage was cultured for longer times prior to lysis and 
4G10 immunoprecipitation. The phosphotyrosine pattern remained strong at 60min 
(Fig 4.15B). At 24h it was diminished, although had not returned to control levels, 
consistent with findings in previous experiments on rested explants (Fig 4.6A). In all 
experiments performed, the bands of interest were reproducibly present and strong at 
10min, so this time point was chosen for further experiments. 
4.6  Identification of tyrosine-phosphorylated proteins from 
pervanadate-stimulated cartilage 
To identify proteins from gels, they would need to be visible on silver staining and be 
present in sufficient quantities for detection by mass spectrometry. The phosphatase 
inhibitor sodium pervanadate had caused marked up-regulation of 
immunoprecipitable tyrosine-phosphorylated proteins in chondrocytes (Fig 4.7). I 
investigated whether explantation into sodium pervanadate, or explantation alone, 
induced tyrosine phosphorylation of proteins which could be detected by silver 
staining following standard 4G10 immunoprecipitation. 
Cartilage was either dissected immediately from the articular surface into RIPA 
buffer, or into medium with or without 10mM sodium pervanadate for 10min. 
Aliquots of lysates were incubated with either a non-immune mouse immunoglobulin 
control on protein A agarose beads (N/I control) or 4G10 beads. Eluates were mixed 
with SDS sample buffer and electrophoresed for either phospho-western blotting with 
4G10 antibody or silver staining. On 4G10 western blotting, there was clear 
regulation of bands following explantation into medium alone. However, the cartilage 
which had been dissected into pervanadate showed strongly increased 
phosphorylation (~100 fold greater than cartilage dissected into medium alone) (Fig 
4.16, left panel). No immunostaining was present in the non-immune precipitates on 
Chapter 4                                     Investigation of tyrosine phosphorylation in cartilage following injury 
 180
phospho-western blotting. However, the non-immune beads did precipitate a number 
of proteins visible on silver stain, some of which aligned with silver stainable bands 
seen following 4G10 immunoprecipitation (Fig 4.16, right panel). The weak silver-
staining bands in 4G10 immunoprecipitates from cartilage explanted into medium 
alone mostly appeared to be non-specific (i.e. some were reduced in the 10min injury 
lane compared with ex-vivo (0), as the former could be washed more extensively). In 
contrast, the 4G10 immunoprecipitates of cartilage explanted into pervanadate 
contained many silver-staining bands which were not present in the non-immune 
precipitates (Fig 4.16, right panel).  
The large quantity of tyrosine-phosphorylated proteins evident on silver staining of 
immunoprecipitates from pervanadate-treated cartilage made pervanadate an 
attractive stimulus for preliminary attempts to identify cartilage phosphoproteins. 
~0.75g cartilage was dissected directly from the articular surface into a tube on dry 
ice. Cartilage was also dissected into either serum-free medium for 10min, or into 
medium containing 10mM pervanadate for 20min prior to lysis and standard 4G10 
immunoprecipitation. 4G10 western blotting or silver staining of the phenyl 
phosphate eluates was carried out. Explantation into pervanadate markedly induced 
tyrosine phosphorylation of many proteins as judged by western blotting. These bands 
were many fold stronger than the bands seen following explantation alone (Fig 4.17, 
left panel, 2 exposures are shown).  
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Figure 4.16. Explantation of cartilage into pervanadate solution induces strong 
protein tyrosine phosphorylation and specific bands on silver staining.
~0.5g cartilage was dissected either directly into ice cold lysis buffer (0) or into culture 
medium with (+) or without (-) 10mM sodium pervanadate for 10min prior to lysis. 
Lysates were incubated overnight with 4G10 beads (4G10) or protein A agarose pre-
incubated with mouse immunoglobulin (N/I control) prior to washing the beads 5 times in 
RIPA, eluting in phenyl phosphate and boiling the eluate with SDS sample buffer. 
Samples were electrophoresed and either assayed for phosphotyrosine content by western 
blotting with 4G10-HRP antibody (western blot) or silver stained (silver stain).
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Figure 4.17. Identification of tyrosine-phosphorylated proteins induced by pervanadate. 
~0.75g cartilage per lane was dissected either immediately into a tube on dry ice (0) or into 
serum-free medium with (+) or without (-) 10mM sodium pervanadate and cultured for 
10min, prior to lysis. Lysates were incubated with 4G10 beads overnight prior to washing the 
beads 5 times in RIPA, eluting in phenyl phosphate and boiling the eluate with SDS sample 
buffer Samples were electrophoresed and either assayed for phosphotyrosine content by 
western blotting with 4G10-HRP antibody (western blot, 2 different exposures shown) or 
silver stained (silver stain). Bands from the silver stained gel were cut out, digested with 
trypsin overnight, and analysed by mass spectrometry.
Abbreviations: Transcriptional endoplasmic reticulum (TER) ATPase; heterogeneous nuclear ribosomal protein 
(HNRP)Q; downstream of tyrosine kinase (DOK)-1; unidentified band (A)
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Multiple strong bands were seen on silver staining of samples from the pervanadate-
stimulated cartilage (Fig 4.17, right panel). All bands were excised, trypsin digested 
and analysed by mass spectrometry. All of the proteins identified were known to be 
tyrosine-phosphorylated, many with multiple sites for tyrosine phosphorylation (Table 
4.1). These identifications were all confirmed in subsequent experiments, with many 
of the proteins such as cortactin identified from multiple bands on further scale-up 
because of their abundance.  
 Table 4.1. Identification of phosphoproteins from pervanadate-stimulated 
cartilage by mass spectrometry. 
Protein Name/ 
Accession number 
Size 
(kDa) 
Function Unique 
peptides 
Coverage 
% 
Ion 
score 
Transitional 
endoplasmic 
reticulum ATPase 
(TERA_HUMAN) 
89 Golgi 
stacking 
3 4.6 181 
Cortactin 
(SRC8_HUMAN) 
80/85 Src 
substrate; 
scaffolding 
protein 
1 2.4 90 
Heterogeneous 
nuclear riboprotein 
Q 
(HNRPQ_HUMAN) 
69 mRNA 
processing 
1 2.1 66 
Docking protein 1  
(DOK1_HUMAN) 
62 Adaptor 
protein 
1 4.8 33 
MS identifications from gel shown in Fig 4.17 are listed. Ion score is 10*Log(P) 
where P is the probability that the observed match is a random event. Individual ion 
scores > 58 indicate identity or extensive homology P<0.05).  
The identification of phosphoproteins validated the approach but none of them 
aligned with the 60 or 100 kD bands induced by explantation alone on the 4G10 blot. 
Some bands e.g. A in the pervanadate lane did align with bands which appeared to be 
regulated by injury alone, but could not be identified. Disappointingly, none of the 
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bands seen on silver stain of the immunoprecipitates made from explanted cartilage 
were identified by mass spectrometry (Fig 4.17, right panel). There was likely to be 
far less phosphotyrosine present in these samples, and silver-stainable bands were 
probably below the limit of detection for mass spectrometry (~100-500 fM). (On 
testing, silver staining had a sensitivity of about 60 fM, data not shown).  
4.7  Identification of injury-induced tyrosine-phosphorylated 
proteins by mass spectrometry 
To obtain sufficient tyrosine-phosphorylated proteins to allow their identification, it 
was necessary to scale-up the procedure. Loading larger volumes of sample on large 
non-gradient gels did not increase the intensity of the bands. It was not possible to 
load more sample on a minigel (50μl well capacity) without concentrating the sample.  
Fig 4.18A shows a 16 fold scale-up of ex vivo versus explanted cartilage compared 
with Fig 4.17. Following 4G10 immunoprecipitation, phenyl phosphate eluates were 
pooled and concentrated using the GE kit. 1/6 of the concentrated sample was 
electrophoresed for western blotting with 4G10 antibody. This confirmed preservation 
of regulation of tyrosine phosphorylation following this procedure (Fig 4.18A, left 
panel). 5/6 of the sample was electrophoresed on the same gel, which was stabbed 
before being divided so that the resulting nicks on the western blot and the silver 
stained gel could be re-aligned. Silver staining of the slab was carried out. A large 
number of protein bands were seen in both lanes (Fig 4.18A, right panel). The 100-
120 kD complex on 4G10 blotting directly aligned with a quadruplet of bands on 
silver stain which appeared to be regulated by injury. All of the bands were manually 
excised and digested with trypsin. A number of proteins were identified by 
electrospray tandem mass spectrometry (Fig 4.18B). The mass spectrometry and 
identification was performed by Dr R.Wait of the Kennedy Institute.  
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Figure 4.18A. Further scale-up and identification of tyrosine-phosphorylated
proteins in injured cartilage.
~12g (0.5g x 24 samples) of porcine cartilage was dissected from MCP joints 
either directly into tubes on dry ice (0) or into serum-free medium and cultured for 
10min (10) prior to lysis. Samples were lysed separately, pre-cleared once with 
50μl protein A agarose and standard 4G10 immunoprecipitation carried out. 
Phenyl phosphate eluates were pooled and concentrated with the clean up kit (GE) 
prior to boiling samples with SDS sample buffer. 1/6 of the concentrated material 
for each sample was electrophoresed and assayed for phosphotyrosine content by 
western blotting with 4G10 antibody (left panel). 5/6 of the concentrated material 
was electrophoresed on the same gel, the gel divided, and silver staining carried 
out (right panel). The figure shows alignment of the two pieces of gel. Bands from 
the silver stained gel were cut out, digested with trypsin overnight, and analysed 
by mass spectrometry.
Markers
(kD)
100-120 kD complex
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A3A1 & A2
B
C1
D1 & 2
E
F
G
H1 & 2
I1
J
K
C2
D3 & 4
L
M
H3
I2
N1 & 2
P1&2
Q
R
S
PolyubiquitinS
Porcine immunoglobulinR
Epidermal growth factor receptorQ
KeratinP
Focal adhesion kinaseN
PaxillinM
Pyruvate kinaseL
Collagen binding protein 2K
Collagen type IIJ
Cartilage oligomeric matrix proteinI
Porcine immunoglobulin (IgM)H
AlbuminG
Protein disulphide isomerase kinaseF
Glucose 6 phosphate isomeraseE
EGF-like repeat and discoidin 1-like domain containing protein 3D
alpha-enolaseC
ActinB
Glyceraldehyde 3 phosphate dehydrogenaseA
Figure 4.18B. Identification of tyrosine-phosphorylated proteins in injured 
cartilage by mass spectrometry.
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The top two bands of the quadruplet which aligned with the 100-120 kD complex on 
4G10 blotting were identified as the tyrosine kinase focal adhesion kinase (FAK) 
(Bands N1 and N2, Fig 4.18B). 3 peptides were identified, the second of which had 
the highest probability of being from FAK alone (Fig 4.19A&B). The alignment was 
with human, dog or chicken FAK, as the full porcine FAK amino acid sequence is not 
known. It does appear to be highly conserved in mammals, however.  
A band on silver stain which aligned with the 60 kD regulated band on phospho-
western was identified as paxillin, a substrate of FAK (Band M, Fig 4.18B). Only a 
single peptide was detected, but this was 30 amino acids long, increasing the 
probability of it being from paxillin alone (Fig 4.20A&B). (The alignment was with 
human paxillin, for the same reasons as above). Both FAK and paxillin are known to 
be tyrosine-phosphorylated, and both were found only in the 10min ‘injured’ cartilage 
lane, although were likely to be at the lower limit of detection for the mass 
spectrometer. None of the peptides detected contained a known tyrosine site 
(phosphorylation of the peptides is not confirmed by this technique in any case).  
In addition, a peptide was found in the digest of the gel slice from the 190 kD region 
of the injury lane which was possibly from the epidermal growth factor receptor 
(EGFR) (Band Q, Fig 4.18B). However this finding was not confirmed in repeat 
experiments. Subsequent western blotting of unconcentrated lysates of injured 
cartilage or 4G10 immunoprecipitates with antibodies to total EGFR, phospho-tyr 
1068 and phospho-tyr 845 EGFR (tyr 845 is a src-dependent tyrosine phosphorylation 
of EGFR) did not confirm EGFR phosphorylation on injury.  
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B
Human PTK-2 (Focal adhesion kinase) amino acid sequence
Figure 4.19. Identication of focal adhesion kinase as a tyrosine-
phosphorylated protein induced by cartilage injury.
A. The full human FAK amino acid sequence is shown (Q81YN9_HUMAN).
The peptide sequences identified by tandem mass spectrometry are
highlighted in red. A search against the NCBI nr database retrieved FAK with 
a score of 78, 60 and 40 for each of the peptides respectively. (Ion score is 
10*Log(P) where P is the probability that the observed match is a random
event. Individual ion scores > 58 indicate identity or extensive homology 
P<0.05). The sequence coverage was 5.6% of the total sequence.
B. Tandem mass spectrum of the second FAK peptide 
RTLLATVDETLPVLPASTHRE is shown.
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1 mddldallad lesttshisk rpvflseetp ysyptgnhty qeiavpppvp pppssealng
61 tildpldqwq psgsrfihqq pqssspvygs saktssvsnp qdsvgspcsr vgeeehvysf
121 pnkqksaeps ptvmstslgs nlseldrlll elnavqhnpp gfpadeanss pplpgalspl
181 ygvpetnspl ggkagpltke kpkrnggrgl edvrpsvesl ldelessvps pvpaitvnqg
241 emsspqrvts tqqqtrisas satreldelm aslsdfkgsw pleevvllvs isssvqegek
301 yphpcaarhr tpslrspdqp ppcpqfmaqg ktgsssppgg ppkpgsqlds mlgslqsdln
361 klgvatvakg vcgackkpia gqvvtamgkt whpehfvcth cqeeigsrnf ferdgqpyce
421 kdyhnlfspr cyycngpild kvvtaldrtw hpehffcaqc gaffgpegfh ekdgkaycrk
481 dyfdmfapkc ggcarailen yisalntlwh pecfvcrecf tpfvngsffe hdgqpycevh
541 yherrgslcs gcqkpitgrc itamakkfhp ehfvcafclk qlnkgtfkeq ndkpycqncf
601 lklfc
Figure 4.20. Identication of paxillin as a tyrosine-phosphorylated
protein induced by cartilage injury.
A. The full human paxillin amino acid sequence is shown (P49023 
PAXI_HUMAN). The peptide sequence identified by tandem mass 
spectrometry is highlighted in red.
B. Tandem mass spectrum of the peptide 
TGSSSPPGGPPKPGSQLDSMLGSLQSDLNK from paxillin. The 
measured m/z of the triply protonated peptide was 980.52, corresponding to 
a deconvoluted Mr of 2938.5283 (calculated value = 2938.4342). A search 
against the NCBI nr database (20090228 release; 7,930,315 sequences) 
retrieved paxillin with a score of 74. (Ion score is 10*Log(P) where P is the 
probability that the observed match is a random event. Individual ion scores 
> 58 indicate identity or extensive homology P<0.05).
Human paxillin amino acid sequence
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Some proteins were identified from the gel in the uninjured lane only, or in both 
uninjured and injured lanes (Fig 4.18B). A number of serum, house-keeping and 
cartilage matrix proteins (not known to be tyrosine-phosphorylated and therefore 
likely to be contaminants) were identified. Some phosphoproteins including α-enolase 
and EGF-like repeat and discoidin 1-like domain containing protein 3 (EDIL-3) were 
present in both lanes. These phosphoproteins were not investigated further on the 
basis that their tyrosine phosphorylation status was not proven to be regulated by 
injury. 
The identification of FAK and paxillin from the gel was of particular interest as they 
aligned with two of the four regions of interest defined by western blotting of 
phosphotyrosines. In a repeat of the experiment, FAK was again identified by mass 
spectrometry, but paxillin was not found and nor were any other further regulated 
phosphoproteins (data not shown). Validation of the injury-induced regulation of 
FAK and paxillin is carried out by immunoprecipitation and western blotting 
experiments described in the next chapter. 
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4.8   Discussion 
Tyrosine kinase activation following cartilage injury is early and reproducible. 
Multiple tyrosine phosphorylations in cartilage occur within 30 seconds of 
explantation. The identification by mass spectrometry of FAK and paxillin as two 
proteins which are phosphorylated in response to injury is interesting. FAK is 
required for cell spreading (the formation of focal adhesions), cell proliferation and 
motility. Knockout of FAK in mice results in an embryonic lethal phenotype due to 
defects in mesodermal tissues and defects in angiogenesis (Shen et al., 2005). The 
mechanism by which FAK becomes activated is not well understood. In response to 
various stimuli including growth factors, integrin binding or cell stress, FAK auto-
phosphorylates on tyr 397 (Lietha et al., 2007). This brings about a conformational 
change in the protein, which allows binding of the auto-phosphorylated site and a 
nearby PxxP motif to src, via src’s SH2 and SH3 domains (Lietha et al., 2007). 
Subsequent phosphorylation of further tyrosine sites in the activation loop of FAK by 
src (tyr 576 and tyr 577) leads to full activation of FAK (Calalb et al., 1995). It is this 
FAK/src complex which then phosphorylates substrates including paxillin (at two 
main sites) (Schaller and Parsons, 1995) and p130cas (crk associated substrate – 
another adaptor protein seen at focal adhesions). The FAK/src complex can also 
associate with PI3 kinase and phospholipase C (Schaller and Schaefer, 2001; Turner, 
2000). Phosphorylation of paxillin creates binding sites for SH2 domains of other 
signalling proteins at focal adhesions, including src, another adaptor protein Crk and 
c-src kinase (Csk – a negative regulator of srcs) (Schaller and Parsons, 1995).  
Whether such tyrosine kinase activity could be part of a mechano-transducing 
mechanism is unknown. There are no reports of FAK phosphorylation in response to 
direct tissue injury. One group showed that stretch of mid-palatal suture cartilages in 
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rats induced FAK expression, formation of stress fibres and ERK activation 
(Takahashi et al., 2003). Another group noted tyrosine phosphorylation after 
mechanical stimulation of cultured chondrocytes, and by investigation of potential 
candidates demonstrated that FAK was phosphorylated (Lee et al., 2000). This 
phosphorylation was suggested to be integrin-dependent. 
The peptide identification by mass spectrometry identifies proteins, and not phospho-
proteins, or phospho-sites. The technique does not confirm that a phospho-protein was 
identified, although the identifications of FAK and paxillin were only made from the 
injured cartilage immunoprecipitates. Mass spectrometry can identify phosphorylated 
amino acids but higher concentrations of the proteins than used here are needed for 
successful identification. In order to confirm the identifications made by mass 
spectrometry, antibodies to the proteins and their phosphorylation sites are used in the 
next chapter.  
2 out of the 4 major protein bands on 4G10 immunoprecipitation were identified by 
mass spectrometry. It is notable that both FAK and paxillin are substrates of src: FAK 
activation is dependent upon phosphorylation by src, and src also appears to be 
capable of phosphorylating paxillin independently of FAK in vitro (Schaller and 
Schaefer, 2001). In addition, a fragment of the EGF receptor was found in the third 
band at 190 kD in one experiment. Like FAK and paxillin, this is another src substrate 
(Wu et al., 2002) but the identity of this band could not verified immunologically. The 
fourth band at 80 kD was in a similar region of the gel to the src substrate cortactin 
which had been identified in pervanadate-treated cartilage lysates. Cortactin is a 
doublet of 80/85 kD. It acts as a scaffolding protein, promoting actin polymerization 
and is also involved in receptor mediated endocytosis and vesicular trafficking 
(Tehrani et al., 2007; Zhu et al., 2007). Further experiments to investigate whether 
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cortactin was phosphorylated upon cartilage injury are also described in the next 
chapter.  
It was surprising that so few bands were seen in injured cartilage 4G10 
immunoprecipitates. Given the complex pattern on 4G10 blotting, one might have 
anticipated more. The low number of proteins might have been because of incomplete 
phosphotyrosine immunoprecipitation. The proteins immunoprecipitated and 
identified probably represented the most abundant and most highly phosphorylated 
(FAK and paxillin both have multiple tyrosine phosphorylation sites). The 
immunoprecipitation process was likely to preferentially enrich multiply 
phosphorylated proteins in this way, and these were not necessarily the most 
important. Various other strategies might have been incorporated to increase the yield 
of phosphoproteins. It has been reported that 4G10 may not immunoprecipitate certain 
phospho-tyrosine motifs, for example where arginine is an adjacent residue 
(Bergstrom Lind et al., 2008). Other groups favour alternative antibodies such as 
PY100, or mixtures of phosphotyrosine antibodies which increase the number of 
identifications, and such a combination could have been tested (Bergstrom Lind et al., 
2008; Hinsby et al., 2003). Another strategy to purify phosphoproteins is immobilised 
metal ion affinity chromatography (IMAC). Here, a column of gallium or iron 
preferentially binds phosphorylated amino acids (Hinsby et al., 2004). However, this 
would preferentially enrich the more abundant serine and threonine phosphorylations 
in preference to tyrosine phosphorylations. It also requires prior digestion to a peptide 
mixture. It was not felt to be suitable for analysis of complex solutions from tissue 
lysates. 
It was possible that other less abundant proteins of a similar size were induced and 
over-lay the identified proteins using this 1D gel system, and have not been identified. 
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The possibility of 2D electrophoresis was considered but would have required further 
scale-up. 
The observation that the induction of tyrosine phosphorylation following injury was 
rapid and strong on western blotting would suggest that chondrocyte activation in the 
tissue may not be restricted to the cut edge: cells distant to the injury may also be 
activated. To test this possibility, phosphorylated proteins would need to be visualised 
in the cartilage by immunolocalisation. Phosphorylation of ATF-2 and translocation 
of the p65 subunit of NFκB 30 minutes after explantation from the articular surface 
has been previously demonstrated throughout the mid and deep zones of cartilage (see 
A. Didangelos, Ph.D. thesis, 2008 and Figure 1.5). However, it is not clear whether 
the immediate response is localised to the cut edge, or whether distant cellular 
activation is seen immediately after the injury. Immunolocalisation of a tyrosine-
phosphorylated protein after injury to another connective tissue is shown later in 
Chapter 6.  
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5 The role of tyrosine kinases in the response of 
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5.1 Introduction 
Dissection of cartilage induced within seconds phosphorylation of tyrosine residues 
on a number of proteins, as visualised by phosphotyrosine immunoprecipitation and 
western blotting. These phosphorylations were prevented by the src inhibitor, PP2. By 
phospho-selective purification from cartilage lysates, two known phosphoproteins, 
focal adhesion kinase (FAK) and its substrate, paxillin were identified from silver 
stained gels. It was important to verify that these proteins accounted for two of the 
regulated bands of interest seen on 4G10 antibody staining. Their phosphorylation in 
response to injury was therefore investigated by the use of antibodies to the proteins 
and to specific phosphorylation sites. It was also important to investigate whether 
FAK or other tyrosine kinases such as src family kinases might be upstream of MAPK 
or IKK activation seen following injury. 
5.2 Verification of mass spectrometry identifications by 
western blotting 
The presence of the proteins in the 4G10 immunoprecipitates was investigated by 
western blotting the precipitates with antibodies. Western blotting for FAK showed a 
band at around 120 kD whose intensity was increased following dissection (FAK is a 
125 kD protein) (Fig 5.1A), and for paxillin a similarly regulated band at 60 kD 
(paxillin is a 68 kD protein) (Fig 5.1B). The membranes were re-probed with 4G10 
antibody (right hand panels). The FAK band aligned with the top 2 bands of the 100-
120 kD cluster on 4G10 western blotting. It did not account for the lower part of the 
4G10-stained complex. The paxillin band on western blot aligned exactly with the 
4G10-stained 60kD band. 
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Figure 5.1. Western blotting of 4G10 immunoprecipitates of injured 
cartilage for (A) FAK and (B) paxillin.
For both A.& B., ~0.5g cartilage was dissected either directly into ice cold 
lysis buffer (0) or into culture medium for 10min (10) prior to lysis. Lysates
were incubated with 4G10 beads overnight prior to washing the beads 5 times 
in RIPA, eluting in phenyl phosphate and boiling the eluates with SDS sample 
buffer. Western blotting of the 4G10 immunoprecipitates with A. antibodies 
to FAK protein (left upper panel), or B. antibody to paxillin protein (left lower 
panel) was carried out. The membranes were re-probed with 4G10 antibody 
(right panels). A. and B. are both representative of 2 experiments.
A
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64
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39
0   10        0   10   Time after dissection (min)   
B
WB: FAK WB: 4G10
WB: paxillin WB: 4G10
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The phosphorylation of tyrosine residues at 60 kD and 100-120 kD was seen within 
20-30sec of injury by phospho-western blotting with 4G10 antibody. To ascertain 
whether the phosphorylation of FAK and paxillin was seen as rapidly after injury, 
freshly dissected cartilage was processed and precipitated with 4G10 as previously. 
Eluates of the precipitates were western blotted for FAK protein. The membrane was 
successively re-probed with antibody to total paxillin and then 4G10 antibody. 
Induction of a doublet was seen 20sec after dissection on western blotting for FAK. 
Induction was stronger at 10min (top panel, Fig 5.2). In contrast, western blotting 
with paxillin antibody showed increase of tyrosine-phosphorylated protein at 10min 
but not by 20sec (middle panel, Fig 5.2). These bands aligned with the respective 
bands stained by 4G10.  
5.2.1 Cortactin is also phosphorylated following cartilage injury 
Another src substrate, cortactin, had been identified from 4G10 immunoprecipitates of 
cartilage treated with sodium pervanadate (Ch 4, Fig 4.17). To test whether tyrosine 
phosphorylation of cortactin occurred after injury, cartilage was either snap frozen or 
dissected into medium for 10min prior to lysis and standard 4G10 
immunoprecipitation. Eluates were western blotted with antibody to cortactin. 
Induction of cortactin tyrosine phosphorylation was seen in cartilage after 
explantation (Fig 5.3). This doublet aligned with the 80 kD band visible on 4G10 
western blotting (see Chapter 4, Fig 4.17). 
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Figure 5.2. FAK is phosphorylated within seconds of explantation of 
articular cartilage.
Trotters were equilibrated at room temperature, and then a total of 8 pieces 
of cartilage (from 4 different trotters) was dissected either immediately into 
ice cold lysis buffer (0) or into medium and cultured for 20sec (0.3) or 
10min prior to lysis. 4G10 immunoprecipitation and western blotting of the 
eluted material was carried out with antibodies to FAK. The membrane was 
then re-probed with paxillin antibody and also with 4G10 antibody (lower 
panel). This is representative of 2 experiments.
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FAK
paxillin
0      0.3      10   Time after dissection (min)
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Figure 5.3. Phosphorylation of cortactin is induced by cartilage 
explantation.
~0.5g cartilage was dissected either directly into a tube on dry ice (0), or 
into medium and cultured for 10min (10) prior to snap freezing. 
Following lysis and 4G10 immunoprecipitation, western blotting of 
eluted material with antibody to cortactin was carried out (left panel). 
The membrane was re-probed with 4G10 antibody (right panel).
WB: cortactin WB: 4G10
0      10              0      10      Time after dissection (min)
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5.3 Investigation of FAK and paxillin phosphorylation in the 
response of cartilage to injury by the use of phospho-site 
specific antibodies 
To confirm that phosphorylated forms of FAK could be detected in cartilage lysates 
as well as 4G10 immunoprecipitates, and to investigate the nature of the 
phosphorylation, antibodies to phosphorylation sites were employed. FAK has 6 
known tyrosine phosphorylation sites. As discussed in Chapter 4, activation of FAK is 
thought to be initiated by auto-phosphorylation at tyr 397. This causes a 
conformational change in the molecule which unmasks two further tyrosine 
phosphorylation sites (tyrs 576 and 577) which are targets for src (generally c-src in 
other cell systems). Their phosphorylation is required for full activation of FAK. 
Western blotting of the cartilage lysates with phospho-tyr 397 (Biosource) and 
phospho-tyr 576 FAK (Upstate) antibodies was carried out. Phospho-tyr 397 
antibodies stained a band at ~120 kD, which was not regulated by injury (Fig 5.4, 
upper panel). In comparison, increase of phospho-tyr 576 FAK staining was seen 
within 10min of dissection (Fig 5.4, middle panel). Phosphorylation was still evident 
at 60min, but had returned to the basal level (0min) by 24h. The membrane was re-
probed with antibodies to ERK to check for equal loading of cellular protein. That 
phospho-397 antibodies did not detect a regulated band suggested either that this site 
was not being phosphorylated or that the antibodies might also detect un-
phosphorylated FAK, and may not be specific for the phospho-form. Neither 
phosphorylated nor un-phosphorylated forms of the peptide used to raise the 
antibodies were available from the manufacturer, so their specificity could not be 
tested. A subsequent experiment where FAK immunoprecipitates from cartilage 
lysates were then probed with phospho-tyr 397 antibodies also showed a band which 
was not regulated by injury (data not shown).  
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phospho-tyr
576 FAK
0        10       30      60      24 h    Time after dissection
125 kD
Figure 5.4. FAK is phosphorylated upon tyr 576 following explantation
of cartilage. 
~0.5g cartilage was dissected either directly into lysis buffer (0) or into 
serum-free medium and cultured for increasing times prior to lysis. Western 
blotting of the cartilage lysates with phospho-tyr 397 FAK antibodies or 
phospho-tyr 576 FAK antibodies was carried out. The membrane was re-
probed with antibodies to ERK to ensure equal cellular protein loading.
phospho-tyr
397 FAK
125 kD
min
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In view of this uncertainty regarding the specificity of phospho-tyr 397 antibodies, 
they were not used in further experiments. They had been used successfully by other 
groups, for example in detecting a regulated band in lysates of human platelets treated 
with low density lipoprotein or thrombin (Relou et al., 2003). 
5.3.1 Phospho-FAK in cartilage 4G10 immunoprecipitates 
Antibodies to FAK protein had been tested on 4G10 immunoprecipitates (Fig 5.1A). 
Eluates of 4G10 immunoprecipitates were also blotted for phospho-tyr 576 FAK. The 
membrane was re-probed with 4G10 antibody. The phospho-tyr 576 FAK antibodies 
detected two strong bands induced by dissection which aligned with the top two bands 
of the 100-120 kD complex on 4G10 blotting (Fig 5.5). These experiments further 
supported the identification of FAK as a kinase which was phosphorylated upon 
cartilage injury. 
5.3.2 Phosphorylation of paxillin is seen in response to 
explantation of cartilage 
Paxillin is also a multiply phosphorylated protein, with 4 known tyrosine 
phosphorylation sites. Src and activated FAK form a complex which phosphorylates 
targets including paxillin (Schaller and Parsons, 1995). Tyr 118 (and tyr 31) are 
phosphorylation sites on paxillin thought to be dependent on FAK or src (Schaller and 
Schaefer, 2001). Antibodies to phospho-tyr 118 paxillin (Cell Signaling) were 
therefore employed in further experiments. 
Cartilage was dissected either directly into lysis buffer (0) or into serum-free medium 
and cultured for either 5 or 10min, or into pervanadate for 10min prior to lysis. 
Western blotting of the cartilage lysates with phospho-tyr 118 paxillin antibodies 
(henceforth referred to as phospho-paxillin antibodies) was carried out. Induction of 
phosphorylation of paxillin was seen within 5min of explantation (Fig 5.6). 
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Figure 5.5. The 100-120 kD complex on 4G10 immunoprecipitation
contains phosphorylated FAK.
~0.5g cartilage per point was dissected either directly into lysis buffer (0) 
or into serum-free medium for 10min prior to lysis and 4G10 
immunoprecipitation. Beads were washed and eluted with phenyl 
phosphate, and western blotting carried out on the eluates with phospho-tyr
576 FAK antibodies. The membrane was re-probed with 4G10 antibody.
This is representative of 3 experiments.
0  10     0  10   Time after dissection (min)
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64
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39
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0       5       10      10 Time after dissection (min)
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Figure 5.6. Paxillin is phosphorylated following explantation of 
cartilage. 
~0.5g cartilage was dissected either directly into lysis buffer (0) or into 
serum-free medium and cultured for increasing times prior to lysis, or into 
medium containing 10mM sodium pervanadate for 10min prior to lysis. 
Western blotting of the cartilage lysates with phospho-tyr 118 paxillin
antibodies was carried out. The membrane was re-probed with antibodies 
to ERK to ensure equal cellular protein loading.
phospho-paxillin 68 kD
ERK
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Pervanadate, as expected, strongly increased tyrosine phosphorylation of paxillin, and 
was included as a positive control in future experiments (Fig 5.6). The ERK western 
blot suggests that the pervanadate sample is underloaded in this experiment. 
The phosphorylated form of paxillin was also shown to be present in the 4G10 
immunoprecipitates of the injured tissue (Fig 5.7A, left panel). The membrane was re-
probed with 4G10. The phospho-paxillin band exactly aligned with the inducible 60 
kD band on 4G10 blotting (Fig 5.7A, right panel).  
The specificity of the band was checked by testing with the immunising phospho-
peptide (obtained from Cell Signaling). Cartilage was dissected directly into lysis 
buffer (0) or into serum-free medium for 10min (10) prior to lysis and standard 4G10 
immunoprecipitation. Eluted material for each experimental condition was pooled and 
4 sets of equal aliquots electrophoresed, transferred on to nitrocellulose and then the 
membrane split into 4. The first membrane was incubated overnight with 1:1000 
dilution of the phospho-paxillin antibodies. The second, third and fourth pieces of 
membrane were incubated overnight with 1:1000 antibodies which had been pre-
incubated for 1h with various concentrations of the control peptide. The next day, all 
four membranes were developed with secondary antibodies and chemiluminescence 
together. In the absence of peptide, a regulated band at 60kD was seen on phospho-
western blotting. At all concentrations of the peptide, the 60 kD stained band was not 
seen (Fig 5.7B). This confirmed the specificity of the antibody. No unphosphorylated 
peptide was available, so I was unable to prove that the antibodies were only 
recognising phosphorylated forms of paxillin. This seemed likely, given that little 
staining with the antibodies of uninjured cartilage lysates was seen (Fig 5.6).  
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IP: 4G10 
WB: phospho-paxillin WB: 4G10
Figure 5.7. The recognition of the 60 kD protein on 4G10 
immunoprecipitation by phospho-paxillin antibodies (A), is prevented by 
pre-incubation with the immunising phospho-paxillin peptide (B).
A. ~0.5g cartilage per point was either dissected directly into lysis buffer (0) 
or into serum-free medium for 10min (10) prior to lysis and 4G10 
immunoprecipitation. Western blotting of eluates with phospho-paxillin
antibodies was carried out.
B. 4 x 0.5g cartilage was either dissected directly into lysis buffer (0) or into 
serum-free medium for 10min (10) prior to lysis and 4G10 
immunoprecipitation. Beads were eluted with phenyl phosphate. Eluted 
material was pooled, electrophoresed, transferred on to nitrocellulose and the 
membrane split into 4. The membranes were incubated overnight with 1:1000 
dilution of the phospho-paxillin antibodies alone, or 1:1000 antibodies which 
had been pre-incubated for 1h with increasing concentrations indicated of the
control phospho-paxillin peptide (peptide). All four membranes were then 
developed together, with secondary antibody and chemiluminescence. 
68 kD
A
B IP: 4G10 
WB: phospho-paxillin
Peptide (μg/ml)
0      10             0      10   Time after dissection
(min)
0  10                        0  10         0   10      0   10 
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5.3.3 A time course of tyrosine phosphorylation of FAK and 
paxillin in response to cartilage injury 
The phospho-FAK and phospho-paxillin antibodies, in conjuction with 4G10 
immunoprecipitation were used in further experiments to examine the induction of 
tyrosine phosphorylation after cartilage injury. Cartilage was lysed at increasing times 
after dissection and culture in serum-free medium. Eluted material from 4G10 
immunoprecipitation was western blotted with antibodies to phospho-tyr 576 FAK 
and phospho-paxillin. The lysates were run separately and western blotting for ERK 
carried out, to ensure that equal amounts of cellular protein had been included in the 
immunoprecipitation. Weak induction of FAK phosphorylation was seen at 30sec 
after explantation in this experiment, confirming earlier findings with anti-FAK 
antibodies (Figs 5.8 & 5.2). Phosphorylation of paxillin was just visible at 30sec after 
explantation, and clearly present at 1min (Figs 5.8 & 5.2). The phosphorylation of 
FAK and paxillin was maximal between 10 and 60min. After 24h, FAK and paxillin 
phosphorylation had declined, but not to baseline levels (Fig 5.8). This was consistent 
with previous experiments which suggested increased tyrosine phosphorylation at 24h 
after explantation on 4G10 western blotting (see Ch 4, Fig 4.15).  
5.3.4 FGF is not required for FAK activation following cartilage 
injury 
Growth factors such as FGF are reported to activate FAK and src (discussed in Ch 1, 
section 1.6), so the activation of FAK and subsequent phosphorylation of paxillin 
could have been due to the release of FGF-2 following cartilage injury. To test this 
hypothesis, similar experiments were performed to those in Chapter 4, section 4.4, but 
western blotting with phospho-FAK and phospho-paxillin antibodies was carried out 
in place of 4G10 antibody.  
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ERK
Figure 5.8. FAK and paxillin phosphorylation are rapid and sustained 
following explantation of cartilage.
Trotters were equilibrated at 37°C, and then a total of 8 pieces of cartilage (from 
4 different trotters) was dissected either immediately into ice cold lysis buffer (0) 
or into medium and cultured for increasing times prior to lysis. 4G10 
immunoprecipitation and western blotting of the eluted material was carried out 
with antibodies to phospho-tyr 576 FAK. The membrane was then re-probed with 
phospho-paxillin antibodies. Lysates were electrophoresed separately for western 
blotting with ERK antibodies, as a control for equal cellular protein loading. This 
is representative of 3 experiments..
phospho-tyr 576 FAK
phospho-paxillin
min
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No increase in phosphorylation of FAK or paxillin was seen in response to re-cutting 
of rested cartilage explants or treatment of rested explants with exogenous FGF-2 
(data not shown). 
The effect of the FGF receptor inhibitor PD173074 on the initial induction of FAK 
and paxillin phosphorylation following explantation was tested. Trotters were injected 
with culture medium with, or without, the FGF receptor inhibitor PD173074 and 
equilibrated at 37°C. Cartilage was then dissected into medium with or without the 
inhibitor and lysates were western blotted for phospho-tyr 576 FAK and phospho-
paxillin. The phosphorylation of FAK induced by explantation was not inhibited by 
PD173074 (Fig 5.9, Expt 1). In contrast, the phosphorylation of paxillin was reduced 
by at least 50% in the presence of the inhibitor. As expected, the strong induction of 
ERK following explantation was also inhibited by around 50% by the FGF receptor 
inhibitor. The membrane was re-probed for total ERK. The results of a second 
experiment are shown in support of these findings (Fig 5.9, Expt 2). This supported 
the previous observation made by 4G10 western blotting of cartilage lysates, that the 
phosphorylation of the 120 kD protein following explantation (subsequently identified 
as FAK) was not primarily dependent on FGF signalling (Ch 4, Fig 4.5A). However, 
paxillin phosphorylation did appear to be partially FGF-dependent, whereas the 
induction of the 60 kD band on 4G10 blotting was not. Possible explanations include 
that there were also FGF-independent tyrosine phosphorylations of other paxillin 
tyrosine residues visualised by 4G10 blotting, or that another 60 kD phosphoprotein 
was also present.  
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Expt 1                               Expt 2
phospho-ERK
phospho-tyr 576 FAK
phospho-paxillin
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Agent used                 - PD   veh - - PD   veh -
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Figure 5.9. The effect of PD173074 on phosphorylation of FAK and paxillin after 
explantation of articular cartilage.
Porcine MCPJs were equilibrated at 37°C and then injected with medium containing 
250nM PD173074 (PD) or medium alone (vehicle), or not injected (-). After 1h, ~0.2g 
cartilage was dissected from each of 2 trotters either directly into lysis buffer (0), or into 
serum-free medium alone (-, veh), or medium containing 250nM PD173074 (PD) and 
cultured for 5min prior to lysis. Cartilage lysates were assayed for phospho-tyr 576 FAK 
by western blotting. The membranes were stripped and re-probed for phospho-paxillin, 
phospho-ERK and ERK, the latter to check for equal cellular protein loading. Two 
different experiments are shown.  
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5.3.5 Attempts at inhibiting chondrocyte FAK activation  
To investigate further the role of focal adhesion kinase in the activation of protein 
kinases in the response of cartilage to injury, a specific inhibitor was required. The 
only commercially available inhibitors of FAK, the tyrphostins, are non-specific (for 
example, they block the EGF pathway) and were not used (Farooki et al., 1998). A 
group from Pfizer recently reported a compound PF573228 as a FAK inhibitor (Slack-
Davis et al., 2007). It was effective at 0.3-3μM at blocking the auto-phosphorylation 
of tyr 397 on FAK when tested on REF52 cells (an immortalised rat fibroblast cell 
line). 1μM PF573228 was tested on a panel of recombinant protein kinases. It was 
relatively selective, showing little significant inhibition of other kinases except the 
related kinase Pyk-2 (by 50%), cyclin-dependent kinase-1 and -7 (by around 80%) 
and glycogen synthase kinase 3β (by 60%) (Slack-Davis et al., 2007). It was unclear 
whether this inhibitor would prevent phosphorylation of FAK by src. It had also not 
been tested on tissues. Pfizer kindly gave a sample of PF573228 for these 
experiments.  
The inhibitor was first tested on primary chondrocyte monolayers. The ability of the 
inhibitor to block the constitutive phosphorylation of FAK and paxillin in adherent 
monolayer culture was examined. (This was the experiment described by J. Slack-
Davis et al but in a different cell type). Resting primary porcine chondrocytes were 
incubated with either the vehicle DMSO or increasing concentrations of the FAK 
inhibitor PF573228 prior to lysis and standard 4G10 immunoprecipitation. Eluates 
were western blotted with antibodies to phospho-tyr 397 FAK, phospho-tyr 576 FAK 
and phospho-paxillin. Phosphorylation of FAK and paxillin was seen in resting 
chondrocytes and this was not affected by the presence of DMSO (Fig 5.10, Expt 1). 
The FAK inhibitor at concentrations of 0.3-3μM appeared to partially inhibit the 
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phosphorylation of paxillin. There was a suggestion of reduction of FAK 576 
phosphorylation, but it was unconvincing. Paradoxically the inhibition appeared to be 
lost at the maximum concentration of PF573228 examined (10μM). Another similar 
experiment is shown (Fig 5.10, Expt 2). 
To clarify whether the inhibitor would inhibit FAK phosphorylation in tissues, further 
experiments were performed on cartilage. Induction of FAK and paxillin 
phosphorylation was seen in response to explantation. Some inhibition of this 
response was evident when cartilage was dissected into 3μM PF573228, but this 
effect was lost in the presence of 10μM inhibitor (Fig 5.11). Explanations for this 
could be that the vehicle DMSO was activating FAK at higher concentrations (it did 
not appear to augment signalling when used as a vehicle control, however) or that the 
inhibitor was not having predictable effects. This could be because of variable tissue 
penetration of cartilage, although this paradoxical effect was only seen at higher 
concentrations of inhibitor. In view of the disappointing and variable results obtained 
with the inhibitor, it was not employed in further experiments.  
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Figure 5.10. The effect of the FAK inhibitor PF573228 on phosphorylation
of FAK and paxillin in adherent primary chondrocytes.
Primary porcine chondrocytes (4 million per point) were isolated and rested 
for 4 days, prior to serum starving for 3h. The vehicle (0.1% DMSO), or 
increasing concentrations of the FAK inhibitor PF573228 in serum-free 
medium were then added to the cells for 1h, prior to lysis and standard 4G10 
immunoprecipitation. Eluted material was electrophoresed for western blotting 
with phospho-tyr 397 FAK antibodies and phospho-paxillin antibodies. Two 
separate experiments are shown. In experiment 1, samples were also assayed 
with phospho-tyr 576 FAK antibodies.
phospho-tyr
397 FAK
phospho-tyr
576 FAK
phospho-
paxillin
0   0.1  0.3  1     3   10  DM           0   0.1  0.3  1    3  10   
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Figure 5.11. The effect of the FAK inhibitor PF573228 on phosphorylation of 
FAK and paxillin following explantation of cartilage.
Porcine MCPJs were opened, and joints equilibrated at 37°C for 4h. ~0.2g cartilage 
was then dissected either directly into a tube on dry ice, or into medium alone, 
medium containing the vehicle 0.1% DMSO (veh), or medium containing 
increasing concentrations of the FAK inhibitor PF573228 and cultured for 10min 
prior to snap freezing. Following lysis, 4G10 immunoprecipitation was carried out 
and western blotting with phospho-FAK 576 antibodies and subsequently phospho-
paxillin antibodies was carried out. This is representative of 2 experiments.
phospho-FAK
phospho-paxillin
0      10    10 10 10 10 Time after dissection (min)
- 1      3      10    veh - PF573228 (μM)
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5.4 The role of src family kinases in the response of cartilage 
to injury 
A number of observations implicated src family kinases in the injury response in 
cartilage. FAK, paxillin and cortactin become phosphorylated upon injury, and all are 
known substrates of src. In the experiments shown earlier in this chapter, I had only 
been able to show a src-dependent phosphorylation of FAK, and had not established 
whether FAK was independently activated (Figs 5.4 & 5.5). The specific src kinase 
inhibitor PP2 had been previously noted to prevent all the injury-induced tyrosine 
phosphorylations of interest on 4G10 blotting (60, 80, 120 and 190 kD) (Ch 4, Fig 
4.5B). Furthermore, I had shown that PP2 reduced the production of activin A after 
explantation (Ch 3, Fig 3.24). The possibility that src family kinases were activated 
after tissue injury was therefore investigated further. 
5.4.1 Src expression and phosphorylation in cartilage 
First, I investigated which src family members were expressed in porcine 
chondrocytes. Cells were serum starved, lysed and western blotting with antibodies to 
the non-haematopoietic src members (src, yes, and fyn) and hck was carried out. All 4 
src members were detected (Fig 5.12).  
To examine whether there was phosphorylation of src members in response to injury, 
pan-phospho src antibodies were employed, which recognise phosphorylation of 
tyrosine residues within certain motifs common to many src members. The 3 src 
tyrosine phosphorylation sites examined (-416,-215 and -418) were reported as being 
associated with src activation (Roskoski, 2005; Vadlamudi et al., 2003).  
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Figure 5.12. Expression of src family members in porcine 
primary chondrocytes.
Porcine chondrocytes were isolated and rested for 3 days, 
prior to being serum starved for 3h. They were lysed and 
western blotting was carried out with antibodies to the 
ubiquitous src members c-src (Santa Cruz), yes and fyn, and 
also to hck. See Chapter 2 for details of the antibodies used.
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Testing the phospho-tyr 416 antibodies (which have probably been used most widely) 
by western blotting cartilage lysates, several non-specific bands were detected (data 
not shown). These included probable heavy chain immunoglobulin and phospho-
ERK, but no band of the expected molecular size of 60 kD was seen. Phospho-tyr 215 
src antibodies recognised a 60 kDa band in cartilage lysates, which was increased by 
pervanadate and weakly 10min after explantation (Fig 5.13A). However, the antibody 
also recognised a number of other proteins in cartilage lysates. Western blotting of the 
lysates with a total c-src antibody was carried out to ensure equal loading. A stronger 
band was seen in lysates stained with phospho-tyr 418 antibodies, particularly when 
the tissue was exposed to pervanadate, but this was not regulated by injury (Fig 
5.13B).  
Immunoprecipitation was carried out to concentrate tyrosine-phosphorylated srcs. 
Western blotting of 4G10 immunoprecipitates with either phospho-src 418 or total src 
(Upstate) antibodies was carried out. Conversely, c-src immunoprecipitates from 
cartilage were also assayed for phosphotyrosine content by 4G10 western blotting. In 
all experiments, a band which was increased by sodium pervanadate, but not by injury 
was seen (data not shown). It was likely that c-src would form a complex with 
activated FAK. However, using non-dissociative immunoprecipitation conditions, no 
evidence for co-immunoprecipitation of c-src with either FAK or paxillin on injury 
could be demonstrated (data not shown). 
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Figure 5.13. Testing phospho-src antibodies on cartilage lysates following 
dissection of the tissue and treatment with pervanadate.
For both A.& B., in separate experiments, ~0.5g cartilage was dissected either
directly into lysis buffer (0), or into medium and cultured for increasing times 
prior to lysis, or into medium containing 10mM sodium pervanadate for 10min 
prior to lysis. 
A. Lysates were assayed for phospho-tyr 215 src by western blotting. The 
samples were also electrophoresed separately for western blotting with total c-
src antibody (Upstate), as a loading control. 
B. Lysates were assayed for phospho-tyr 418 src by western blotting, and the 
membrane re-probed with antibodies to ERK to check for equal cellular 
protein loading. 
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5.4.2 Immunoprecipitation and activity of c-src in cartilage lysates 
Given that I had been unable to show convincing evidence of src phosphorylation 
upon tissue injury with either phospho-antibodies or immunoprecipitation-western 
blotting, I sought evidence of src activation by kinase assay. This measured the ability 
of c-src to auto-phosphorylate, and also to phosphorylate a known src substrate 
enolase (enolase had been detected in cartilage 4G10 immunprecipitates by mass 
spectrometry, see chapter 4, Fig 4.18B). The conditions for the immunoprecipitation 
with a monoclonal antibody to c-src (Upstate) were optimised, and showed a band of 
appropriate size on western blotting of the immunoprecipitates with src antibody, but 
also detected heavy chain immunoglobulin, just below the band of interest (see later, 
Fig 5.15). Cartilage was either dissected directly on to dry ice, or into medium for 
10min or 30min prior to snap freezing, or into medium containing 10mM sodium 
pervanadate for 10min as a positive control. A pre-clearing step with protein G 
agarose beads was included to deplete immunoglobulin in the samples, prior to 
immunprecipitation for 1h with the c-src antibody (Upstate). The ability of the 
immunoprecipitate to phosphorylate enolase was assessed by [γ-32P]ATP kinase 
assay. Two bands were evident on autoradiography of the gel: an upper band at 60 
kD, consistent with c-src auto-phosphorylation, and a lower band at 47 kD, likely to 
represent phosphorylated enolase (Fig 5.14). As controls for the assay, cartilage lysate 
was either incubated with an irrelevant mouse IgG monoclonal antibody (Lane 5) 
which gave a different (presumably non-specific) band to the two described, or the 
enolase was omitted and only the 60 kD band was seen (Lane 7). No bands were seen 
when lysate was excluded from the assay (Lane 6). Compared with uninjured 
cartilage, the lysates after injury at both 10 and 30min had reduced src activity in the 
assay, both in terms of auto-phosphorylation and phosphorylation of the substrate 
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enolase (Lanes 3&4, Fig 5.14). Dissecting and culturing cartilage in sodium 
pervanadate for 10min returned src activity to baseline levels (Lane 8).  
This unexpected finding was made in three separate experiments. It suggested that 
constitutive c-src activity was reduced following injury. It was possible that either the 
amount or activity of c-src in lysates was reduced. Another possibility was that the src 
was less accessible to the antibody. To test these possibilities, cartilage was dissected 
into serum-free medium for increasing times prior to lysis. Lysates were pre-cleared 
and then western blotting of an aliquot of the lysate immediately carried out (top 
panel, Fig 5.15). This showed that equal amounts of c-src were present in the lysates 
prior to immunoprecipitation. The remaining lysate was incubated with monoclonal 
antibodies to c-src and protein G agarose for 1h. The immunoprecipitates were boiled 
with sample buffer, prior to electrophoresis and western blotting for c-src (second 
panel, Fig 5.15). The supernatant of the immunoprecipitates was assessed for residual 
c-src content by western blotting (third panel, Fig 5.15). Compared with ex vivo ‘0’ 
samples, explantation for 5min or more affected the ability of the monoclonal 
antibody to immunoprecipitate c-src from the lysates (second panel, Fig 5.15). This 
phenomenon could be explained by conformational change in c-src, modification, or 
binding of another protein which masked the epitope, which included the SH2 site. 
The experiment supported the possibility that the src was less accessible to the 
antibody, rather than that its activity or concentration was reduced after injury. 
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Figure 5.14. c-src activity by kinase assay appears reduced following 
explantation of cartilage.
~0.5g cartilage was either dissected immediately into a tube on dry ice (0), or into 
medium for 10 or 30min prior to snap freezing, or into 10mM sodium pervanadate
for 10min as a positive control. Cartilage was lysed and pre-cleared with protein G 
agarose, prior to incubation with 4μg monoclonal antibody to c-src and protein G 
agarose beads for 1h. Beads were washed, and the ability of the immunoprecipitate
to phosphorylate the substrate enolase (lower band) was assessed by [γ-32P]ATP 
kinase assay. As internal controls for the assay, further aliquots of pooled lysate from 
10min-cultured cartilage were either incubated with an irrelevant mouse IgG
monoclonal antibody and protein G agarose beads (Ig, Lane 5), or the kinase assay 
carried out without the addition of enolase, (En, Lane 7). RIPA alone instead of 
cartilage lysate was also included in the assay (L, Lane 6). This is representative of 3 
different experiments.
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Figure 5.15. The effect of dissection and culture on c-src in cartilage 
explants.
Trotters were equilibrated at 37°C. ~0.5g cartilage was dissected into serum-
free medium and cultured for increasing times prior to lysis. Lysates were pre-
cleared by incubation with protein G agarose beads for 30min. 150μl pre-
cleared lysate was then assayed for c-src by western blotting (pre-IP). The 
remaining lysate was incubated with antibody to c-src and protein G agarose. 
The immunoprecipitates were assayed for c-src by western blotting (IP c-src).
The supernatant recovered from the immunprecipitates was also assayed for c-
src content by western blotting (post-IP). The ‘pre-IP’ membrane was stripped 
and re-probed for ERK to ensure equal cellular protein loading. 2 different 
experiments are shown.
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5.4.3  The effect of PP2 on MAPK and IKK activation 
The src inhibitor PP2 had been previously noted to suppress induction of bands at 60 
and 120 kDa on 4G10 blotting (Ch 4, Fig 4.5B). Whether PP2 suppressed FAK (and 
paxillin) phosphorylation on explantation was checked. Porcine MCP joints were pre-
injected with medium plus DMSO or increasing concentrations of PP2. Cartilage was 
then dissected either onto dry ice, or into medium alone, or into medium containing 
DMSO or PP2, and cultured for 10min. Lysates were assayed for phospho-tyr 576 
FAK (the src-dependent FAK phosphorylation) and phospho-paxillin by western 
blotting. Phosphorylation of paxillin followed dissection of cartilage. 10μM PP2 
reduced this phosphorylation to baseline levels (Fig 5.16). The staining of phospho-
FAK in this experiment was disappointing (there was some batch variation in the 
antibody). However, there was suppression of FAK phosphorylation at 10 μM PP2. 
Lower concentrations of PP2 (0.1 or 1μM) did not appear to substantially reduce 
phosphorylation of either FAK or paxillin following explantation, and for this reason 
10μM PP2 was used in further experiments. Western blotting of phospho-tyr 576 
FAK or phospho-paxillin was used as an internal control for subsequent experiments 
with PP2.  
It appeared that src was required for phosphorylation of both FAK and paxillin after 
cartilage injury. Whether src activation was required for other inflammatory 
signalling such as MAPK activation following cartilage injury was investigated. 
Porcine MCPJs were injected with medium containing either DMSO or 10μM PP2. 
Cartilage was then dissected either directly into a tube on dry ice, or into medium 
with, or without, the inhibitor for 10min prior to lysis. Following 
immunoprecipitation with 4G10, eluates were assayed by western blotting.  
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Figure 5.16. PP2 suppresses phosphorylation of FAK and paxillin after 
cartilage injury.
Porcine MCP joints were injected with medium plus the vehicle (0.1% DMSO) or 
medium containing increasing concentrations of PP2, or not injected and 
equilibrated at 37°C for 1h. Then, ~0.5g cartilage was dissected either directly into 
a tube on dry ice (0), or into medium containing 0.1% DMSO or appropriate 
concentrations of the inhibitor, or into medium alone and cultured for 10min prior 
to snap freezing. Lysates were assayed for phospho-tyr 576 FAK and phospho-
paxillin by western blotting. The membrane was stripped and re-probed for ERK, 
to ensure equal cellular protein loading.  
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The induction of phosphorylation of FAK and paxillin by dissection was inhibited 
almost to baseline levels by the presence of PP2 (upper panels, Fig 5.17A). Lysates 
from the same experiment were electrophoresed and assayed for the 3 phospho-
MAPKs by western blotting. Increased phosphorylation of all 3 MAPKs was seen 
10min after dissection. In the presence of PP2, no difference was seen in the 
activation of any of the MAPKs (lower panels, Fig 5.17A). The injection of joints 
with the vehicle 0.1% DMSO in medium appeared to reduce the subsequent 
phosphorylation of ATF-2 in some experiments, as seen here. Therefore experiments 
were carried out without prior injection. Cartilage was instead dissected directly into 
the inhibitor, medium containing DMSO, or medium alone. Again, there was 
suppression of FAK and paxillin phosphorylation, but no inhibition of MAPK 
signalling in the presence of PP2 (Fig 5.17B). These experiments both suggested that 
src was not required for MAPK activation following explanation.  
Whether PP2 had any effect on IKK activity seen following cartilage injury was also 
investigated. Porcine MCPJs were injected with 10μM PP2, the vehicle 0.1% DMSO, 
or not injected and equilibrated at 37°C. Cartilage was dissected and assayed for IKK 
activity as described previously. The phosphorylation of IκBα was quantified by 
phosphorimaging and the membrane was re-probed for IKKα to check for equal 
protein loading. Activation of IKK was seen upon dissection and maximal by 5min, as 
had been shown previously (Fig 5.18 & Ch 3, Fig 3.4). The presence of PP2 or 
DMSO did not affect the activation of IKK. It was concluded that whilst src (and 
possibly FAK) were activated by explantation, they were unlikely to be responsible 
for the activation of the MAPKs and IKK. 
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10μM PP2       - +       - - - +        - -
0.1% DMSO        - - +        - - - +       -
phospho-tyr 576 FAK
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A                              B
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Figure 5.17. PP2 has no effect on the induction of MAPK signalling following 
explantation of cartilage, either with (A), or without (B), prior intra-articular
injection of inhibitor.
A. Porcine MCPJs were equilibrated at 37°C and injected with medium containing 
either the vehicle 0.1% DMSO or 10μM PP2 for the last hour, or not injected. ~0.2g 
cartilage was then dissected from each of 2 joints either directly into a tube on dry ice, 
or into medium alone, or medium containing either 0.1% DMSO or 10μM PP2 for 
10min prior to lysis. 
B. Porcine MCPJs were equilibrated at 37°C. ~0.2g cartilage was then dissected from 
each of two joints either directly into a tube on dry ice, or into medium alone, or 
medium containing either 0.1% DMSO or 10μM PP2 for 10min prior to lysis. 
For both A.& B., 4G10 immunoprecipitation was carried out from pooled lysates, and 
eluted material assayed for phospho-FAK and phospho-paxillin by western blotting 
(upper 2 panels). Lysates from the same experiment were electrophoresed and assayed 
for phospho-ATF-2, phospho-p38 MAPK, phospho-ERK and total ERK by western 
blotting (lower 4 panels).  
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Figure 5.18. Testing the effect of PP2 on IKK activation caused by 
explantation of articular cartilage.
Porcine MCPJs were equilibrated at 37°C and then injected with medium 
containing 10μM PP2 (PP2), or medium containing 0.1% DMSO 
(vehicle), or not injected (-). After 1h, ~0.2g cartilage was dissected from 
each of 2 trotters either directly into kinase assay lysis buffer (0), or into 
serum-free medium alone (-), or medium containing 10 μM PP2 (PP2), or 
into medium containing 0.1% DMSO (vehicle) and cultured for 
increasing times indicated prior to lysis. Pooled lysates were incubated 
with antibody to IKK, and the ability of the immunoprecipitates to 
phosphorylate the substrate IκBα assessed by kinase assay. Quantitation
of phosphorylation of the substrate is shown as a % of the 0 
measurement. The membrane was stripped and re-probed for IKKα to 
ensure equal immunoprecipitation of the IKK complex from samples.
This is representative of 3 experiments.  
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5.5 The effect of the FGF receptor tyrosine kinase inhibitor, 
PD173074 on MAPK and IKK signalling after cartilage 
explantation 
The tyrosine phosphorylation seen following explantation appeared to be largely src-
dependent (Ch 4, Fig 4.5B). Inhibition of the FGF receptor had previously been 
shown to cause partial suppression of paxillin phosphorylation, but FAK and general 
tyrosine phosphorylation were largely unaffected (Fig 5.9 & also Ch 4, Fig 4.5A). 
This suggested that src activity was probably independent of FGF. The FGF receptor 
inhibitor PD173074 suppressed activation of the ERK pathway after explantation (Ch 
3, Fig 3.18). The effects of this agent on the other MAPK pathways were therefore 
explored. 
In similar experiments to Fig 5.17A, trotters were equilibrated and then injected with 
medium containing 250nM FGF receptor inhibitor PD173074, or the vehicle medium 
alone, or not injected. Cartilage was then dissected and lysate was examined for the 3 
phosphorylated forms of the MAPKs, and also for phospho-Akt. The membrane was 
stripped and re-probed for ERK to ensure equal cellular protein loading. Two separate 
experiments are shown. In both cases, there was suppression of phospho-ATF-2 and 
phospho-p38 as well as phospho-ERK in the presence of the FGF receptor inhibitor 
(Fig 5.19). The results with phospho-Akt were less clear, with one experiment 
suggesting suppression, and the other being equivocal. These results were unexpected. 
They suggested that FGF signalling was at least partially responsible for the activation 
of all 3 MAPK pathways after injury, not just ERK.  
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Expt 1                                Expt 2
phospho-ATF-2
phospho-p38 MAPK
phospho-ERK
phospho-Akt
ERK
Agent used                - PD   veh - - PD   veh -
Time after dissection (min)                0       5      5     5                0       5      5     5  
Figure 5.19. The effect of PD173074 on activation of MAPK and PI3 kinase after 
explantation of articular cartilage.
Porcine MCPJs were equilibrated at 37°C and then injected with medium containing 
250nM PD173074 (PD) or medium alone (vehicle), or not injected (-). After 1h, ~0.2g 
cartilage was dissected from each of 2 trotters either directly into kinase assay lysis
buffer (0), or into serum-free medium alone (-, veh), or medium containing 250nM 
PD173074 (PD) and cultured for 5min prior to lysis. Cartilage lysates were assayed for 
phospho-ATF-2 and phospho-Akt by western blotting. The membranes were stripped 
and re-probed for phospho-p38 MAPK, phospho-ERK and ERK, the latter to check for 
equal cellular protein loading. Two separate experiments are shown.  
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In view of the unexpected apparent FGF-dependence of JNK activity, the effect of the 
FGF receptor inhibitor upon activation of IKK was investigated. Lysates from the 2 
experiments in Fig 5.19 were assayed for activity of IKK. Injection of the vehicle 
alone had little effect on IKK signalling (Fig 5.20A). Figure 5.20B shows the 
combined results. In the two experiments, the IKK activation was about 50% reduced 
by the FGF receptor inhibitor PD173074 (Fig 5.20A&B). These results suggested that 
FGF signalling was involved in the activation of all 3 MAPKs and IKK following 
cartilage injury. 
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Figure 5.20. The effect of PD173074 on IKK activity caused by dissection of 
articular cartilage.
A. Porcine MCPJs were equilibrated at 37°C and then injected with medium containing 
250nM PD173074 (PD) or medium alone (vehicle), or not injected (-). After 1h, ~0.2g 
cartilage was dissected from each of 2 trotters either directly into kinase assay lysis
buffer (0), or into serum-free medium alone (-, veh), or medium containing 250nM 
PD173074 (PD) and cultured for 5min prior to lysis. Pooled lysates were incubated 
with antibody to IKK, and the ability of the immunoprecipitates to phosphorylate the 
substrate IκBα assessed by kinase assay. Quantitation of phosphorylation of the 
substrate is shown as a % of the 5 min un-injected measurement. The membrane was 
stripped and re-probed for IKKα to ensure equal immunoprecipitation of the IKK 
complex from samples. 2 separate experiments are shown.
B. The results from the 2 experiments were pooled. The mean of IKK activity from 
5min uninjected points from individual experiments was normalised to 100%, and 
quantitation of IKK activity of other samples expressed as a % of this. The bars show 
the mean % integral and the error bar shows the standard deviation of these 
measurements. ***P=0.002 vs. untreated (-), by unpaired t-test.
***
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IKKα
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5.6 Discussion 
The identification by mass spectrometry of FAK and one of its substrates paxillin as 
proteins phosphorylated upon injury was confirmed. By using immunoprecipitation 
with 4G10 followed by western blot with either antibodies to the proteins or to their 
known phosphorylation sites, their phosphorylation was shown to be regulated by 
injury. On electrophoresis, they aligned with 2 of the areas of interest on the 4G10 
staining pattern: FAK aligned with the upper end of the 100-120 kD complex and 
paxillin aligned with the 60kD band.  
The phospho-FAK antibodies were disappointing. There was high background 
staining on western blotting and variable staining of the antigen between batches of 
antibodies. Their specificity for phosphorylated FAK was uncertain, particularly in 
the case of phospho-tyr 397 antibodies, but to test this would have meant synthesising 
the un-phosphorylated and phosphorylated forms of the antigen peptides. If only a 
small percentage of the FAK is phosphorylated on tyr 397 at any given time and the 
antibody has some affinity for the non-phosphorylated protein, a change in the FAK 
band on cell activation may not be detectable. The Pfizer FAK inhibitor did not prove 
useful in experiments with chondrocytes or cartilage. It gave variable and 
unconvincing results and had paradoxical effects at higher concentrations. This meant 
that the role of FAK in the injury response could not be investigated further 
pharmacologically.  
The identification of cortactin as a further injury-induced phosphorylation which 
accounted for the 80 kD doublet on 4G10 blotting was further evidence for src 
activation, since it is a well-characterised substrate of src family kinases: tyrs 421, 
466 and 482 on cortactin are targeted by srcs (Daly, 2004; Huang et al., 1998). 
Cortactin has also been reported to be phosphorylated by other tyrosine kinases 
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including syk and fer (Daly, 2004). The 190 kD band and the lower end of the 100-
120 kD complex were not identified. It is possible that the proteins identified may 
simply overlie other phosphoproteins of the same size. This is always a potential 
pitfall with mass spectrometric identification of proteins from 1D gels. 
It seems likely that srcs, or src-like kinases are activated following explantation. They 
play a role in regulating expression of activin A after cartilage injury. Three known 
src substrates are phosphorylated in the response, and the specific src kinase family 
inhibitor PP2 suppresses these phosphorylations. I was unable to directly show any 
activation of srcs following cartilage injury. Whilst there was no detectable change in 
src phosphorylation following injury, a change in the immunoprecipitability of src 
was found. This suggested that the protein may have been involved in interactions or 
have undergone a conformational change, masking an epitope. Such events could be 
associated with change in location or function of the enzyme in the cell. It is possible 
that other src family members such as fyn, yes or hck, which are all expressed in 
porcine chondrocytes, were involved in the increase in protein tyrosine 
phosphorylation. It would be interesting to assay their activity following cartilage 
injury. Pharmacological suppression of src signalling had no effect on the activation 
of MAPKs or IKK following explantation. This suggests that any src signalling that 
occurs is in parallel to MAPK and IKK activation. The effects of PP2 on other gene 
expression in cartilage following injury should be investigated.  
MAPK and IKK activation following explantation is suppressed by approximately 
50% by the FGF receptor inhibitor PD173074. It was known that FGF was likely to 
be responsible for ERK activation following explantation, but the effects on the other 
pathways were unexpected (Vincent et al., 2002). Growth factors such as FGF are not 
usually considered to be activators of inflammatory signalling pathways. In resting 
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cartilage explants, FGF did not activate IKK. In previous experiments on 
chondrocytes and resting explants FGF did not cause JNK phosphorylation (A. 
Didangelos, Ph.D. thesis, 2008). The fact that the inhibition was only around 50% 
suggests that either it was inefficient or there was an additional mechanism activating 
signalling which FGF-2 augmented. 
The FGF receptor inhibitor did not suppress the tyrosine phosphorylation pattern seen 
on 4G10 blotting. Thus, in general the tyrosine phosphorylation following injury 
appeared to be src-dependent, rather than FGF-dependent.  
I have illustrated the possible events that my experiments suggest follow injury in 
Figure 5.21. It is likely that some unknown event, X initiates IKK and MAPK 
activation and that this is amplified by FGF-2. The src activation appears to be largely 
independent of FGF-2 so I have shown this as being initiated by another event, Y 
(although X and Y could of course be the same). FGF-2 may contribute to the src 
activation (e.g. paxillin phosphorylation), so I have indicated the possible contribution 
with the broken line. The src inhibitor affects activin A expression, so src may be 
necessary for optimum gene expression.  
There is always a concern that pharmacological inhibitors induce non-specific effects, 
particularly at the higher concentrations used on tissue. Previous testing on 
chondrocytes suggested that PD173074 did not target other growth factor-induced 
ERK signalling (T. Vincent, Ph.D. thesis, 2002). It was designed as an FGFR1 
inhibitor (Mohammadi et al., 1998). Given the high degree of homology of FGFRs, it 
is likely that this compound has effects on other receptors in the family, although no 
systematic studies have been carried out in this regard (Ezzat et al., 2005).  
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FGF-2
IKK/MAPKsSrc
Cartilage gene response to injury
Figure 5.21. Scheme of the signalling response to cartilage injury. 
Stimuli X and Y could be the same or separate, and remain unidentified. Following 
injury, X and Y occur and cause activation of IKK, MAPKs and src family kinases. 
All of these pathways have been implicated in the net gene response to cartilage 
injury. FGF signalling contributes to 50% of IKK and MAPK signalling seen 
following injury. It is unclear if it has any effect on src. To exert this effect, FGF 
might augment signal X, or act directly on IKK and MAPKs, or in the higher 
control of these pathways.  
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To clarify the role of FGF-2 in injury-induced MAPK and IKK signalling, 
experiments could be carried out in FGF-2 null mice. In the light of my findings, 
reduction in the activation of these pathways in response to wounding of cartilage 
would be expected.  
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6 The response of synovium to injury 
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6.1 Introduction 
I wanted to find out whether the intracellular signalling caused by sharp injury was a 
response unique to articular cartilage, or whether it occurred in other connective 
tissues upon injury. Synovium is a soft vascular connective tissue which lines joints. 
It comprises a lining layer of cells classified as type A (macrophage-like) and B 
(fibrocyte-like). These rest on a loose connective tissue of variable thickness outside 
which is the joint capsule, a dense fibrous tissue. 
6.2 Signalling in synovium in response to injury 
Synovium from a porcine trotter (~0.2g) was quickly dissected from the capsule either 
directly into a tube on dry ice or into serum-free culture medium. Tissue was left in 
medium for 10min, then rapidly washed. It was lysed in RIPA buffer and western 
blotting for phospho-ATF-2, phospho-p38 MAPK and phospho-ERK was carried out. 
The membrane was re-probed with antibodies to ERK as a loading control. As in 
cartilage, the MAPKs were seen to be strongly activated in synovium by dissection 
and culture (Fig 6.1).  
Synovial lysates were examined for phosphotyrosine content by western blotting with 
the 4G10 antibody. Induction of many phosphotyrosine bands was seen in response to 
dissection (Fig 6.2A). The major features of the pattern were similar to those seen in 
the lysates of injured articular cartilage (Fig 6.2B). There was very striking increase in 
tyrosine phosphorylation of a 60 kD protein in synovium. The membrane was stripped 
and re-probed with ERK antibody. In synovium, ERK 1 appears more abundant than 
ERK 2. (The converse is true for cartilage). 
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Figure 6.1. MAPKs are activated following dissection of synovium into 
culture medium.
~0.2g synovium was dissected either into lysis buffer (0) or into serum-free 
medium and cultured for 10min prior to lysis. Western blotting of lysates for 
phospho-ATF-2, phospho-p38 MAPK and phospho-ERK was carried out. 
The membrane was stripped and re-probed for ERK to ensure equal cellular 
protein loading.
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Figure 6.2. Tyrosine phosphorylation in (A) synovium and (B) 
cartilage in response to dissection into culture medium. 
In separate experiments, ~0.1g synovium (A) or ~0.5g cartilage (B) was 
dissected from a porcine MCP joint either immediately into a tube on dry 
ice (0) or into serum-free medium and cultured for 10min prior to lysis. 
Western blotting with 4G10 antibody was carried out. The membranes 
were re-probed for ERK. A. and B. are separate experiments, but are 
aligned for comparison.
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The time course of the phosphorylation, and its possible dependence on contact of the 
tissue with culture medium was examined. Synovium was dissected either 
immediately into a tube on dry ice, or dissected into culture medium for increasing 
times, or into a dry tube for 10min prior to snap freezing, lysis and western blotting 
with 4G10 antibody. The tyrosine phosphorylation seen in synovium following 
dissection was, as in the case of cartilage, rapid and not dependent on culture medium 
(Fig 6.3A). Many bands including some at 55 kD, 60 kD, and 100 kD were seen to be 
induced in synovium following injury, whether or not culture medium was present. 
Again, these aligned with inducible bands of the same size in lysates of injured 
cartilage which were run on the same gel for comparison (Fig 6.3B). 3 times as much 
material from cartilage as synovium was loaded: the cartilage and synovial samples 
loaded thus had a similar amount of ERK, suggesting a possibly similar content of 
cellular protein was present. Tyrosine phosphorylation was far stronger in synovium 
however (Fig 6.3 shows the same exposure of the membrane for all samples).  
4G10 immunoprecipitation was employed to investigate further the protein tyrosine 
phosphorylation in synovium. The pattern of phosphotyrosine bands in synovial and 
cartilage 4G10 immunoprecipitates was very similar (Fig 6.4). 
To test whether FAK, paxillin and cortactin accounted for the phosphorylated proteins 
at 100, 60 and 80 kD, 4G10 immunoprecipitation of synovial lysates was carried out 
and eluates were western blotted with antibodies to phospho-tyr 576 FAK. The 
membrane was re-probed with phospho-paxillin antibodies and cortactin antibody. 
Dissection induced a doublet that stained with phospho-FAK antibodies which 
aligned with the top of the 100-120 kD cluster on 4G10 blotting (Fig 6.5).  
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A B
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Figure 6.3. Dissection of synovium rapidly induces tyrosine 
phosphorylation which is not dependent on contact with culture 
medium.  
A. ~0.1g synovium was dissected from each porcine MCP joint either into 
ice cold lysis buffer (0) or into culture medium for increasing times prior to
lysis, or into a dry tube for 10min at 37°C prior to lysis (10 dry).
B. Joints were opened and equilibrated at 37°C. ~0.5g cartilage was either 
dissected immediately into lysis buffer (0), or into a dry tube (10 dry) or 
culture medium (10 ex) for 10min prior to lysis, or the surface was scored 
(see Materials & Methods for details) and the trotter returned to the 
incubator for 10min, prior to dissecting the scored cartilage rapidly into 
lysis buffer (10 scr). 
For both A. & B., lysates were run on the same gel for comparison. (3 times 
as much estimated protein from cartilage as synovium was 
electrophoresed). Western blotting with 4G10 antibody was carried out. 
The membrane was re-probed with ERK as a loading control.
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Figure 6.4. A similar pattern of tyrosine-phosphorylated proteins is 
precipitated by 4G10 antibody from dissected synovium (A) and 
cartilage (B).
A.~0.2g synovium was dissected either directly into ice cold lysis buffer (0) 
or into culture medium for 10min (10) prior to lysis in RIPA. 
B. ~0.5g cartilage was dissected either directly into ice cold lysis buffer (0) 
or into culture medium for 10min (10) prior to lysis in RIPA. 
For both A. and B., lysates were incubated with 4G10 beads overnight prior 
to washing the beads 5 times in RIPA, eluting in phenyl phosphate and 
boiling the eluate with SDS sample buffer. Western blotting with 4G10 
antibody was carried out.
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Figure 6.5. Phosphorylation of FAK, paxillin and cortactin is induced 
by synovial injury.
.~0.2g synovium was dissected either directly into lysis buffer (0), or into 
medium and cultured for 10min (10), prior to lysis and 4G10 
immunoprecipitation. Beads were eluted with phenyl phosphate. Western 
blotting of eluates for phospho-tyr 576 FAK, phospho-paxillin and cortactin
was carried out.
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Strong induction of phospho-paxillin was also seen which aligned with the 60 kD 
band on 4G10 blotting. The cortactin antibody stained a doublet at 80 kD (Fig 6.5). 
This doublet also aligned with the doublet seen on 4G10 western blotting (see Fig 6.4 
for position of this doublet).  
All of this work was performed on synovium from the MCP joints of pigs, but similar 
tyrosine phosphorylation was also seen in injured cartilage and synovium from 
porcine knees (data not shown). 
6.3 Attempts at phosphoprotein identification from 
synovium 
Given that synovium is far more cellular than cartilage, and the strength of the 
phosphorylation in response to injury, this tissue seemed a promising source for 
further scale-up and mass spectrometric identification of more tyrosine-
phosphorylated proteins. It was possible that a src or src-like kinase might be found, 
and also the 190 kD protein identified (this appeared to be phosphorylated in both 
tissues). 
Conditions for 4G10 immunoprecipitation were optimised for synovium in the same 
way as had previously been shown for cartilage. Equal amounts of synovium were 
dissected into RIPA buffer and lysed for increasing times prior to clarification and 
boiling with sample buffer. These experiments suggested that a shorter lysis time for 
synovium of 90min gave optimal extraction of phosphorylated proteins (Fig 6.6). 
Optimal conditions, such as length of immunoprecipitation with 4G10 beads were 
otherwise found to be similar to those used for cartilage (data not shown, see 
Materials & Methods, Fig 2.3 for summary of 4G10 immunoprecipitation protocol for 
synovium).  
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Figure 6.6. Optimal duration of lysis for phosphotyrosine
immunoprecipitation from synovial lysates.
~0.1g synovium was dissected into culture medium for 10min prior to 
lysis in RIPA buffer, shaking at 4°C for the increasing times indicated. 
Lysis buffer was removed, clarified and western blotting of the lysates
with 4G10 antibody to assay the phosphotyrosine content was carried out.
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The phosphorylation pattern was preserved on phospho-western blotting after 
concentration of synovial eluates with the GE kit. However, the silver stain of these 
samples was dominated by many bands which were identified by mass spectrometry 
as mainly porcine immunoglobulin and albumin (data not shown). In further 
experiments, synovium was extensively washed prior to lysis. This depleted serum 
protein bands when stained with silver or Coomassie Brilliant Blue (data not shown). 
Increased pre-clearing of lysates was also carried out. Despite these measures, silver 
staining patterns of control and dissected tissue samples were indistinguishable and 
complex (Fig 6.7): no injury-dependent bands were seen. The lanes of the gels were 
sliced and analysed by mass spectrometry but no peptides were found restricted to the 
injury lane samples. There was heavy contamination with serum protein and some 
abundant cellular proteins such as actin were found when samples were concentrated. 
Given the low amounts of tyrosine-phosphorylated proteins in the samples compared 
to the non-specific contaminants, further attempts at purification from synovial 
preparations were abandoned. 
6.4 The effect of pharmacological inhibitors on intracellular 
signalling in injured synovium 
One uncertainty in testing pharmacological inhibitors on cartilage was their 
penetration into the tissue. The protein kinase inhibitors needed to be injected into the 
joint prior to dissection of cartilage. Some unpredictable effects were seen with this 
approach, such as the effect of 0.1% DMSO on phosphorylation of ATF-2 (Ch 5, Fig 
5.17, Expt 1). Because pieces of synovium were far smaller and probably more 
permeable to small molecule inhibitors than cartilage, I avoided prior injection.  
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Figure 6.7. Scale-up: attempts to identify tyrosine-phosphorylated proteins in 
injured synovium.
~1g ( 0.12g x 8 samples) of porcine synovium was dissected from the MCP joint 
either directly into tubes on dry ice (0) or into serum-free medium and cultured for 
10min (10). All samples were washed and vortexed 5 times, and then washed for a 
further 3 x 10min rotating at 4°C prior to lysis. Samples were lysed separately, 
pre-cleared with 100μl protein A agarose and 100μl protein G agarose twice for 
30min and then standard 4G10 immunoprecipitation was carried out. Phenyl 
phosphate eluates were pooled and concentrated with the clean up kit (GE) prior to 
boiling samples with SDS sample buffer. 1/6 of the concentrated material for each 
sample was electrophoresed and assayed for phosphotyrosine content by western 
blotting with 4G10 antibody (4G10). 5/6 of the concentrated material was 
electrophoresed on the same gel, the gel divided, and silver staining carried out. 
The figure shows alignment of the two pieces of gel. Bands from the silver stained 
gel were cut out, digested with trypsin overnight, and analysed by mass 
spectrometry.
Immunoglobulin
(heavy chain)
Actin
Catalase
Myosin light chain
Pyruvate dehydrogenase
Keratin
Trypsin
Albumin
Markers
(kD)
 
Chapter 6                                                                                             The response of synovium to injury 
 250
Although similar intracellular signalling pathways were activated in synovium in 
response to injury, their regulation may be different to cartilage. Experiments testing 
the effects of the same inhibitors on synovium were therefore carried out. 
It was possible that blocking src signalling in synovium would have different effects 
to those seen in cartilage. ~0.2g synovium was dissected either directly into a tube on 
dry ice, or into medium with or without 10μM PP2 for 10min prior to lysis. Lysates 
were electrophoresed and western blotting for phospho-paxillin carried out. (This was 
sometimes used alone, as a single read-out of FAK/src signalling). The induction of 
phospho-paxillin upon dissection was largely prevented by PP2, as seen previously in 
cartilage (Fig 6.8). The lysates were subsequently assayed for phospho-ATF-2, 
phospho-p38 and phospho-ERK by western blotting. PP2 had no effect on the 
induction of any of these pathways after synovial injury (Fig 6.8). The synovium 
behaved similarly to cartilage in that src (and possibly FAK) activity did not cause the 
MAPK activation seen on injury.  
The FGF receptor inhibitor reduced both MAPK and IKK signalling after explantation 
of cartilage. Cartilage contains a pool of FGF-2 in the pericellular matrix, which is 
released upon injury and contributes to cell activation (Vincent et al., 2002; Vincent et 
al., 2007). Whether synovium has extracellular FGF-2 in similar quantities and would 
respond in the same way was unknown. I therefore tested the FGF receptor inhibitor 
on the synovial tissue. In a similar way to that shown in Fig 6.8, synovium was either 
dissected into a tube on dry ice, or into medium with, or without, 250nM PD173074 
for 10min prior to lysis. Western blotting of lysates for the 3 phospho-MAPKs was 
carried out.  
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Figure 6.8. PP2 has no effect on the induction of MAPK signalling following 
dissection and culture of synovium.
~0.2g synovium was dissected either directly into a tube on dry ice (0), or into 
medium with or without 10μM PP2 for 10min prior to lysis. Lysates were 
electrophoresed and western blotting for phospho-paxillin, phospho-ATF-2, 
phospho-p38 and phospho-ERK was carried out. The membrane was stripped and 
re-probed with ERK to ensure equal cellular protein loading. This result is 
representative of 2 similar experiments.
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Induction of all 3 MAPK pathways was again seen following synovial injury, and the 
FGF receptor inhibitor did not prevent this (Fig 6.9, upper panels). On re-probing the 
membrane with ERK antibodies, it was apparent that the sample treated with 
PD173074 was somewhat overloaded in this experiment. However, the western blot 
for phospho-ERK mirrored this pattern, suggesting that the inhibitor was not reducing 
MAPK activation in this tissue. The lysates were also assayed for IKK activity. 
Phosphorylation of the substrate IκBα was increased following synovial dissection, 
showing that in addition to activation of the MAPK pathways, IKK signalling was 
also induced (Fig 6.9, lower panel). Again, the presence of the FGF receptor inhibitor 
did not affect the activation of IKK in synovium, in contrast to its effects in cartilage 
(Ch 5, Fig 5.20). This experiment needs to be repeated. 
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Figure 6.9. PD173074 has no effect on the induction of MAPK or IKK 
signalling following dissection and culture of synovium.
~0.2g synovium was dissected either directly into a tube on dry ice (0), or 
into medium with or without 250nM PD173074 for 10min prior to lysis. 
Lysates were electrophoresed and western blotting for phospho-ATF-2, 
phospho-p38 and phospho-ERK carried out. The membrane was stripped 
and re-probed with ERK (upper panels). IKK activity in the lysates was also 
measured by kinase assay (lower panel). 
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6.5 Immunolocalisation of phospho-paxillin in injured 
synovium 
The only cell type in cartilage is the chondrocyte. In contrast, there are many different 
cell types in synovium. I investigated the site of cellular activation in dissected 
synovium. For immunohistochemistry, phospho-paxillin antibodies were chosen. 
These detected a single strong band in synovial lysates at 60 kD, which aligned with 
the striking band on 4G10 staining (Figs 6.5 & 6.2). The phospho-FAK antibodies 
were unsuitable because they gave a high background. Synovium was dissected either 
immediately into formaldehyde (which had been equilibrated at 37°C to improve its 
tissue penetration), or dissected into medium with, or without, sodium pervanadate for 
10min prior to fixation in warm formaldehyde. Tissues were then embedded in 
paraffin, sectioned and immunohistochemistry carried out, with incubation of the 
sections in 1:50 phospho-paxillin antibody at room temperature for 1h (see Materials 
& Methods for details, section 2.10). 
There was little phospho-paxillin staining in ex vivo tissue (Fig 6.10). In contrast, 
synovium cultured in sodium pervanadate had small areas of strong phospho-paxillin 
staining throughout the tissue. These appeared to be small blood vessels. Synovium 
which had been dissected and left in serum-free medium alone also showed cellular 
staining with the antibodies. This was weaker than that seen with pervanadate, and 
appeared proportionate to the relative strength of staining on western blot with 
phospho-paxillin antibodies in response to these 2 stimuli (Ch 5, Fig 5.6). The 
staining was seen most clearly at x100 magnification. The phospho-paxillin staining 
on synovial injury appeared to be throughout the tissue, rather than just at the cut edge 
(see middle panels, x100 magnification). There was no staining of the sections when 
incubated with a non-immune rabbit IgG, as a control for the procedure (lower panels, 
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Fig 6.10). Sections of synovium dissected and cultured for shorter times were 
examined, but a clear temporal or spatial pattern of cell activation could not be 
defined (data not shown). 
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Figure 6.10. Immunolocalisation of phospho-paxillin in synovium after 
dissection. 
Synovium was dissected either immediately into formaldehyde (which had 
been equilibrated at 37°C), or dissected into medium alone (10) or into 
medium containing 10mM sodium pervanadate (10V) for 10min, prior to 
fixation in warm formaldehyde. Tissues were then embedded in paraffin, 
sectioned and standard immunohistochemistry protocol carried out with 
incubation of the sections with 1:50 phospho-paxillin antibody at room 
temperature for 1h. As a control, other sections were incubated with a non-
specific immunoglobulin instead (IgG control). All sections were stained 
with diaminobenzidine. Nuclei are stained blue and phospho-paxillin brown. 
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6.6 Discussion 
Connective tissues such as synovium and cartilage appear to have similar initial 
responses to injury. MAPKs, IKK and src-like signalling are induced in both tissues. 
This may represent a ubiquitous response of connective tissue to injury. It would be 
interesting to investigate whether other tissues such as skin which contain connective 
tissue elements respond in a similar manner. 
The mechanism of activation of the intracellular pathways in the two tissues showed 
one major difference. The FGF receptor inhibitor did not prevent the activation of 
MAPK signalling and IKK in synovium, whereas it caused partial suppression of 
activation of these pathways in cartilage. Synovial and cartilage extracellular matrix 
architecture is very different. It may be that there is no perlecan or FGF-2 in synovial 
matrix as there is in cartilage. These findings would support the hypothesis that 
connective tissues, and perhaps all tissues, respond to injury by activation of 
inflammatory signalling pathways, via an unknown mechanism. In the case of 
cartilage, the simultaneous release of FGF-2 from the tissue enhances the signalling. 
This secondary augmentation does not appear to occur in synovium. (It may have 
been prudent to inject the joints with inhibitor to check that this did not make a 
difference). It would be interesting to investigate this further by looking for FGF-2 in 
synovium, by ELISA of conditioned medium, or western blotting of lysates. The 
differing findings in these two tissues also suggest that the observation in cartilage is 
not simply due to toxicity or non-specific effects of the FGF receptor inhibitor on 
cells.  
The effect of inhibition of src was similar in both cartilage and synovium. This lends 
support to the findings in cartilage. These kinases appear to be activated in parallel to 
the MAPK pathways. The mechanism of their activation and the subsequent effect on 
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cartilage physiology remain unknown. They do not appear in either tissue to be 
responsible for MAPK activation. Their effects on IKK signalling in synovium were 
not assessed, but seem likely to be similar to cartilage.  
That further phospho-proteins could not be identified by preparing and 
immunoprecipitating larger quantities of synovial lysates was disappointing. 
Contamination with serum proteins was probably due to a combination of synovial 
fluid contamination and serum proteins which were present in the tissue itself. 
Depletion of serum proteins via a binding column was considered, but this would not 
have addressed contamination with other cellular proteins. These columns are also 
designed to bind human or mouse protein, and we were unsure how they would 
perform with porcine protein. Given that there were some differences in the initial 
appearance of 4G10 western blotting of synovial lysates compared with cartilage 
lysates, it was perhaps surprising that the 4G10 immunoprecipitates of the two tissues 
appeared so similar. As discussed previously in Chapter 4, it was possible that 4G10 
was not immunoprecipitating all tyrosine-phosphorylated proteins. However, even if 
further tyrosine kinases were identified via this approach, the lack of effect of PP2 on 
our pathways of interest meant that this was unlikely to identify a key pathway in the 
initiation of MAPK signalling. 
The results from the histology were interesting. It will be important to establish which 
cells in synovium are responding to injury, and this could be investigated by the use 
of specific immuno-labelling for different cell populations. It would have been 
interesting to examine the response of cartilage by immunohistochemistry. However, 
technical issues (fixed sections falling off slides, non-specific staining in frozen 
sections) prevented this. 
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Explantation of articular cartilage activates the NFκB pathway in addition to MAPKs 
and src-dependent signalling (Summary schematic, see Fig 7.1). All of these pathways 
appear to contribute to the gene response to injury. The most upstream kinase shown 
to be activated in response to injury is IKK. This is the beginning of the canonical 
NFκB pathway since the kinase assay detects the trimeric IKK complex. Further 
questions include whether or not IKKα and/or β are activated, what controls IKK 
activation and whether other pathways leading to activation of NFκB are activated by 
injury. TAK-1 is the best characterised enzyme known to activate IKK. It 
phosphorylates specific serine residues on IKKα and β (Ch 1, Fig 1.4). TAK-1 
deficient cells have severe defects of both IL-1 and TNFα induction of inflammatory 
signalling pathways (Shim et al., 2005; Sato et al. 2005). However, a preliminary 
experiment which needs to be repeated suggests that TAK-1 is not activated by 
cartilage explantation.  
If the activation of IKK is not TAK-1 dependent, the role of other MKKKs would 
need to be explored. NIK and MKKKs (MEKKs)-1,-2 and -3, when overexpressed, 
are reported to activate NFκB via IKK (Hacker and Karin, 2006; Malinin et al., 1997; 
Yang et al., 2001). However, whether they are important for in vivo activation of IKK 
is less clear. MEKK3 is required in addition to TAK-1 for TNFα-induced IKK 
activation in embryonic fibroblasts (Blonska et al., 2005; Yang et al., 2001). NIK and 
MEKK1 knockout mice do not have defects in TNF or IL-1-mediated IKK activation, 
although interestingly the latter do have abnormal wound healing (Xiao et al., 2001; 
Yujiri et al., 2000). Ultimately, the most efficient way of dissecting the higher control 
of IKK activation would be to examine the responses to injury of mouse cartilage. 
This would enable the investigation of the role of key signalling molecules by the use 
of knock-out animals. These would include the higher kinases TAK-1, NIK, and 
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MEKK1-3. Use of MyD88 and TRAF-2 deficient mice would allow us to understand 
whether TIR or TNF signalling respectively are required for the injury response (Ch 
4, Fig 1.4).  
My experimental evidence is consistent with the activation of srcs by injury. Which 
family member(s) is activated, and the mechanism by which this occurs are unknown. 
Although growth factors such as PDGF and FGF are typically thought to activate src, 
I found little evidence that FGF-2, while activating the cartilage on injury, was 
contributing significantly to src activation. The only src substrate whose 
phosphorylation was reduced by the FGFR inhibitor was paxillin. Quantitation of 
relative amounts of src family members in chondrocytes by RT-PCR could indicate 
which are likely candidates. Kinase assays for possible candidates (e.g. yes and fyn) 
could then be carried out in the same way as described for c-src. It may be that the 
apparent src activation is not due to a change in intrinsic activity following injury, but 
to interactions with other proteins affecting localisation or access to substrates within 
the cell. Although src-like activity appeared to contribute to gene induction upon 
injury, it was not responsible for IKK or MAPK activation. Whether srcs are activated 
by the same mechanism as IKK and MAPKs following injury, or by a different 
mechanism remains unclear. There is extensive and persistent tyrosine 
phosphorylation in cartilage explants following injury. It may be this continuing 
response which makes cultured cartilage behave differently from the intact articular 
surface.  
FGF-2 augments MAPK and IKK signalling following injury, and this may be a 
particular feature of cartilage. In contrast, the FGFR inhibitor had no effect on 
activation of protein kinases when synovium was injured. Thus, some other 
mechanism accounts for IKK and MAPK activation following injury. In cartilage, 
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FGF enhances this signalling by around 50%. This data was gained with the use of a 
pharmacological inhibitor. Preliminary murine experiments on MAPK signalling in 
the FGF knock-out are under way (K. Chong & T. Vincent). How, and at what level, 
FGF exerts this effect is currently a difficult question to address, given our lack of 
knowledge of control of higher signalling in this system. It is interesting that FGF is 
suppressive of IL-1-induced catabolic processes in vitro and appears to be 
chondroprotective in surgically-induced OA in the mouse and yet it promotes 
inflammatory signalling upon injury (Sawaji et al., 2008; Chia et al., 2009). These 
observations perhaps illustrate the difference in response between cultured cells or 
tissues and ex vivo/in vivo tissue. This difference has been evident throughout this 
work and should inform our approach to further studies of how resting intact tissues 
detect wounding.  
Immunolocalisation experiments in synovium suggest that a mechanical stimulus may 
somehow activate cells distant to the site of an injury. This suggests a novel signalling 
mechanism in connective tissues which is not understood. This could be explored by 
further experiments immunolocalising other signalling molecules in injured cartilage, 
synovium or other connective tissues. Such a mechanism would potentially have far-
reaching implications for our understanding of the response of tissues to injury in 
general. 
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Cartilge injury
IKK
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Fig ure 7.1. Signalling activated by cartilage injury. 
A schematic of the signalling shown to be activated by immediate injury to the 
intact articular surface. Some pathways appear to be regulated in part by the release 
of FGF-2 (e.g. MAPKs) whereas some appear to be FGF-independent (e.g. the 
phosphorylation of FAK). Blue typeface shows the pathways that the experiments 
presented in this thesis have shown to be activated by signalling after injury and the 
influence of FGF on these pathways.  
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Activin A Is an Anticatabolic Autocrine Cytokine in
Articular Cartilage Whose Production Is Controlled by
Fibroblast Growth Factor 2 and NF-B
Susan Alexander, Fiona Watt, Yasunobu Sawaji, Monika Hermansson, and Jeremy Saklatvala
Objective. Proteomic analysis has previously
shown that activin A, a member of the transforming
growth factor  family, is produced by human articular
cartilage. This study was undertaken to investigate
whether activin A affects cartilage matrix catabolism
and how its production is regulated.
Methods. The effect of exogenous activin A on
interleukin-1–induced aggrecanase-generated neo-
epitope production was assessed by Western blotting,
using medium from human cartilage explants. Levels of
activin A production were determined by enzyme-linked
immunosorbent assay. For genes of interest, messenger
RNA (mRNA) induction in cartilage explants or pri-
mary chondrocyte monolayers was assessed by reverse
transcriptase–polymerase chain reaction. Activin A ac-
tivity in cartilage explant medium was measured by
incubating it with human dermal fibroblasts and deter-
mining the increase in phospho-Smad2 by Western
blotting.
Results. Activin A (1–10 ng/ml) suppressed
aggrecanase-mediated cleavage of aggrecan in human
articular cartilage. Activin A mRNA and protein secre-
tion were induced by dissection and culture of human or
porcine articular cartilage. This activin A was bio-
logically active. Its production was due to an active
cellular process and was enhanced in osteoarthritic
(OA) tissue. Activin A production on dissection was
reduced by 80% by the fibroblast growth factor (FGF)
receptor inhibitor PD173074 and by 70% by the IKK
inhibitor BMS345541.
Conclusion. Activin A is potentially an anticata-
bolic molecule in articular cartilage. Its expression is
induced by wounding in an FGF-2– and NF-B–
dependent manner. OA cartilage produced more activin
A than did normal cartilage in vitro.
Proteomic analysis of the proteins secreted by
human articular cartilage in vitro has revealed activin A
as a potential regulatory molecule of the tissue (1).
Activin A is a member of the transforming growth factor
 (TGF) family (2,3) and is a homodimer of proteo-
lytically processed inhibin A chains. Inhibin -chains
also heterodimerize with the inhibin -chain to form
inhibins. Activins bind and activate activin receptors on
the cell surface. Inhibin binds to the receptors but does
not activate them.
There are 4 genetically different mammalian
inhibin -chains: A, B, C, and E. These potentially form
either homodimers or heterodimers, giving rise to ac-
tivins A, B, AB, and so on. Proteomic analysis of
cartilage has not revealed any inhibin -chains, suggest-
ing that activin, rather than inhibin, is the likely product
(1). Both pro–inhibin A (35-kd) and processed inhibin
A (14-kd) forms have been found, but no inhibin B or
C chains have been identified. Activins, besides binding
to cell surface receptors, also bind to follistatin or
follistatin-related protein, which act as inhibitors by
preventing binding to the receptors.
Activin was originally discovered as a molecule in
ovarian follicular fluid that caused pituitary cells in
culture to secrete follicle-stimulating hormone, while
inhibin was found to be an inhibitor of this process (2,3).
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Inhibin A–knockout mice have severe craniofacial
abnormalities, suggesting that activin A or inhibin is
important for intramembranous development of bone
(4). Activin A is produced at sites of inflammation and is
induced in cultured cells by inflammatory stimuli, such
as interleukin-1 (IL-1) or bacterial lipopolysaccharide,
and by growth factors (5). It is strongly expressed in
injured skin (6), in inflamed gastrointestinal mucosa
(7,8), and in the lung in conditions associated with
pulmonary fibrosis (9). It is also found in synovial fluid
in inflammatory arthritis (10).
Overexpression of follistatin in the basal epidermis
of the skin was found to delay wound healing in mice, while
overexpression of activin A increased the amount of gran-
ulation tissue formed and subsequent scarring, suggesting
that activins play a physiologic role in the healing process
(11). The function of activin A in inflammation is uncer-
tain. Its relationship to TGF makes it likely to be a
regulatory molecule, but its diverse effects on gene expres-
sion in different cell types are consistent with both proin-
flammatory and antiinflammatory roles (3).
The activin receptors are related to those of TGF
(12). Activins and inhibins bind to the activin type II or IIB
receptors. The type II receptors are constitutively active
serine/threonine protein kinases which, when engaged,
bind, phosphorylate, and activate the type I receptor,
activin receptor–like kinase 4 (ALK-4), which is also a
serine/threonine protein kinase. ALK-4 then phosphory-
lates the transcription factors Smad2 and Smad3. Smad2
and Smad3 are also activated by the TGF receptor. TGF
is a pleiotropic cytokine. It is immunomodulatory, chemo-
tactic for leukocytes, stimulates deposition of collagen, and
may inhibit expression of inflammatory response proteins
(13). It can reduce the IL-1–induced degradation of carti-
lage proteoglycan (14–16).
Because activin A shares a postreceptor mecha-
nism with TGF, we investigated the effect of activin A
on articular cartilage. It physiologically antagonized
aggrecanolysis stimulated by IL-1. Osteoarthritic (OA)
cartilage explants appeared to secrete more activin A
than normal tissue, so we therefore explored how this
potentially autocrine anticatabolic cytokine might act
and how its production in cartilage is controlled.
MATERIALS AND METHODS
Cartilage. Porcine articular cartilage was dissected
from the metacarpophalangeal (MCP) joints of freshly slaugh-
tered 3–6-month-old pigs obtained from a local abattoir.
Normal and OA human femoral head cartilage and OA knee
cartilage were obtained from patients at Charing Cross Hos-
pital (London, UK) who were undergoing joint replacement
surgery for either fractured femoral neck or OA. Normal knee
cartilage was obtained from patients at the Royal National
Orthopaedic Hospital (RNOH; Stanmore, Middlesex, UK)
who were undergoing surgery for tumors involving the lower
leg (not involving the knee). All human samples were used with
consent from the local ethics committees (Riverside Research
Ethics Committee and Joint RNOH/Institute of Orthopaedics
and Musculoskeletal Science Research Ethics Committee),
and written informed consent was obtained from all patients.
Human dermal fibroblasts were obtained from infant foreskin
and were used at passages 7–16.
Reagents. Fetal calf serum and Dulbecco’s modified
Eagle’s medium (DMEM) (both from BioWhittaker, Verviers,
Belgium) were supplemented with 25 mM HEPES, 1.25
units/ml penicillin, 100 g/ml streptomycin, and 2 g/ml am-
photericin B. The DuoSet enzyme-linked immunosorbent as-
say (ELISA) kit for activin A was obtained from R&D Systems
(Minneapolis, MN). Recombinant human activin A, TGF,
follistatin, and neutralizing mouse monoclonal antibodies
(mAb) to activin A and TGF were also from R&D Systems.
Rabbit polyclonal antibody to phosphorylated Smad2 was
obtained from Cell Signaling Technology (Beverly, MA), and
murine mAb to phosphorylated ERK was from Sigma (Poole,
UK). Rabbit polyclonal antibody to ERK was from Santa Cruz
Biotechnology (Santa Cruz, CA). Chondroitinase ABC and
keratanase were obtained from Seikagaku Kogyo (Tokyo,
Japan). Mouse mAb to aggrecan neoepitope ARGSV was
provided by Bruce Caterson (University of Cardiff, Cardiff,
UK). Sheep tissue inhibitor of metalloproteinases 1 (TIMP-1)
antibody was provided by Hideaki Nagase (Kennedy Institute,
London, UK), and mAb to TIMP-3 was obtained from Fuji
Chemical (Takaoka, Japan). Horseradish peroxidase (HRP)–
linked anti-mouse IgG or anti-rabbit IgG was from Dako
(Glostrup, Denmark). The electrochemiluminescence Western
blot detection system was from Amersham Biosciences (Little
Chalfont, UK).
The fibroblast growth factor receptor (FGFR) kinase
inhibitor PD173074, also called SB402451, was provided by
Stephen Skaper (GlaxoSmithKline, London, UK). U0126 was
from Promega (Madison, WI), and MG-132 was from Biomol
(Plymouth Meeting, PA). SB202190, LY294002, BMS345541,
PP1, PP2, Go¨6983, and Go¨6976 were from Calbiochem (La
Jolla, CA).
Preparation and culture of cartilage explants. Carti-
lage was dissected into DMEM (supplemented as indicated
above) and washed briefly to remove synovial fluid. Cartilage was
cut into pieces 3–4 mm3. It was then cultured at 0.5 gm/ml,
1 gm/ml, or as indicated, in DMEM for up to 20 hours.
Assay for aggrecanase-generated neoepitope. Three
pieces of cartilage were cultured in 1 well of a 48-well plate in
250 l of medium for 24 hours in the absence or presence of
IL-1 (10 ng/ml). For each assay, 3 culture wells were used (i.e.,
9 explants). The medium samples were deglycosylated at 37°C
overnight with chondroitinase ABC and keratanase in 50 mM
Tris HCl (pH 7.5), 50 mM sodium acetate, and 10 mM EDTA.
Deglycosylated proteoglycan from the medium was precipi-
tated with ice-cold acetone, air-dried, and resuspended in
sodium dodecyl sulfate (SDS) sample buffer. Samples were
loaded onto an 8% Tris–glycine gel and separated by SDS–
polyacrylamide gel electrophoresis (PAGE) under reducing
conditions. Protein was electrophoretically transferred to poly-
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vinylidene difluoride (PVDF) membrane, and aggrecan frag-
ments were detected with the BC-3 antibody to the ARGSV
neoepitope. After reaction with HRP-linked anti-mouse IgG
antibody, proteins were detected by electrochemiluminescence.
Western blotting for determination of phospho-ERK
and phospho-Smad2 content. Cartilage tissue was snap-frozen
and kept at 70°C until used. Cellular protein was extracted
with radioimmunoprecipitation assay (RIPA) buffer (20 mM
Tris HCl [pH 7.4], 150 mM NaCl, 5 mM EDTA, 1% [volume/
volume] Triton X-100, 0.1% [weight/volume] SDS, 1% [w/v]
sodium deoxycholate, 0.5% [v/v] Igepal CA-630, 1 mM phenyl-
methylsulfonyl fluoride, 10 M E64, 1 g/ml pepstatin A, and
10 g/ml aprotinin) at 4°C for 2 hours with agitation. Extracts
were clarified by centrifugation (at 13,000 revolutions per
minute for 20 minutes) and mixed with reducing SDS sample
buffer. Samples were boiled, subjected to SDS-PAGE on a
10% gel, transferred to PVDF membrane, and immuno-
stained, and proteins were visualized by electrochemilumines-
cence, all as described above. For cells, fibroblasts were lysed in
ice-cold RIPA buffer and left on ice for 10 minutes. Lysates were
scraped and aspirated from the culture surface, clarified by
centrifugation, and mixed with reducing SDS sample buffer.
Samples were boiled, subjected to SDS-PAGE on a 12.5% gel,
and immunostained for phospho-Smad2, which was visualized by
electrochemiluminescence as described above.
RNA isolation and reverse transcriptase–polymerase
chain reaction (RT-PCR). Approximately 200 mg of cartilage
was homogenized with a Polytron rotor-stator homogenizer in
3 ml of TRI Reagent (Helena Biosciences, Gateshead, UK),
then extracted with chloroform. The aqueous phase was mixed
with an equal volume of 70% (v/v) ethanol, and RNA was
extracted with the QIAamp RNA Blood Mini kit (Qiagen,
Chatsworth, CA). Total RNA (1 g) was reverse-transcribed
using Superscript II (Invitrogen, San Diego, CA). PCR was
performed using Ready-to-Go PCR beads (Amersham Bio-
sciences) with the appropriate primers. Amplified DNA was
analyzed on a 1% (w/v) agarose gel and then visualized by
ethidium bromide staining.
RT-PCR primers (MWG Biotech, Ebersberg, Ger-
many) and conditions were as follows: for ADAMTS-4, sense
5-ACCACTTTGACACAGCCATTCTG-3 and antisense 5-
ACCCCCACAGGTCCGAGAGCAG-3 (annealing at 63°C,
27 cycles); for ADAMTS-5, sense 5-TGTGCTGTGA-
TTGAAGACGAT-3 and antisense 5-GACTGCAGGAG-
CGGTGAGTGG-3 (annealing at 60°C, 24 cycles); for inhibin
A (17), sense 5-GACATCCGGACTGCCTGCGAGCAG-3
and antisense 5-GTAGCCGGACGGAGCGATTAGCCAG-
TC-3 (annealing at 65°C, 30 cycles); and for GAPDH, sense
5-CATGGAGAAGGCTGGGGCTC-3 and antisense 5-
ATGAGGTCCACCACCCTGTT-3 (annealing at 60°C, 23
cycles).
RESULTS
Physiologic antagonism of the aggrecanase-
mediated cleavage of aggrecan in articular cartilage by
activin A. Explants of normal human femoral condylar
cartilage were rested for 24 hours after dissection into
culture medium. They were then stimulated with IL-1 or
were left resting for a further 24 hours, after which the
culture medium was analyzed by Western blotting for
released aggrecan fragments containing the neoepitope
ARGSV. This sequence forms the new N-terminal se-
quence generated by aggrecanase cleavage of the major
cartilage proteoglycan aggrecan between E373 and A374.
The likely potential aggrecanases in cartilage are
ADAMTS-4 and ADAMTS-5 (18–20).
IL-1 stimulation caused the expected release of
ARGSV-bearing fragments from the cartilage (Fig-
ure 1). Inclusion of recombinant human activin A in the
Figure 1. Activin A inhibition of aggrecan cleavage in human articu-
lar cartilage stimulated with interleukin-1 (IL-1). A and B, Normal
human femoral condylar cartilage was dissected from fresh surgical
specimens from a 16-year-old girl (A) and a 51-year-old woman (B).
Explants were washed and rested overnight in serum-free Dulbecco’s
modified Eagle’s medium (DMEM), preincubated for 30 minutes in
the presence or absence of activin A, and then left untreated or treated
with 10 ng/ml IL-1 for 24 hours. Aggrecan fragments released into
conditioned medium were detected by Western blotting with the
antibody to the ARGSV neoepitope as described in Materials and
Methods. C, Confluent human chondrocytes (from a 43-year-old man)
in primary culture were serum-starved, preincubated for 30 minutes in
the presence or absence of activin A, and then left untreated or treated
with 10 ng/ml IL-1 for 4 hours. RNA was extracted and subjected to
reverse transcriptase–polymerase chain reaction for ADAMTS-4,
ADAMTS-5, and GAPDH. D, Human cartilage explants (from a
51-year-old woman) were rested overnight in serum-free DMEM,
preincubated for 30 minutes in the presence or absence of activin A,
and then left untreated or treated with 10 ng/ml IL-1 for 24 hours.
Secreted tissue inhibitor of metalloproteinases 1 (TIMP-1) and
TIMP-3 were detected by Western blotting. In experiments for
TIMP-3, heparin was added to the medium before addition of activin
A, to trap the protein.
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culture, which was added 1 hour before the addition of
IL-1, suppressed the release of the proteoglycan frag-
ment in a dose-dependent manner. The results shown
were obtained with cartilage from a 16-year-old girl
(Figure 1A) and a 51-year-old woman (Figure 1B).
Suppression occurred with 1–10 ng/ml activin A. The
steady-state levels of both ADAMTS-4 and ADAMTS-5
mRNA were increased by IL-1 stimulation of isolated
human chondrocytes, but these were unaffected by
activin A at 10 ng/ml (Figure 1C). Some suppression of
ADAMTS-5 mRNA was seen at the high concentration
of 100 ng/ml. We have been unable to detect either
ADAMTS-4 or ADAMTS-5 proteins by Western blot-
ting with a number of different antibodies.
Aggrecanases are inhibited by TIMP-3 (21). We
examined the effect of activin A on the expression of
TIMP-3 and, because of the relationship of activin A to
TGF, on the expression of TIMP-1 (22). Activin A
increased the amount of TIMP-1 in the cartilage explant
medium, while IL-1 decreased it (Figure 1D). However,
activin A did not increase the amount of TIMP-1 in the
presence of IL-1. At the mRNA level, the amount of
TIMP-1 was unaffected by IL-1 stimulation, but the
modest 2-fold increase caused by activin A (similar to
that shown for protein in Figure 1D) was prevented
(results not shown). IL-1 stimulation caused a reduction
in the amount of TIMP-3 in the medium, and this was
also unaffected by the presence of activin A (Figure 1D).
At the mRNA level, neither IL-1 nor activin A had any
consistent marked effect on the levels of TIMP-3 expres-
sion (results not shown).
Activin A induction in cartilage by dissection and
culture. The fact that activin A inhibits the aggrecanase
cleavage induced by IL-1 suggests that it could be an
autocrine anticatabolic molecule. It was therefore im-
portant to establish how the production of activin A was
controlled. Proteomic analysis showed that both large
and small forms of inhibin A chain were produced by
cartilage. These corresponded to the precursor pro–
inhibin A, and the mature processed inhibin A, which
homodimerizes to form activin A. We used ELISA to
measure the levels of production of activin A.
Articular cartilage was dissected from porcine
MCP joints into DMEM and cultured for 16 hours, and
the activin A content in the medium was determined
(Figure 2A). To establish the extent to which activin A
was newly synthesized or was preformed in the tissue,
explants were cultured with the protein synthesis inhib-
itor cycloheximide (CHX) or were rapidly frozen and
thawed 3 times upon dissection. These explants released
little detectable activin A, which suggested that the
Figure 2. A, Secretion of activin A by freshly dissected cartilage.
Porcine cartilage was dissected and cultured for 16 hours in 1 gm/ml
serum-free Dulbecco’s modified Eagle’s medium (DMEM). Some
explants were cultured with 10 g/ml cycloheximide, some were frozen
and thawed 3 times before culture, and some were left untreated.
Activin A content in medium was determined by enzyme-linked
immunosorbent assay (ELISA). Bars show the mean SD of triplicate
cultures.   P  0.0001 versus untreated cultures, by unpaired
t-test. B, Induction of inhibin A mRNA by dissection. Porcine
articular cartilage was dissected directly into ice-cold TRI Reagent and
homogenized prior to RNA extraction (0 hours), or was cultured in
serum-free DMEM for 4 hours or 20 hours before homogenization and
extraction of RNA. Reverse transcriptase–polymerase chain reaction
for determination of inhibin A and GAPDH levels was carried out as
described in Materials and Methods. C, Levels of activin A production
in normal and osteoarthritic (OA) cartilage. Human articular cartilage
was dissected from normal-appearing femoral heads of 4 patients (3
women and 1 man; mean age 83 years [range 78–86 years]) who were
undergoing surgery for femoral neck fracture (normal) or from the
joints of 8 patients (5 women and 3 men; mean age 70 years [range
54–84 years]) who were undergoing joint replacement for OA. Carti-
lage explants were cultured for 16 hours in serum-free DMEM, and
explants were then incubated for a further 5 hours in 1 gm/ml fresh
serum-free DMEM. Medium was collected, and activin A content was
determined by ELISA. Horizontal bars show the mean.   P 
0.0043 versus normal cartilage, by unpaired t-test.
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cytokine from the live explants was synthesized in the
culture. It is not possible to measure the synthesis of
activin A protein in vivo; however, inhibin A mRNA
was barely detectable in cartilage ex vivo, but was
strongly induced after dissection and culture (Figure
2B). Higher levels of mRNA were present at 4 hours
after injury than at 20 hours after injury. Thus, activin A
expression is strongly induced by the physical injury of
dissection. Interestingly, explants of human OA hip and
knee cartilage secreted more of the cytokine than did
tissue from joints with an apparently normal surface
(Figure 2C).
Production of biologically active activin A by
cartilage. It was important to show that the cartilage
protein was biologically active. It might be inactive, or its
activity might be masked by either follistatin or inhibin.
Phosphorylation of Smad2 in human skin fibroblasts was
used as an indicator of activity of the activin A in cartilage
conditioned medium. Fibroblasts were used as a readily
available human target cell. They were serum-starved, then
treated for 45 minutes with the stimulus, harvested, and
subjected to Western blotting for determination of
phospho-Smad2 content (Figure 3). Blots were also stained
for ERK to check for even loading. The strongly induced
phosphorylated band caused by adding TGF (Figure 3,
lane 2) or activin A (lane 3) was identified as phospho-
Smad2. The faint retarded band was unidentified.
The effect of activin A was prevented by prein-
cubating it with either a neutralizing antibody (Figure 3,
lane 4) or with follistatin (lane 5). Culture medium
conditioned with either human cartilage (lane 6) or
porcine cartilage (lane 9) increased the level of phos-
phorylation of Smad2 as compared with that seen in
unstimulated cells (lane 1). Both human and porcine
Figure 3. Phosphorylation of Smad2 in human fibroblasts due to the presence of activin A in medium conditioned
with live cartilage explants. Conditioned medium from both human and porcine cartilage explant cultures was
collected and diluted 1:4 with fresh Dulbecco’s modified Eagle’s medium (DMEM). These diluted medium samples
were preincubated for 2 hours alone or with either a neutralizing antibody (ab) to activin A (5 g/ml) or
recombinant follistatin (2.5 g/ml). Confluent human dermal fibroblasts were kept overnight in serum-free DMEM
and then stimulated for 45 minutes with the test samples in serum-free DMEM. Cells were washed and lysed. The
lysates were subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis and immunoblotted for
phosphorylated Smad2. Samples were also blotted for ERK protein to show even loading of the lysates. Samples
tested contained either no stimulus, 10 ng/ml transforming growth factor  (TGF), 50 ng/ml activin A, medium
conditioned with human cartilage (Hu. Med.), or medium conditioned with porcine cartilage (Porc. Med.), with or
without antibody to activin A or recombinant follistatin as indicated.
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conditioned medium induced additional fainter retarded
bands, which were unidentified. Adding the activin A
neutralizing antibody nullified the effect of both the
human (lane 7 versus lane 6) and porcine (lane 10 versus
lane 9) cartilage conditioned medium. Follistatin was
also added to cartilage conditioned medium (lanes 8 and
11), and it suppressed Smad2 phosphorylation to the
same extent as did antibody to activin A. These results
Figure 4. Dependence of activin A expression on fibroblast growth factor 2 (FGF-2). A, FGF-2 induction of
inhibin A mRNA in rested cartilage explants. Explants of porcine cartilage were rested for 24 hours in
serum-free Dulbecco’s modified Eagle’s medium (DMEM) and then left untreated or treated overnight with
20 ng/ml FGF-2. RNA was extracted and subjected to reverse transcriptase–polymerase chain reaction for
inhibin A and GAPDH. Results of 1 of 2 experiments are shown. B and C, Inhibition of activin A production
in freshly dissected porcine (B) and human (C) articular cartilage by FGF receptor inhibitor (PD173074).
Articular cartilage was dissected into 1 gm/ml of serum-free DMEM containing vehicle (darkly shaded bars) or
250 nM FGF receptor inhibitor (PD173074) (lightly shaded bars). Medium was collected and replaced with fresh
DMEM in the presence or absence of the inhibitor at the times shown, and the activin A content was measured.
Experiments were performed in triplicate; bars show the results of 1 representative experiment.
3720 ALEXANDER ET AL
Figure 5. Efficient blocking of signaling and activin A expression induced by dissection and culture of
articular cartilage, by intraarticular injection of inhibitors. Porcine metacarpophalangeal joints were
initially injected with 3 ml of serum-free Dulbecco’s modified Eagle’s medium (DMEM) containing
vehicle (veh) (0.1% DMSO), 250 nM fibroblast growth factor receptor inhibitor PD173074 (PD), 20 M
MEK-1 inhibitor U0126 (U), 10 M of IKK-2 inhibitor BMS345541 (BMS), a combination of PD173074
and BMS345541, or 10 g/ml cycloheximide (cyclo) or were left untreated (none). Following equilibra-
tion at 37°C for 2 hours, cartilage was dissected. A, Cartilage was dissected directly into ice-cold lysis
buffer or was cultured for 30 minutes in serum-free DMEM in the presence or absence of inhibitor prior
to lysis. Phospho-ERK content in cartilage lysates was determined by Western blotting. The membrane
was stripped and reprobed for determination of total ERK content. B, Cartilage was dissected into 1
gm/ml of DMEM in the presence or absence of inhibitor and cultured for 16 hours. Activin A content in
the medium was determined by enzyme-linked immunosorbent assay. Bars show the mean  SD of 8
different cultures.   P  0.0001 versus untreated cartilage (none), by unpaired t-test. C, Cartilage
was dissected directly into ice-cold TRI Reagent or was dissected and cultured for 4 hours in DMEM in
the presence or absence of inhibitor prior to homogenization of cartilage explants, RNA extraction, and
reverse transcriptase–polymerase chain reaction for determination of inhibin A and GAPDH levels.
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show that the activin A produced by cartilage was active
and accounted for essentially all Smad2 phosphorylation
caused by the conditioned medium.
Factors regulating the production of activin A by
articular cartilage. Having shown that activin A is
synthesized by injured cartilage, is biologically active,
and accounts for the TGF-like activity produced by
tissue in culture, we investigated factors regulating its
synthesis. We have previously shown that wounding or
dissecting articular cartilage causes the release of FGF-2
from a pericellular pool where it is sequestered by
perlecan (23,24). The release causes prolonged chondro-
cyte activation, as judged by stimulation of ERK (23).
Dissection also rapidly activates inflammatory signaling
pathways. There is strong activation of JNK and p38
MAPK and degradation of IB (25). The signaling upon
injury is sufficient to induce the expression of inflamma-
tory response genes. The mechanism of activation of
inflammatory signaling is unknown. FGF-2 release ex-
plains the prolonged ERK activation, but FGF-2 does
not activate JNK or NF-B in cartilage. It is likely that
activin A production was dependent on the chondrocyte
activation caused by dissection.
FGF-2 added to porcine explants adapted to
culture induced activin A mRNA (Figure 4A). We
therefore first assessed the role of FGF-2 in activin A
production caused by dissection and culture by using the
compound PD173074, an inhibitor of the FGFR tyrosine
kinase. This agent is selective for FGFR but also exerts
some activity against the platelet-derived growth factor
receptor (23,26). Figure 4B shows the results of an
experiment conducted with porcine cartilage. Medium
was removed from freshly dissected tissue at the indi-
cated times and replaced with fresh serum-free DMEM.
Activin A content in medium samples harvested at
different time points was determined. Production of
activin A peaked between 8 and 16 hours and declined
thereafter. When cartilage was dissected into medium
containing PD173074, activin A synthesis was inhibited
60% (Figure 4B). A similar experiment was carried
out with human femoral head cartilage, and activin A
production was inhibited to a similar degree (Figure
4C).
Activation of signaling caused by dissection of
cartilage is very rapid, and we have found that to achieve
maximal inhibition of signaling with pharmacologic
agents, it is better to not only dissect the cartilage into a
solution containing the inhibitor, but also to first inject
the inhibitor into the joint so that it distributes through
the cartilage before the tissue is injured. To test the
effect of the FGFR inhibitor on the activation of chon-
drocytes caused when cartilage is dissected, we injected
it into porcine MCP joints. After 2 hours the joints were
opened, and the articular cartilage was dissected into
DMEM containing the inhibitor. The explants were
either lysed immediately or after 30 minutes and were
Western blotted for determination of phospho-ERK and
total ERK protein content (Figure 5A).
The explants left for 30 minutes after dissection
showed, as expected, strong phosphorylation of ERK
when compared with those lysed immediately. This
activation was unaffected by the presence of vehicle, but
was nearly completely prevented by the presence of
PD173074 (Figure 5A). A similarly effective inhibition
of ERK activation was seen when U0126, an inhibitor of
MEK-1, was used (Figure 5A). Figure 5B shows that
when PD173074 was injected before dissection, activin A
production was inhibited over 80%. Taken together, the
results of these pharmacologic experiments strongly
suggested that activin A production was highly depen-
dent on FGF-2.
It was likely that other signaling pathways acti-
vated by injury also contributed to the change in expres-
sion of the cytokine. One candidate is the pathway
leading to the activation of NF-B. Performing the
dissection in the presence of the IKK inhibitor
BMS345541 reduced the production of activin A by
about 70% (Figure 5B). Another way of inhibiting
Table 1. Summary of the effects of signaling pathway inhibitors on
the production of activin A caused by dissection and culture*
Inhibitor (concentration tested)/target
% inhibition,
mean (range)
BMS345541 (10 M)/IKK 71 (63–78)
MG-132 (10 M)/proteasome 49 (28–70)
SB202190 (20 M)/p38 MAPK 17 (2–33)
PD173074 (250 nM)/FGFR 82 (79–84)
U0126 (10 M)/MEK-1 51 (34–66)
LY294002 (10 M)/PI 3-kinase 12
Go¨6983/Go¨6976 (100 nM)/PKC 0
PP2 (10 M)/Src family kinases 60 (52–66)
PP1 (10 M)/Src family kinases 51
* Intact porcine metacarpophalangeal joints were injected with 3 ml of
serum-free Dulbecco’s modified Eagle’s medium (DMEM) plus 10
g/ml cycloheximide, the given inhibitor, or the vehicle (serum-free
DMEM plus 0.1% DMSO) or were left untreated and equilibrated at
37°C for 2 hours. Joints were then opened and cartilage was dissected
into 1 gm/ml of DMEM in the presence or absence of inhibitor and
cultured for 16 hours. Activin A content in medium was determined by
enzyme-linked immunosorbent assay. Each experiment was performed
with quadruplicate cultures for each condition. Mean activin A pro-
duction (ng/ml) was measured in the presence and absence of each
inhibitor, and the percentage inhibition was calculated. The range
shows minimum and maximum percentage inhibition where 1 exper-
iment was performed. FGFR  fibroblast growth factor receptor;
PI 3-kinase  phosphatidylinositol 3-kinase; PKC  protein kinase C.
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activation of NF-B is to use proteasome inhibitors,
which prevent the degradation of phosphorylated IB.
MG-132, a widely used inhibitor, also reduced activin A
production (Table 1). Combining the IKK inhibitor with
the FGFR inhibitor did not have a significantly greater
effect than either agent alone (Figure 5B).
To achieve maximal inhibition, we used CHX in
the experiment, which reduced activin A production by
more than 90% (Figure 5B). Since NF-B is antiapop-
totic, we were concerned that the reduction in activin A
production caused by inhibitors of NF-B activation
over a period of 20 hours was due to cell death.
However, inhibition of inhibin A mRNA was seen at an
early time point (4 hours) after dissection with each
inhibitor alone and in combination (Figure 5C). The p38
MAPK inhibitor SB202190 was also tested but had no
significant effect on activin A production under these
conditions (Table 1). We were unable to block JNK
signaling pharmacologically in cartilage, so its contribu-
tion could not be determined. These results suggest that
the burst of activin A production after dissection and
culture, which peaks between 8 and 16 hours, is depen-
dent on both FGF-2 and NF-B.
Stimulation of FGFR activates several signaling
pathways. In addition to the ERK MAPK pathway
(which is probably Ras-dependent), protein kinase C
(PKC), phosphatidylinositol 3-kinase (PI 3-kinase), and
Src family kinases are all likely to be activated. The
effects of inhibitors of these pathways were tested (Table
1). LY294002, a PI 3-kinase inhibitor, and PKC inhibi-
tors had no effect on activin A production. However,
both the MEK-1 inhibitor U0126 and the Src family
kinase inhibitors PP1 and PP2 caused inhibition (Figure
5B and Table 1). It is therefore likely that the ERK
pathway and Src family kinases are important for the
effect of FGF-2.
DISCUSSION
The results of the present study showed that a
function of activin A in cartilage may be to oppose
cartilage-catabolizing stimuli such as IL-1. This means it
is potentially an autocrine anticatabolic cytokine and
might limit cartilage degradation in inflammation. The
mechanism of action is unclear, since activin A did not
regulate mRNA for the known IL-1–inducible aggre-
canases ADAMTS-4 and ADAMTS-5. It also did not
alter the amounts of TIMP-3 mRNA or protein in the
medium. Activin A modestly increased TIMP-1 produc-
tion, but this was not seen when IL-1 was present
(TIMP-1 is only a weak inhibitor of aggrecanases).
Investigation of the mechanism of action of activin A
was hampered by our inability to detect the aggre-
canases in cartilage cultures by Western blotting.
It was surprising that activin A accounted for
virtually all of the active material that activated Smad2
in the culture medium from human OA and porcine
cartilage. However, we did not acidify the medium in
order to release TGF from its latency peptide, to which
it may be bound. A study published in 1991 showed that
calf articular cartilage produced TGF and sequestered
it in the extracellular matrix (27), and several other
studies have demonstrated the expression of TGF
mRNA and activity by cultured chondrocytes (28–31). In
light of the findings of the present study, the relative
importance of TGF and activin A as potentially chon-
droprotective proteins endogenous to articular cartilage
needs to be investigated.
Activin A was clearly induced by wounding the
cartilage and could provide a homeostatic mechanism to
limit damage to the extracellular matrix. Production of
the cytokine was dependent partly on FGF-2 and partly
on inflammatory signaling, since it was markedly re-
duced by the FGFR inhibitor, the IKK inhibitor, and the
proteasome inhibitor. In the context of inflammatory
signaling, FGF-2 therefore appears to enhance the in-
duction of the gene. Since FGF-2 is a normal pericellular
constituent and activates chondrocytes upon physiologic
loading (24,32), the question arises as to whether FGF-2
is a sufficient stimulus, and whether activin A is pro-
duced in the absence of inflammatory stress and exerts a
chondroprotective action normally in the tissue.
Activin A mRNA was detectable in the cartilage
ex vivo, and when we used FGF-2 to treat explants that
had been adapted to culture, we saw an increase in
mRNA. This suggests that FGF-2 is a sufficient stimulus
for activin A expression. However, we were not able to
detect a significant increase in secreted activin A from
these explants. This was puzzling, but the explants were
spontaneously secreting some activin A all the time, and
the amount that is continuously removed by the cells is
unknown. In previous studies using isolated chondro-
cytes (1) or fibroblasts (5), FGF-2 was shown to be a
sufficient stimulus for activin A production.
The in vitro experiments undertaken in the
present study should be interpreted with caution, but it
is likely that activin A is produced at a low level
normally, and not solely after wounding or injury. How-
ever, further experiments are needed to determine
whether activin A functions in the tissue under normal,
as well as stressful, conditions. It is difficult in these
experiments to separate the effects of dissection from
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the effects of tissue culture. OA cartilage explants
secreted more of the cytokine than did normal tissue; to
what extent this reflects increased production in vivo,
perhaps as an attempt to reduce aggrecanolysis, or
represents a change in responsiveness of the tissue to the
insult of dissection and culture is not known.
We have only examined the expression and re-
sponse of one component of the activin/inhibin system to
cartilage injury. Inhibin -chains and follistatin may be
produced, and their expression might also be altered by,
injury. Interestingly, follistatin mRNA expression is in-
creased in OA cartilage (33), and if this is reflected at the
protein level, there should be a reduction in activin activity.
It is possible to draw some tentative conclusions
regarding the intracellular signaling pathways control-
ling activin A production in cartilage. Activin A produc-
tion was dependent on NF-B, as evidenced by the
reduced production caused by both the IKK and protea-
some inhibitors. With regard to other inflammatory
pathways, blocking p38 MAPK had no effect, and we
were unable to block JNK specifically in cartilage with
the available agents. FGF-2 strongly activates ERK in
cartilage, and the inhibitor of activation of MEK-1,
which blocks the activation of ERK, had an effect
comparable with that of the inhibitor of FGFR itself.
FGF-2 would be expected to activate PKC and PI
3-kinase, but these did not appear to be necessary for
activin A induction. The Src family kinase inhibitors
reduced activin A production; therefore, FGF-2 controls
activin A expression via ERK and possibly Src.
It should be stressed that although wounding the
cartilage rapidly activates inflammatory signaling and
causes instantaneous release of FGF-2, the mechanism
of these phenomena is unknown. FGF-2 alone does not
activate inflammatory signaling (NF-B and JNK), and
we have not been able to identify any soluble material
released from the injured tissue as a stimulus of the
inflammatory activation.
The possibility that articular cartilage acts via
endogenous anticatabolic mechanisms has implications
for the pathogenesis and treatment of OA. The disease
is generally thought to result from matrix destruction
due to production of proteinases caused by a cryptic
stimulus. However, if there are endogenous anticata-
bolic mechanisms, and activin A may represent one,
then failure of these could lead to an imbalance
between catabolism and anabolism, resulting in exces-
sive aggrecan degradation. By the same logic, therapy
could be directed at boosting endogenous protective
mechanisms.
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